id	sid	tid	token	lemma	pos
aiua-10886	1	1	stesura	stesura	PROPN
aiua-10886	1	2	seveso	seveso	PROPN
aiua-10886	1	3	archivio	archivio	PROPN
aiua-10886	1	4	italiano	italiano	X
aiua-10886	1	5	di	di	X
aiua-10886	1	6	urologia	urologia	PROPN
aiua-10886	1	7	e	e	PROPN
aiua-10886	1	8	andrologia	andrologia	PROPN
aiua-10886	1	9	2022	2022	NUM
aiua-10886	1	10	;	;	PUNCT
aiua-10886	1	11	94	94	NUM
aiua-10886	1	12	,	,	PUNCT
aiua-10886	1	13	4390	4390	NUM
aiua-10886	1	14	original	original	ADJ
aiua-10886	1	15	paper	paper	NOUN
aiua-10886	1	16	no	no	DET
aiua-10886	1	17	conflict	conflict	NOUN
aiua-10886	1	18	of	of	ADP
aiua-10886	1	19	interest	interest	NOUN
aiua-10886	1	20	declared	declare	VERB
aiua-10886	1	21	.	.	PUNCT
aiua-10886	2	1	introduction	introduction	NOUN
aiua-10886	2	2	prostate	prostate	NOUN
aiua-10886	2	3	cancer	cancer	NOUN
aiua-10886	2	4	(	(	PUNCT
aiua-10886	2	5	pca	pca	PROPN
aiua-10886	2	6	)	)	PUNCT
aiua-10886	2	7	represents	represent	VERB
aiua-10886	2	8	a	a	DET
aiua-10886	2	9	major	major	ADJ
aiua-10886	2	10	health	health	NOUN
aiua-10886	2	11	problem	problem	NOUN
aiua-10886	2	12	as	as	SCONJ
aiua-10886	2	13	it	it	PRON
aiua-10886	2	14	is	be	AUX
aiua-10886	2	15	the	the	DET
aiua-10886	2	16	second	second	ADJ
aiua-10886	2	17	most	most	ADV
aiua-10886	2	18	commonly	commonly	ADV
aiua-10886	2	19	diagnosed	diagnose	VERB
aiua-10886	2	20	malignancy	malignancy	NOUN
aiua-10886	2	21	among	among	ADP
aiua-10886	2	22	males	male	NOUN
aiua-10886	2	23	leading	lead	VERB
aiua-10886	2	24	to	to	ADP
aiua-10886	2	25	severe	severe	ADJ
aiua-10886	2	26	morbidity	morbidity	NOUN
aiua-10886	2	27	and	and	CCONJ
aiua-10886	2	28	mortality	mortality	NOUN
aiua-10886	2	29	(	(	PUNCT
aiua-10886	2	30	1	1	NUM
aiua-10886	2	31	)	)	PUNCT
aiua-10886	2	32	.	.	PUNCT
aiua-10886	3	1	pca	pca	PROPN
aiua-10886	3	2	presents	present	VERB
aiua-10886	3	3	a	a	DET
aiua-10886	3	4	wide	wide	ADJ
aiua-10886	3	5	variety	variety	NOUN
aiua-10886	3	6	of	of	ADP
aiua-10886	3	7	clinical	clinical	ADJ
aiua-10886	3	8	behavior	behavior	NOUN
aiua-10886	3	9	ranging	range	VERB
aiua-10886	3	10	from	from	ADP
aiua-10886	3	11	tumors	tumor	NOUN
aiua-10886	3	12	of	of	ADP
aiua-10886	3	13	low	low	ADJ
aiua-10886	3	14	metastatic	metastatic	ADJ
aiua-10886	3	15	potential	potential	NOUN
aiua-10886	3	16	to	to	ADP
aiua-10886	3	17	highly	highly	ADV
aiua-10886	3	18	aggressive	aggressive	ADJ
aiua-10886	3	19	tumors	tumor	NOUN
aiua-10886	3	20	characterized	characterize	VERB
aiua-10886	3	21	by	by	ADP
aiua-10886	3	22	a	a	DET
aiua-10886	3	23	high	high	ADJ
aiua-10886	3	24	risk	risk	NOUN
aiua-10886	3	25	of	of	ADP
aiua-10886	3	26	biochemical	biochemical	ADJ
aiua-10886	3	27	failure	failure	NOUN
aiua-10886	3	28	and	and	CCONJ
aiua-10886	3	29	metastasis	metastasis	NOUN
aiua-10886	3	30	development	development	NOUN
aiua-10886	3	31	after	after	ADP
aiua-10886	3	32	initial	initial	ADJ
aiua-10886	3	33	treatment	treatment	NOUN
aiua-10886	3	34	(	(	PUNCT
aiua-10886	3	35	2	2	NUM
aiua-10886	3	36	)	)	PUNCT
aiua-10886	3	37	.	.	PUNCT
aiua-10886	4	1	as	as	SCONJ
aiua-10886	4	2	several	several	ADJ
aiua-10886	4	3	molecular	molecular	ADJ
aiua-10886	4	4	pathways	pathway	NOUN
aiua-10886	4	5	and	and	CCONJ
aiua-10886	4	6	oncogenes	oncogene	NOUN
aiua-10886	4	7	are	be	AUX
aiua-10886	4	8	involved	involve	VERB
aiua-10886	4	9	in	in	ADP
aiua-10886	4	10	pca	pca	NOUN
aiua-10886	4	11	progression	progression	NOUN
aiua-10886	4	12	to	to	ADP
aiua-10886	4	13	lethal	lethal	ADJ
aiua-10886	4	14	disease	disease	NOUN
aiua-10886	4	15	,	,	PUNCT
aiua-10886	4	16	understanding	understand	VERB
aiua-10886	4	17	the	the	DET
aiua-10886	4	18	genetic	genetic	ADJ
aiua-10886	4	19	and	and	CCONJ
aiua-10886	4	20	molecular	molecular	ADJ
aiua-10886	4	21	differences	difference	NOUN
aiua-10886	4	22	separating	separate	VERB
aiua-10886	4	23	indolent	indolent	ADJ
aiua-10886	4	24	from	from	ADP
aiua-10886	4	25	highly	highly	ADV
aiua-10886	4	26	aggressive	aggressive	ADJ
aiua-10886	4	27	tumors	tumor	NOUN
aiua-10886	4	28	is	be	AUX
aiua-10886	4	29	the	the	DET
aiua-10886	4	30	cornerstone	cornerstone	NOUN
aiua-10886	4	31	of	of	ADP
aiua-10886	4	32	risk	risk	NOUN
aiua-10886	4	33	stratification	stratification	NOUN
aiua-10886	4	34	and	and	CCONJ
aiua-10886	4	35	selection	selection	NOUN
aiua-10886	4	36	of	of	ADP
aiua-10886	4	37	best	good	ADJ
aiua-10886	4	38	treatment	treatment	NOUN
aiua-10886	4	39	available	available	ADJ
aiua-10886	4	40	.	.	PUNCT
aiua-10886	5	1	the	the	DET
aiua-10886	5	2	pi3	pi3	NOUN
aiua-10886	5	3	-	-	PUNCT
aiua-10886	5	4	k	k	NOUN
aiua-10886	5	5	-	-	NOUN
aiua-10886	5	6	akt	akt	NOUN
aiua-10886	5	7	molecular	molecular	ADJ
aiua-10886	5	8	pathway	pathway	NOUN
aiua-10886	5	9	,	,	PUNCT
aiua-10886	5	10	found	find	VERB
aiua-10886	5	11	to	to	PART
aiua-10886	5	12	be	be	AUX
aiua-10886	5	13	upregulated	upregulate	VERB
aiua-10886	5	14	in	in	ADP
aiua-10886	5	15	30	30	NUM
aiua-10886	5	16	-	-	SYM
aiua-10886	5	17	50	50	NUM
aiua-10886	5	18	%	%	NOUN
aiua-10886	5	19	of	of	ADP
aiua-10886	5	20	pca	pca	NOUN
aiua-10886	5	21	patients	patient	NOUN
aiua-10886	5	22	,	,	PUNCT
aiua-10886	5	23	regulates	regulate	VERB
aiua-10886	5	24	a	a	DET
aiua-10886	5	25	variety	variety	NOUN
aiua-10886	5	26	of	of	ADP
aiua-10886	5	27	cellular	cellular	ADJ
aiua-10886	5	28	function	function	NOUN
aiua-10886	5	29	including	include	VERB
aiua-10886	5	30	cell	cell	NOUN
aiua-10886	5	31	survival	survival	NOUN
aiua-10886	5	32	and	and	CCONJ
aiua-10886	5	33	proliferation	proliferation	NOUN
aiua-10886	5	34	,	,	PUNCT
aiua-10886	5	35	cell	cell	NOUN
aiua-10886	5	36	growth	growth	NOUN
aiua-10886	5	37	and	and	CCONJ
aiua-10886	5	38	differentiation	differentiation	NOUN
aiua-10886	5	39	and	and	CCONJ
aiua-10886	5	40	cell	cell	NOUN
aiua-10886	5	41	cycle	cycle	NOUN
aiua-10886	5	42	progression	progression	NOUN
aiua-10886	5	43	and	and	CCONJ
aiua-10886	5	44	metabolism	metabolism	NOUN
aiua-10886	5	45	(	(	PUNCT
aiua-10886	5	46	3	3	NUM
aiua-10886	5	47	)	)	PUNCT
aiua-10886	5	48	.	.	PUNCT
aiua-10886	6	1	the	the	DET
aiua-10886	6	2	phosphate	phosphate	NOUN
aiua-10886	6	3	and	and	CCONJ
aiua-10886	6	4	tensin	tensin	PROPN
aiua-10886	6	5	homolog	homolog	PROPN
aiua-10886	6	6	gene	gene	NOUN
aiua-10886	6	7	(	(	PUNCT
aiua-10886	6	8	pten	pten	NOUN
aiua-10886	6	9	)	)	PUNCT
aiua-10886	6	10	,	,	PUNCT
aiua-10886	6	11	a	a	DET
aiua-10886	6	12	tumor	tumor	NOUN
aiua-10886	6	13	suppressor	suppressor	NOUN
aiua-10886	6	14	gene	gene	NOUN
aiua-10886	6	15	located	locate	VERB
aiua-10886	6	16	on	on	ADP
aiua-10886	6	17	chromosome	chromosome	NOUN
aiua-10886	6	18	10q23.3	10q23.3	NUM
aiua-10886	6	19	,	,	PUNCT
aiua-10886	6	20	is	be	AUX
aiua-10886	6	21	quite	quite	ADV
aiua-10886	6	22	frequently	frequently	ADV
aiua-10886	6	23	mutated	mutate	VERB
aiua-10886	6	24	in	in	ADP
aiua-10886	6	25	pca	pca	NOUN
aiua-10886	6	26	patients	patient	NOUN
aiua-10886	6	27	and	and	CCONJ
aiua-10886	6	28	acts	act	VERB
aiua-10886	6	29	as	as	ADP
aiua-10886	6	30	a	a	DET
aiua-10886	6	31	regulator	regulator	NOUN
aiua-10886	6	32	of	of	ADP
aiua-10886	6	33	pi3	pi3	NOUN
aiua-10886	6	34	-	-	PUNCT
aiua-10886	6	35	k	k	NOUN
aiua-10886	6	36	-	-	NOUN
aiua-10886	6	37	akt	akt	NOUN
aiua-10886	6	38	molecular	molecular	ADJ
aiua-10886	6	39	pathway	pathway	NOUN
aiua-10886	6	40	(	(	PUNCT
aiua-10886	6	41	4	4	NUM
aiua-10886	6	42	)	)	PUNCT
aiua-10886	6	43	.	.	PUNCT
aiua-10886	7	1	erg	erg	PROPN
aiua-10886	7	2	oncogene	oncogene	NOUN
aiua-10886	7	3	(	(	PUNCT
aiua-10886	7	4	ets	et	NOUN
aiua-10886	7	5	related	relate	VERB
aiua-10886	7	6	gene	gene	NOUN
aiua-10886	7	7	)	)	PUNCT
aiua-10886	7	8	is	be	AUX
aiua-10886	7	9	a	a	DET
aiua-10886	7	10	member	member	NOUN
aiua-10886	7	11	of	of	ADP
aiua-10886	7	12	the	the	DET
aiua-10886	7	13	ets	ets	PROPN
aiua-10886	7	14	gene	gene	NOUN
aiua-10886	7	15	family	family	NOUN
aiua-10886	7	16	located	locate	VERB
aiua-10886	7	17	in	in	ADP
aiua-10886	7	18	chromosome	chromosome	NOUN
aiua-10886	7	19	21q22.2	21q22.2	NUM
aiua-10886	7	20	(	(	PUNCT
aiua-10886	7	21	5	5	NUM
aiua-10886	7	22	)	)	PUNCT
aiua-10886	7	23	.	.	PUNCT
aiua-10886	8	1	in	in	ADP
aiua-10886	8	2	50	50	NUM
aiua-10886	8	3	%	%	NOUN
aiua-10886	8	4	of	of	ADP
aiua-10886	8	5	pca	pca	NOUN
aiua-10886	8	6	patients	patient	NOUN
aiua-10886	8	7	erg	erg	INTJ
aiua-10886	8	8	is	be	AUX
aiua-10886	8	9	involved	involve	VERB
aiua-10886	8	10	as	as	ADP
aiua-10886	8	11	a	a	DET
aiua-10886	8	12	fusion	fusion	NOUN
aiua-10886	8	13	protein	protein	NOUN
aiua-10886	8	14	with	with	ADP
aiua-10886	8	15	transmembrane	transmembrane	ADJ
aiua-10886	8	16	protease	protease	NOUN
aiua-10886	8	17	,	,	PUNCT
aiua-10886	8	18	serine	serine	NOUN
aiua-10886	8	19	2	2	NUM
aiua-10886	8	20	(	(	PUNCT
aiua-10886	8	21	tmprss2	tmprss2	ADV
aiua-10886	8	22	)	)	PUNCT
aiua-10886	8	23	,	,	PUNCT
aiua-10886	8	24	a	a	DET
aiua-10886	8	25	protein	protein	NOUN
aiua-10886	8	26	encoded	encode	VERB
aiua-10886	8	27	by	by	ADP
aiua-10886	8	28	tmprss2	tmprss2	ADP
aiua-10886	8	29	gene	gene	NOUN
aiua-10886	8	30	located	locate	VERB
aiua-10886	8	31	in	in	ADP
aiua-10886	8	32	21q22.3	21q22.3	NUM
aiua-10886	8	33	(	(	PUNCT
aiua-10886	8	34	6	6	NUM
aiua-10886	8	35	)	)	PUNCT
aiua-10886	8	36	.	.	PUNCT
aiua-10886	9	1	although	although	SCONJ
aiua-10886	9	2	ets	et	NOUN
aiua-10886	9	3	fusion	fusion	NOUN
aiua-10886	9	4	is	be	AUX
aiua-10886	9	5	encountered	encounter	VERB
aiua-10886	9	6	early	early	ADV
aiua-10886	9	7	in	in	ADP
aiua-10886	9	8	the	the	DET
aiua-10886	9	9	carcinogenesis	carcinogenesis	NOUN
aiua-10886	9	10	process	process	NOUN
aiua-10886	9	11	,	,	PUNCT
aiua-10886	9	12	the	the	DET
aiua-10886	9	13	presence	presence	NOUN
aiua-10886	9	14	of	of	ADP
aiua-10886	9	15	the	the	DET
aiua-10886	9	16	fusion	fusion	NOUN
aiua-10886	9	17	protein	protein	NOUN
aiua-10886	9	18	is	be	AUX
aiua-10886	9	19	also	also	ADV
aiua-10886	9	20	associated	associate	VERB
aiua-10886	9	21	with	with	ADP
aiua-10886	9	22	poorly	poorly	ADV
aiua-10886	9	23	differentiated	differentiated	ADJ
aiua-10886	9	24	tumors	tumor	NOUN
aiua-10886	9	25	,	,	PUNCT
aiua-10886	9	26	higher	high	ADJ
aiua-10886	9	27	stage	stage	NOUN
aiua-10886	9	28	disease	disease	NOUN
aiua-10886	9	29	as	as	ADV
aiua-10886	9	30	well	well	ADV
aiua-10886	9	31	as	as	ADP
aiua-10886	9	32	lymph	lymph	NOUN
aiua-10886	9	33	node	node	NOUN
aiua-10886	9	34	involvement	involvement	NOUN
aiua-10886	9	35	(	(	PUNCT
aiua-10886	9	36	7	7	NUM
aiua-10886	9	37	)	)	PUNCT
aiua-10886	9	38	.	.	PUNCT
aiua-10886	10	1	as	as	ADV
aiua-10886	10	2	far	far	ADV
aiua-10886	10	3	as	as	SCONJ
aiua-10886	10	4	it	it	PRON
aiua-10886	10	5	concerns	concern	VERB
aiua-10886	10	6	the	the	DET
aiua-10886	10	7	clinical	clinical	ADJ
aiua-10886	10	8	impact	impact	NOUN
aiua-10886	10	9	of	of	ADP
aiua-10886	10	10	pten	pten	ADJ
aiua-10886	10	11	loss	loss	NOUN
aiua-10886	10	12	combined	combine	VERB
aiua-10886	10	13	with	with	ADP
aiua-10886	10	14	the	the	DET
aiua-10886	10	15	presence	presence	NOUN
aiua-10886	10	16	of	of	ADP
aiua-10886	10	17	ets	et	NOUN
aiua-10886	10	18	fusion	fusion	NOUN
aiua-10886	10	19	protein	protein	NOUN
aiua-10886	10	20	,	,	PUNCT
aiua-10886	10	21	both	both	CCONJ
aiua-10886	10	22	preclinical	preclinical	ADJ
aiua-10886	10	23	and	and	CCONJ
aiua-10886	10	24	clinical	clinical	ADJ
aiua-10886	10	25	studies	study	NOUN
aiua-10886	10	26	suggest	suggest	VERB
aiua-10886	10	27	that	that	SCONJ
aiua-10886	10	28	the	the	DET
aiua-10886	10	29	co	co	NOUN
aiua-10886	10	30	-	-	NOUN
aiua-10886	10	31	existence	existence	NOUN
aiua-10886	10	32	of	of	ADP
aiua-10886	10	33	these	these	DET
aiua-10886	10	34	aberrations	aberration	NOUN
aiua-10886	10	35	may	may	AUX
aiua-10886	10	36	be	be	AUX
aiua-10886	10	37	indicative	indicative	ADJ
aiua-10886	10	38	of	of	ADP
aiua-10886	10	39	poor	poor	ADJ
aiua-10886	10	40	prognosis	prognosis	NOUN
aiua-10886	10	41	(	(	PUNCT
aiua-10886	10	42	8)	8)	NUM
aiua-10886	10	43	.	.	PUNCT
aiua-10886	11	1	the	the	DET
aiua-10886	11	2	aim	aim	NOUN
aiua-10886	11	3	of	of	ADP
aiua-10886	11	4	this	this	DET
aiua-10886	11	5	study	study	NOUN
aiua-10886	11	6	is	be	AUX
aiua-10886	11	7	to	to	PART
aiua-10886	11	8	evaluate	evaluate	VERB
aiua-10886	11	9	the	the	DET
aiua-10886	11	10	clinical	clinical	ADJ
aiua-10886	11	11	impact	impact	NOUN
aiua-10886	11	12	of	of	ADP
aiua-10886	11	13	pten	pten	ADJ
aiua-10886	11	14	loss	loss	NOUN
aiua-10886	11	15	and	and	CCONJ
aiua-10886	11	16	erg	erg	NOUN
aiua-10886	11	17	rearrangement	rearrangement	NOUN
aiua-10886	11	18	in	in	ADP
aiua-10886	11	19	terms	term	NOUN
aiua-10886	11	20	of	of	ADP
aiua-10886	11	21	oncologic	oncologic	ADJ
aiua-10886	11	22	results	result	NOUN
aiua-10886	11	23	in	in	ADP
aiua-10886	11	24	patients	patient	NOUN
aiua-10886	11	25	diagnosed	diagnose	VERB
aiua-10886	11	26	with	with	ADP
aiua-10886	11	27	localized	localized	ADJ
aiua-10886	11	28	pca	pca	NOUN
aiua-10886	11	29	who	who	PRON
aiua-10886	11	30	underwent	undergo	VERB
aiua-10886	11	31	radical	radical	ADJ
aiua-10886	11	32	prostatectomy	prostatectomy	NOUN
aiua-10886	11	33	.	.	PUNCT
aiua-10886	12	1	materials	material	NOUN
aiua-10886	12	2	and	and	CCONJ
aiua-10886	12	3	methods	method	NOUN
aiua-10886	12	4	data	datum	NOUN
aiua-10886	12	5	were	be	AUX
aiua-10886	12	6	collected	collect	VERB
aiua-10886	12	7	in	in	ADP
aiua-10886	12	8	a	a	DET
aiua-10886	12	9	prospective	prospective	ADJ
aiua-10886	12	10	way	way	NOUN
aiua-10886	12	11	from	from	ADP
aiua-10886	12	12	a	a	DET
aiua-10886	12	13	total	total	NOUN
aiua-10886	12	14	of	of	ADP
aiua-10886	12	15	74	74	NUM
aiua-10886	12	16	patients	patient	NOUN
aiua-10886	12	17	who	who	PRON
aiua-10886	12	18	underwent	undergo	VERB
aiua-10886	12	19	open	open	ADJ
aiua-10886	12	20	radical	radical	ADJ
aiua-10886	12	21	retropubic	retropubic	ADJ
aiua-10886	12	22	objectives	objective	NOUN
aiua-10886	12	23	:	:	PUNCT
aiua-10886	12	24	phosphate	phosphate	VERB
aiua-10886	12	25	and	and	CCONJ
aiua-10886	12	26	tensin	tensin	PROPN
aiua-10886	12	27	homolog	homolog	PROPN
aiua-10886	12	28	gene	gene	NOUN
aiua-10886	12	29	(	(	PUNCT
aiua-10886	12	30	pten	pten	NOUN
aiua-10886	12	31	)	)	PUNCT
aiua-10886	12	32	acts	act	VERB
aiua-10886	12	33	as	as	ADP
aiua-10886	12	34	a	a	DET
aiua-10886	12	35	regulator	regulator	NOUN
aiua-10886	12	36	of	of	ADP
aiua-10886	12	37	pi3	pi3	NOUN
aiua-10886	12	38	-	-	PUNCT
aiua-10886	12	39	kakt	kakt	NOUN
aiua-10886	12	40	molecular	molecular	ADJ
aiua-10886	12	41	pathway	pathway	NOUN
aiua-10886	12	42	.	.	PUNCT
aiua-10886	13	1	ets	et	NOUN
aiua-10886	13	2	related	related	ADJ
aiua-10886	13	3	gene	gene	NOUN
aiua-10886	13	4	(	(	PUNCT
aiua-10886	13	5	erg	erg	PROPN
aiua-10886	13	6	)	)	PUNCT
aiua-10886	13	7	,	,	PUNCT
aiua-10886	13	8	an	an	DET
aiua-10886	13	9	oncogene	oncogene	NOUN
aiua-10886	13	10	located	locate	VERB
aiua-10886	13	11	in	in	ADP
aiua-10886	13	12	chromosome	chromosome	NOUN
aiua-10886	13	13	21q22.2	21q22.2	NUM
aiua-10886	13	14	,	,	PUNCT
aiua-10886	13	15	is	be	AUX
aiua-10886	13	16	involved	involve	VERB
aiua-10886	13	17	in	in	ADP
aiua-10886	13	18	prostate	prostate	NOUN
aiua-10886	13	19	cancer	cancer	NOUN
aiua-10886	13	20	(	(	PUNCT
aiua-10886	13	21	pca	pca	PROPN
aiua-10886	13	22	)	)	PUNCT
aiua-10886	13	23	by	by	ADP
aiua-10886	13	24	serine	serine	NOUN
aiua-10886	13	25	2	2	NUM
aiua-10886	13	26	(	(	PUNCT
aiua-10886	13	27	tmprss2	tmprss2	ADV
aiua-10886	13	28	)	)	PUNCT
aiua-10886	13	29	,	,	PUNCT
aiua-10886	13	30	a	a	DET
aiua-10886	13	31	protein	protein	NOUN
aiua-10886	13	32	encoded	encode	VERB
aiua-10886	13	33	by	by	ADP
aiua-10886	13	34	tmprss2	tmprss2	DET
aiua-10886	13	35	gene	gene	NOUN
aiua-10886	13	36	.	.	PUNCT
aiua-10886	14	1	the	the	DET
aiua-10886	14	2	aim	aim	NOUN
aiua-10886	14	3	of	of	ADP
aiua-10886	14	4	this	this	DET
aiua-10886	14	5	study	study	NOUN
aiua-10886	14	6	is	be	AUX
aiua-10886	14	7	to	to	PART
aiua-10886	14	8	evaluate	evaluate	VERB
aiua-10886	14	9	the	the	DET
aiua-10886	14	10	clinical	clinical	ADJ
aiua-10886	14	11	impact	impact	NOUN
aiua-10886	14	12	of	of	ADP
aiua-10886	14	13	pten	pten	ADJ
aiua-10886	14	14	loss	loss	NOUN
aiua-10886	14	15	and	and	CCONJ
aiua-10886	14	16	erg	erg	NOUN
aiua-10886	14	17	rearrangement	rearrangement	NOUN
aiua-10886	14	18	in	in	ADP
aiua-10886	14	19	terms	term	NOUN
aiua-10886	14	20	of	of	ADP
aiua-10886	14	21	oncologic	oncologic	ADJ
aiua-10886	14	22	results	result	NOUN
aiua-10886	14	23	in	in	ADP
aiua-10886	14	24	patients	patient	NOUN
aiua-10886	14	25	diagnosed	diagnose	VERB
aiua-10886	14	26	with	with	ADP
aiua-10886	14	27	localized	localized	ADJ
aiua-10886	14	28	pca	pca	NOUN
aiua-10886	14	29	who	who	PRON
aiua-10886	14	30	underwent	undergo	VERB
aiua-10886	14	31	radical	radical	ADJ
aiua-10886	14	32	prostatectomy	prostatectomy	NOUN
aiua-10886	14	33	.	.	PUNCT
aiua-10886	15	1	materials	material	NOUN
aiua-10886	15	2	and	and	CCONJ
aiua-10886	15	3	methods	method	NOUN
aiua-10886	15	4	:	:	PUNCT
aiua-10886	15	5	prospective	prospective	ADJ
aiua-10886	15	6	data	datum	NOUN
aiua-10886	15	7	were	be	AUX
aiua-10886	15	8	collected	collect	VERB
aiua-10886	15	9	from	from	ADP
aiua-10886	15	10	a	a	DET
aiua-10886	15	11	total	total	NOUN
aiua-10886	15	12	of	of	ADP
aiua-10886	15	13	74	74	NUM
aiua-10886	15	14	patients	patient	NOUN
aiua-10886	15	15	who	who	PRON
aiua-10886	15	16	underwent	undergo	VERB
aiua-10886	15	17	open	open	ADJ
aiua-10886	15	18	radical	radical	ADJ
aiua-10886	15	19	retropubic	retropubic	NOUN
aiua-10886	15	20	prostatectomy	prostatectomy	NOUN
aiua-10886	15	21	for	for	ADP
aiua-10886	15	22	localized	localized	ADJ
aiua-10886	15	23	pca	pca	NOUN
aiua-10886	15	24	and	and	CCONJ
aiua-10886	15	25	immunohistochemical	immunohistochemical	ADJ
aiua-10886	15	26	study	study	NOUN
aiua-10886	15	27	was	be	AUX
aiua-10886	15	28	performed	perform	VERB
aiua-10886	15	29	in	in	ADP
aiua-10886	15	30	tissue	tissue	NOUN
aiua-10886	15	31	samples	sample	NOUN
aiua-10886	15	32	.	.	PUNCT
aiua-10886	16	1	the	the	DET
aiua-10886	16	2	primary	primary	ADJ
aiua-10886	16	3	antibodies	antibody	NOUN
aiua-10886	16	4	for	for	ADP
aiua-10886	16	5	anti	anti	ADJ
aiua-10886	16	6	-	-	ADJ
aiua-10886	16	7	erg	erg	ADJ
aiua-10886	16	8	antibody	antibody	NOUN
aiua-10886	16	9	as	as	ADV
aiua-10886	16	10	well	well	ADV
aiua-10886	16	11	as	as	ADP
aiua-10886	16	12	anti	anti	ADJ
aiua-10886	16	13	-	-	ADJ
aiua-10886	16	14	pten	pten	ADJ
aiua-10886	16	15	antibody	antibody	NOUN
aiua-10886	16	16	were	be	AUX
aiua-10886	16	17	obtained	obtain	VERB
aiua-10886	16	18	from	from	ADP
aiua-10886	16	19	dako	dako	PROPN
aiua-10886	16	20	.	.	PUNCT
aiua-10886	17	1	erg	erg	PROPN
aiua-10886	17	2	was	be	AUX
aiua-10886	17	3	considered	consider	VERB
aiua-10886	17	4	positive	positive	ADJ
aiua-10886	17	5	if	if	SCONJ
aiua-10886	17	6	at	at	ADV
aiua-10886	17	7	least	least	ADV
aiua-10886	17	8	20	20	NUM
aiua-10886	17	9	%	%	NOUN
aiua-10886	17	10	of	of	ADP
aiua-10886	17	11	the	the	DET
aiua-10886	17	12	evaluated	evaluate	VERB
aiua-10886	17	13	cells	cell	NOUN
aiua-10886	17	14	were	be	AUX
aiua-10886	17	15	stained	stain	VERB
aiua-10886	17	16	at	at	ADP
aiua-10886	17	17	least	least	ADJ
aiua-10886	17	18	with	with	ADP
aiua-10886	17	19	medium	medium	ADJ
aiua-10886	17	20	intensity	intensity	NOUN
aiua-10886	17	21	.	.	PUNCT
aiua-10886	18	1	pten	pten	NOUN
aiua-10886	18	2	protein	protein	NOUN
aiua-10886	18	3	loss	loss	NOUN
aiua-10886	18	4	was	be	AUX
aiua-10886	18	5	considered	consider	VERB
aiua-10886	18	6	when	when	SCONJ
aiua-10886	18	7	the	the	DET
aiua-10886	18	8	intensity	intensity	NOUN
aiua-10886	18	9	of	of	ADP
aiua-10886	18	10	cytoplasmic	cytoplasmic	ADJ
aiua-10886	18	11	and	and	CCONJ
aiua-10886	18	12	nuclear	nuclear	ADJ
aiua-10886	18	13	staining	staining	NOUN
aiua-10886	18	14	was	be	AUX
aiua-10886	18	15	mild	mild	ADJ
aiua-10886	18	16	or	or	CCONJ
aiua-10886	18	17	entirely	entirely	ADV
aiua-10886	18	18	negative	negative	ADJ
aiua-10886	18	19	across	across	ADP
aiua-10886	18	20	>	>	X
aiua-10886	18	21	10	10	NUM
aiua-10886	18	22	%	%	NOUN
aiua-10886	18	23	of	of	ADP
aiua-10886	18	24	tumor	tumor	NOUN
aiua-10886	18	25	cells	cell	NOUN
aiua-10886	18	26	.	.	PUNCT
aiua-10886	19	1	results	result	NOUN
aiua-10886	19	2	:	:	PUNCT
aiua-10886	19	3	homogenous	homogenous	ADJ
aiua-10886	19	4	loss	loss	NOUN
aiua-10886	19	5	of	of	ADP
aiua-10886	19	6	pten	pten	NOUN
aiua-10886	19	7	was	be	AUX
aiua-10886	19	8	associated	associate	VERB
aiua-10886	19	9	with	with	ADP
aiua-10886	19	10	higher	high	ADJ
aiua-10886	19	11	clinical	clinical	ADJ
aiua-10886	19	12	international	international	ADJ
aiua-10886	19	13	society	society	NOUN
aiua-10886	19	14	of	of	ADP
aiua-10886	19	15	urological	urological	ADJ
aiua-10886	19	16	pathology	pathology	NOUN
aiua-10886	19	17	(	(	PUNCT
aiua-10886	19	18	isup	isup	NOUN
aiua-10886	19	19	)	)	PUNCT
aiua-10886	19	20	grade	grade	NOUN
aiua-10886	19	21	(	(	PUNCT
aiua-10886	19	22	p	p	NOUN
aiua-10886	19	23	=	=	NOUN
aiua-10886	19	24	0.018	0.018	NUM
aiua-10886	19	25	)	)	PUNCT
aiua-10886	19	26	while	while	SCONJ
aiua-10886	19	27	no	no	DET
aiua-10886	19	28	statistical	statistical	ADJ
aiua-10886	19	29	significant	significant	ADJ
aiua-10886	19	30	association	association	NOUN
aiua-10886	19	31	was	be	AUX
aiua-10886	19	32	present	present	ADJ
aiua-10886	19	33	regarding	regard	VERB
aiua-10886	19	34	the	the	DET
aiua-10886	19	35	presence	presence	NOUN
aiua-10886	19	36	of	of	ADP
aiua-10886	19	37	erg	erg	PROPN
aiua-10886	19	38	rearrangement	rearrangement	NOUN
aiua-10886	19	39	with	with	ADP
aiua-10886	19	40	either	either	CCONJ
aiua-10886	19	41	isupc	isupc	NOUN
aiua-10886	19	42	or	or	CCONJ
aiua-10886	19	43	isupp	isupp	ADJ
aiua-10886	19	44	.	.	PUNCT
aiua-10886	20	1	after	after	SCONJ
aiua-10886	20	2	a	a	DET
aiua-10886	20	3	median	median	NOUN
aiua-10886	20	4	follow	follow	VERB
aiua-10886	20	5	up	up	ADP
aiua-10886	20	6	of	of	ADP
aiua-10886	20	7	34	34	NUM
aiua-10886	20	8	months	month	NOUN
aiua-10886	20	9	,	,	PUNCT
aiua-10886	20	10	24	24	NUM
aiua-10886	20	11	patients	patient	NOUN
aiua-10886	20	12	developed	develop	VERB
aiua-10886	20	13	biochemical	biochemical	ADJ
aiua-10886	20	14	recurrence	recurrence	NOUN
aiua-10886	20	15	.	.	PUNCT
aiua-10886	21	1	no	no	DET
aiua-10886	21	2	statistical	statistical	ADJ
aiua-10886	21	3	significant	significant	ADJ
aiua-10886	21	4	correlation	correlation	NOUN
aiua-10886	21	5	of	of	ADP
aiua-10886	21	6	erg	erg	PROPN
aiua-10886	21	7	status	status	NOUN
aiua-10886	21	8	with	with	ADP
aiua-10886	21	9	biochemical	biochemical	ADJ
aiua-10886	21	10	recurrence	recurrence	NOUN
aiua-10886	21	11	was	be	AUX
aiua-10886	21	12	noted	note	VERB
aiua-10886	21	13	while	while	SCONJ
aiua-10886	21	14	pten	pten	NOUN
aiua-10886	21	15	was	be	AUX
aiua-10886	21	16	associated	associate	VERB
aiua-10886	21	17	with	with	ADP
aiua-10886	21	18	biochemical	biochemical	ADJ
aiua-10886	21	19	recurrence	recurrence	NOUN
aiua-10886	21	20	development	development	NOUN
aiua-10886	21	21	in	in	ADP
aiua-10886	21	22	a	a	DET
aiua-10886	21	23	statistical	statistical	ADJ
aiua-10886	21	24	significant	significant	ADJ
aiua-10886	21	25	way	way	NOUN
aiua-10886	21	26	.	.	PUNCT
aiua-10886	22	1	lastly	lastly	ADV
aiua-10886	22	2	the	the	DET
aiua-10886	22	3	combination	combination	NOUN
aiua-10886	22	4	of	of	ADP
aiua-10886	22	5	pten	pten	ADJ
aiua-10886	22	6	loss	loss	NOUN
aiua-10886	22	7	with	with	ADP
aiua-10886	22	8	erg	erg	PROPN
aiua-10886	22	9	rearrangement	rearrangement	ADJ
aiua-10886	22	10	presence	presence	NOUN
aiua-10886	22	11	was	be	AUX
aiua-10886	22	12	detected	detect	VERB
aiua-10886	22	13	more	more	ADV
aiua-10886	22	14	often	often	ADV
aiua-10886	22	15	in	in	ADP
aiua-10886	22	16	higher	high	ADJ
aiua-10886	22	17	isupc	isupc	NOUN
aiua-10886	22	18	and	and	CCONJ
aiua-10886	22	19	isupp	isupp	ADJ
aiua-10886	22	20	as	as	ADV
aiua-10886	22	21	well	well	ADV
aiua-10886	22	22	as	as	ADP
aiua-10886	22	23	biochemical	biochemical	ADJ
aiua-10886	22	24	recurrence	recurrence	NOUN
aiua-10886	22	25	development	development	NOUN
aiua-10886	22	26	,	,	PUNCT
aiua-10886	22	27	although	although	SCONJ
aiua-10886	22	28	in	in	ADP
aiua-10886	22	29	a	a	DET
aiua-10886	22	30	non	non	ADJ
aiua-10886	22	31	statistical	statistical	ADJ
aiua-10886	22	32	significant	significant	ADJ
aiua-10886	22	33	way	way	NOUN
aiua-10886	22	34	.	.	PUNCT
aiua-10886	23	1	conclusions	conclusion	NOUN
aiua-10886	23	2	:	:	PUNCT
aiua-10886	23	3	homogenous	homogenous	ADJ
aiua-10886	23	4	and	and	CCONJ
aiua-10886	23	5	heterogenous	heterogenous	ADJ
aiua-10886	23	6	pten	pten	NOUN
aiua-10886	23	7	loss	loss	NOUN
aiua-10886	23	8	was	be	AUX
aiua-10886	23	9	associated	associate	VERB
aiua-10886	23	10	with	with	ADP
aiua-10886	23	11	biochemical	biochemical	ADJ
aiua-10886	23	12	recurrence	recurrence	NOUN
aiua-10886	23	13	.	.	PUNCT
aiua-10886	24	1	no	no	DET
aiua-10886	24	2	association	association	NOUN
aiua-10886	24	3	of	of	ADP
aiua-10886	24	4	erg	erg	PROPN
aiua-10886	24	5	and	and	CCONJ
aiua-10886	24	6	biochemical	biochemical	ADJ
aiua-10886	24	7	recurrence	recurrence	NOUN
aiua-10886	24	8	was	be	AUX
aiua-10886	24	9	noted	note	VERB
aiua-10886	24	10	.	.	PUNCT
aiua-10886	25	1	the	the	DET
aiua-10886	25	2	combination	combination	NOUN
aiua-10886	25	3	of	of	ADP
aiua-10886	25	4	pten	pten	ADJ
aiua-10886	25	5	loss	loss	NOUN
aiua-10886	25	6	and	and	CCONJ
aiua-10886	25	7	erg	erg	PROPN
aiua-10886	25	8	rearrangement	rearrangement	PROPN
aiua-10886	25	9	presented	present	VERB
aiua-10886	25	10	a	a	DET
aiua-10886	25	11	trend	trend	NOUN
aiua-10886	25	12	for	for	ADP
aiua-10886	25	13	higher	high	ADJ
aiua-10886	25	14	isupc	isupc	NOUN
aiua-10886	25	15	and	and	CCONJ
aiua-10886	25	16	isupp	isupp	ADJ
aiua-10886	25	17	as	as	ADV
aiua-10886	25	18	well	well	ADV
aiua-10886	25	19	as	as	ADP
aiua-10886	25	20	biochemical	biochemical	ADJ
aiua-10886	25	21	recurrence	recurrence	NOUN
aiua-10886	25	22	but	but	CCONJ
aiua-10886	25	23	not	not	PART
aiua-10886	25	24	in	in	ADP
aiua-10886	25	25	a	a	DET
aiua-10886	25	26	statistical	statistical	ADJ
aiua-10886	25	27	significant	significant	ADJ
aiua-10886	25	28	way	way	NOUN
aiua-10886	25	29	.	.	PUNCT
aiua-10886	26	1	key	key	ADJ
aiua-10886	26	2	words	word	NOUN
aiua-10886	26	3	:	:	PUNCT
aiua-10886	26	4	erg	erg	NOUN
aiua-10886	26	5	;	;	PUNCT
aiua-10886	26	6	pten	pten	ADJ
aiua-10886	26	7	;	;	PUNCT
aiua-10886	26	8	prostate	prostate	NOUN
aiua-10886	26	9	cancer	cancer	NOUN
aiua-10886	26	10	;	;	PUNCT
aiua-10886	26	11	radical	radical	ADJ
aiua-10886	26	12	prostatectomy	prostatectomy	NOUN
aiua-10886	26	13	.	.	PUNCT
aiua-10886	26	14	submitted	submit	VERB
aiua-10886	26	15	18	18	NUM
aiua-10886	26	16	july	july	PROPN
aiua-10886	26	17	2022	2022	NUM
aiua-10886	26	18	;	;	PUNCT
aiua-10886	26	19	accepted	accept	VERB
aiua-10886	26	20	24	24	NUM
aiua-10886	26	21	july	july	PROPN
aiua-10886	26	22	2022	2022	NUM
aiua-10886	26	23	clinical	clinical	ADJ
aiua-10886	26	24	impact	impact	NOUN
aiua-10886	26	25	of	of	ADP
aiua-10886	26	26	erg	erg	PROPN
aiua-10886	26	27	and	and	CCONJ
aiua-10886	26	28	pten	pten	VERB
aiua-10886	26	29	status	status	NOUN
aiua-10886	26	30	in	in	ADP
aiua-10886	26	31	prostate	prostate	NOUN
aiua-10886	26	32	cancer	cancer	NOUN
aiua-10886	26	33	patients	patient	NOUN
aiua-10886	26	34	underwent	undergo	VERB
aiua-10886	26	35	radical	radical	ADJ
aiua-10886	26	36	prostatectomy	prostatectomy	NOUN
aiua-10886	26	37	charalampos	charalampos	NOUN
aiua-10886	26	38	fragkoulis	fragkoulis	PROPN
aiua-10886	26	39	1	1	NUM
aiua-10886	26	40	,	,	PUNCT
aiua-10886	26	41	ioannis	ioannis	PROPN
aiua-10886	26	42	glykas	glykas	PROPN
aiua-10886	26	43	1	1	NUM
aiua-10886	26	44	,	,	PUNCT
aiua-10886	26	45	lazaros	lazaro	VERB
aiua-10886	26	46	tzelves	tzelve	NOUN
aiua-10886	26	47	2	2	NUM
aiua-10886	26	48	,	,	PUNCT
aiua-10886	26	49	panagiotis	panagiotis	NOUN
aiua-10886	26	50	velissarios	velissario	NOUN
aiua-10886	26	51	stamatakos	stamatakos	VERB
aiua-10886	26	52	1	1	NUM
aiua-10886	26	53	,	,	PUNCT
aiua-10886	26	54	georgios	georgios	PROPN
aiua-10886	26	55	papadopoulos	papadopoulos	PROPN
aiua-10886	26	56	1	1	NUM
aiua-10886	26	57	,	,	PUNCT
aiua-10886	26	58	georgios	georgios	PROPN
aiua-10886	26	59	stathouros	stathouros	PROPN
aiua-10886	26	60	1	1	NUM
aiua-10886	26	61	,	,	PUNCT
aiua-10886	26	62	athanasios	athanasio	NOUN
aiua-10886	26	63	dellis	delli	VERB
aiua-10886	26	64	3	3	NUM
aiua-10886	26	65	,	,	PUNCT
aiua-10886	26	66	konstantinos	konstantinos	PROPN
aiua-10886	26	67	ntoumas	ntoumas	PROPN
aiua-10886	26	68	1	1	NUM
aiua-10886	26	69	,	,	PUNCT
aiua-10886	26	70	akrivi	akrivi	NOUN
aiua-10886	26	71	kostopoulou	kostopoulou	ADJ
aiua-10886	26	72	4	4	NUM
aiua-10886	26	73	,	,	PUNCT
aiua-10886	26	74	charalampos	charalampos	NOUN
aiua-10886	26	75	deliveliotis	deliveliotis	PROPN
aiua-10886	26	76	2	2	NUM
aiua-10886	26	77	,	,	PUNCT
aiua-10886	26	78	athanasios	athanasio	NOUN
aiua-10886	26	79	papatsoris	papatsoris	VERB
aiua-10886	26	80	2	2	NUM
aiua-10886	26	81	1	1	NUM
aiua-10886	26	82	department	department	NOUN
aiua-10886	26	83	of	of	ADP
aiua-10886	26	84	urology	urology	NOUN
aiua-10886	26	85	,	,	PUNCT
aiua-10886	26	86	general	general	ADJ
aiua-10886	26	87	hospital	hospital	NOUN
aiua-10886	26	88	of	of	ADP
aiua-10886	26	89	athens	athens	PROPN
aiua-10886	26	90	“	"	PUNCT
aiua-10886	26	91	g.	g.	PROPN
aiua-10886	26	92	gennimatas	gennimatas	PROPN
aiua-10886	26	93	”	"	PUNCT
aiua-10886	26	94	,	,	PUNCT
aiua-10886	26	95	athens	athens	PROPN
aiua-10886	26	96	,	,	PUNCT
aiua-10886	26	97	greece	greece	PROPN
aiua-10886	26	98	;	;	PUNCT
aiua-10886	26	99	2	2	NUM
aiua-10886	26	100	2nd	2nd	PROPN
aiua-10886	26	101	department	department	NOUN
aiua-10886	26	102	of	of	ADP
aiua-10886	26	103	urology	urology	NOUN
aiua-10886	26	104	,	,	PUNCT
aiua-10886	26	105	school	school	NOUN
aiua-10886	26	106	of	of	ADP
aiua-10886	26	107	medicine	medicine	NOUN
aiua-10886	26	108	,	,	PUNCT
aiua-10886	26	109	sismanoglio	sismanoglio	NOUN
aiua-10886	26	110	hospital	hospital	PROPN
aiua-10886	26	111	,	,	PUNCT
aiua-10886	26	112	national	national	ADJ
aiua-10886	26	113	and	and	CCONJ
aiua-10886	26	114	kapodistrian	kapodistrian	ADJ
aiua-10886	26	115	university	university	PROPN
aiua-10886	26	116	of	of	ADP
aiua-10886	26	117	athens	athens	PROPN
aiua-10886	26	118	,	,	PUNCT
aiua-10886	26	119	athens	athens	PROPN
aiua-10886	26	120	,	,	PUNCT
aiua-10886	26	121	greece	greece	PROPN
aiua-10886	26	122	;	;	PUNCT
aiua-10886	26	123	3	3	NUM
aiua-10886	26	124	1st	1st	PROPN
aiua-10886	26	125	department	department	NOUN
aiua-10886	26	126	of	of	ADP
aiua-10886	26	127	urology	urology	NOUN
aiua-10886	26	128	,	,	PUNCT
aiua-10886	26	129	school	school	NOUN
aiua-10886	26	130	of	of	ADP
aiua-10886	26	131	medicine	medicine	NOUN
aiua-10886	26	132	,	,	PUNCT
aiua-10886	26	133	laiko	laiko	ADJ
aiua-10886	26	134	hospital	hospital	NOUN
aiua-10886	26	135	,	,	PUNCT
aiua-10886	26	136	national	national	ADJ
aiua-10886	26	137	and	and	CCONJ
aiua-10886	26	138	kapodistrian	kapodistrian	ADJ
aiua-10886	26	139	university	university	PROPN
aiua-10886	26	140	of	of	ADP
aiua-10886	26	141	athens	athens	PROPN
aiua-10886	26	142	,	,	PUNCT
aiua-10886	26	143	athens	athens	PROPN
aiua-10886	26	144	,	,	PUNCT
aiua-10886	26	145	greece	greece	PROPN
aiua-10886	26	146	;	;	PUNCT
aiua-10886	26	147	4	4	NUM
aiua-10886	26	148	department	department	NOUN
aiua-10886	26	149	of	of	ADP
aiua-10886	26	150	pathology	pathology	PROPN
aiua-10886	26	151	,	,	PUNCT
aiua-10886	26	152	general	general	ADJ
aiua-10886	26	153	hospital	hospital	NOUN
aiua-10886	26	154	of	of	ADP
aiua-10886	26	155	athens	athens	PROPN
aiua-10886	26	156	“	"	PUNCT
aiua-10886	26	157	g.	g.	PROPN
aiua-10886	26	158	gennimatas	gennimatas	PROPN
aiua-10886	26	159	”	"	PUNCT
aiua-10886	26	160	,	,	PUNCT
aiua-10886	26	161	athens	athens	PROPN
aiua-10886	26	162	,	,	PUNCT
aiua-10886	26	163	greece	greece	PROPN
aiua-10886	26	164	.	.	PUNCT
aiua-10886	27	1	doi	doi	PROPN
aiua-10886	27	2	:	:	PUNCT
aiua-10886	27	3	10.4081	10.4081	NUM
aiua-10886	27	4	/	/	SYM
aiua-10886	27	5	aiua.2022.4.390	aiua.2022.4.390	NOUN
aiua-10886	27	6	summary	summary	NOUN
aiua-10886	27	7	391archivio	391archivio	PROPN
aiua-10886	27	8	italiano	italiano	NOUN
aiua-10886	27	9	di	di	X
aiua-10886	27	10	urologia	urologia	PROPN
aiua-10886	27	11	e	e	PROPN
aiua-10886	27	12	andrologia	andrologia	PROPN
aiua-10886	27	13	2022	2022	NUM
aiua-10886	27	14	;	;	PUNCT
aiua-10886	27	15	94	94	NUM
aiua-10886	27	16	,	,	PUNCT
aiua-10886	27	17	4	4	NUM
aiua-10886	27	18	erg	erg	ADV
aiua-10886	27	19	and	and	CCONJ
aiua-10886	27	20	pten	pten	VERB
aiua-10886	27	21	status	status	NOUN
aiua-10886	27	22	in	in	ADP
aiua-10886	27	23	prostate	prostate	NOUN
aiua-10886	27	24	cancer	cancer	NOUN
aiua-10886	27	25	prostatectomy	prostatectomy	NOUN
aiua-10886	27	26	for	for	ADP
aiua-10886	27	27	localized	localized	ADJ
aiua-10886	27	28	pca	pca	NOUN
aiua-10886	27	29	during	during	ADP
aiua-10886	27	30	the	the	DET
aiua-10886	27	31	years	year	NOUN
aiua-10886	27	32	2017	2017	NUM
aiua-10886	27	33	and	and	CCONJ
aiua-10886	27	34	2018	2018	NUM
aiua-10886	27	35	.	.	PUNCT
aiua-10886	28	1	demographic	demographic	ADJ
aiua-10886	28	2	information	information	NOUN
aiua-10886	28	3	,	,	PUNCT
aiua-10886	28	4	psa	psa	VERB
aiua-10886	28	5	levels	level	NOUN
aiua-10886	28	6	at	at	ADP
aiua-10886	28	7	diagnosis	diagnosis	NOUN
aiua-10886	28	8	and	and	CCONJ
aiua-10886	28	9	clinical	clinical	ADJ
aiua-10886	28	10	tnm	tnm	PROPN
aiua-10886	28	11	stage	stage	NOUN
aiua-10886	28	12	were	be	AUX
aiua-10886	28	13	recorded	record	VERB
aiua-10886	28	14	.	.	PUNCT
aiua-10886	29	1	all	all	DET
aiua-10886	29	2	patients	patient	NOUN
aiua-10886	29	3	underwent	undergo	VERB
aiua-10886	29	4	bone	bone	NOUN
aiua-10886	29	5	scan	scan	NOUN
aiua-10886	30	1	and	and	CCONJ
aiua-10886	30	2	ct	ct	PROPN
aiua-10886	30	3	scan	scan	NOUN
aiua-10886	30	4	prior	prior	ADV
aiua-10886	30	5	to	to	ADP
aiua-10886	30	6	surgery	surgery	NOUN
aiua-10886	30	7	for	for	ADP
aiua-10886	30	8	staging	stage	VERB
aiua-10886	30	9	purpose	purpose	NOUN
aiua-10886	30	10	.	.	PUNCT
aiua-10886	31	1	patients	patient	NOUN
aiua-10886	31	2	with	with	ADP
aiua-10886	31	3	psa	psa	NOUN
aiua-10886	31	4	levels	level	NOUN
aiua-10886	31	5	above	above	ADP
aiua-10886	31	6	20	20	NUM
aiua-10886	31	7	ng	ng	PROPN
aiua-10886	31	8	/	/	SYM
aiua-10886	31	9	dl	dl	PROPN
aiua-10886	31	10	were	be	AUX
aiua-10886	31	11	excluded	exclude	VERB
aiua-10886	31	12	from	from	ADP
aiua-10886	31	13	the	the	DET
aiua-10886	31	14	study	study	NOUN
aiua-10886	31	15	.	.	PUNCT
aiua-10886	32	1	histopathological	histopathological	ADJ
aiua-10886	32	2	examination	examination	NOUN
aiua-10886	32	3	of	of	ADP
aiua-10886	32	4	radical	radical	ADJ
aiua-10886	32	5	prostatectomy	prostatectomy	NOUN
aiua-10886	32	6	specimens	specimen	NOUN
aiua-10886	32	7	defined	define	VERB
aiua-10886	32	8	the	the	DET
aiua-10886	32	9	pathological	pathological	ADJ
aiua-10886	32	10	stage	stage	NOUN
aiua-10886	32	11	,	,	PUNCT
aiua-10886	32	12	histopathological	histopathological	ADJ
aiua-10886	32	13	type	type	NOUN
aiua-10886	32	14	as	as	ADV
aiua-10886	32	15	well	well	ADV
aiua-10886	32	16	as	as	ADP
aiua-10886	32	17	the	the	DET
aiua-10886	32	18	gleason	gleason	PROPN
aiua-10886	32	19	score	score	NOUN
aiua-10886	32	20	.	.	PUNCT
aiua-10886	33	1	patients	patient	NOUN
aiua-10886	33	2	were	be	AUX
aiua-10886	33	3	followed	follow	VERB
aiua-10886	33	4	up	up	ADP
aiua-10886	33	5	by	by	ADP
aiua-10886	33	6	psa	psa	NOUN
aiua-10886	33	7	testing	testing	NOUN
aiua-10886	33	8	every	every	DET
aiua-10886	33	9	three	three	NUM
aiua-10886	33	10	months	month	NOUN
aiua-10886	33	11	until	until	SCONJ
aiua-10886	33	12	biochemical	biochemical	ADJ
aiua-10886	33	13	recurrence	recurrence	NOUN
aiua-10886	33	14	defined	define	VERB
aiua-10886	33	15	as	as	ADP
aiua-10886	33	16	psa	psa	NOUN
aiua-10886	33	17	levels	level	NOUN
aiua-10886	33	18	above	above	ADP
aiua-10886	33	19	0.2	0.2	NUM
aiua-10886	33	20	ng	ng	PROPN
aiua-10886	33	21	/	/	SYM
aiua-10886	33	22	dl	dl	PROPN
aiua-10886	33	23	.	.	PROPN
aiua-10886	33	24	immunohistochemical	immunohistochemical	ADJ
aiua-10886	33	25	study	study	NOUN
aiua-10886	33	26	was	be	AUX
aiua-10886	33	27	performed	perform	VERB
aiua-10886	33	28	in	in	ADP
aiua-10886	33	29	paraffinembedded	paraffinembedde	VERB
aiua-10886	33	30	formalin	formalin	NOUN
aiua-10886	33	31	-	-	PUNCT
aiua-10886	33	32	fixed	fix	VERB
aiua-10886	33	33	tissue	tissue	NOUN
aiua-10886	33	34	samples	sample	NOUN
aiua-10886	33	35	.	.	PUNCT
aiua-10886	34	1	sections	section	NOUN
aiua-10886	34	2	of	of	ADP
aiua-10886	34	3	4	4	NUM
aiua-10886	34	4	mm	mm	NOUN
aiua-10886	34	5	were	be	AUX
aiua-10886	34	6	mounted	mount	VERB
aiua-10886	34	7	on	on	ADP
aiua-10886	34	8	tomo	tomo	NOUN
aiua-10886	34	9	slides	slide	NOUN
aiua-10886	34	10	and	and	CCONJ
aiua-10886	34	11	fixated	fixated	ADJ
aiua-10886	34	12	in	in	ADP
aiua-10886	34	13	oven	oven	NOUN
aiua-10886	34	14	at	at	ADP
aiua-10886	34	15	70	70	NUM
aiua-10886	34	16	-	-	SYM
aiua-10886	34	17	80	80	NUM
aiua-10886	34	18	°	°	NOUN
aiua-10886	34	19	c	c	X
aiua-10886	34	20	,	,	PUNCT
aiua-10886	34	21	de	de	ADJ
aiua-10886	34	22	-	-	ADJ
aiua-10886	34	23	waxed	waxed	ADJ
aiua-10886	34	24	in	in	ADP
aiua-10886	34	25	xylene	xylene	NOUN
aiua-10886	34	26	and	and	CCONJ
aiua-10886	34	27	then	then	ADV
aiua-10886	34	28	underwent	undergo	VERB
aiua-10886	34	29	through	through	ADP
aiua-10886	34	30	decreasing	decrease	VERB
aiua-10886	34	31	concentrations	concentration	NOUN
aiua-10886	34	32	of	of	ADP
aiua-10886	34	33	alcohol	alcohol	NOUN
aiua-10886	34	34	.	.	PUNCT
aiua-10886	35	1	for	for	ADP
aiua-10886	35	2	antierg	antierg	ADJ
aiua-10886	35	3	antibody	antibody	NOUN
aiua-10886	35	4	,	,	PUNCT
aiua-10886	35	5	the	the	DET
aiua-10886	35	6	primary	primary	ADJ
aiua-10886	35	7	antibody	antibody	NOUN
aiua-10886	35	8	was	be	AUX
aiua-10886	35	9	obtained	obtain	VERB
aiua-10886	35	10	from	from	ADP
aiua-10886	35	11	dako	dako	PROPN
aiua-10886	35	12	(	(	PUNCT
aiua-10886	35	13	flex	flex	ADJ
aiua-10886	35	14	monoclonal	monoclonal	NOUN
aiua-10886	35	15	rabbit	rabbit	NOUN
aiua-10886	35	16	rabbit	rabbit	NOUN
aiua-10886	35	17	anti	anti	ADJ
aiua-10886	35	18	-	-	ADJ
aiua-10886	35	19	human	human	ADJ
aiua-10886	35	20	erg	erg	NOUN
aiua-10886	35	21	,	,	PUNCT
aiua-10886	35	22	clone	clone	PROPN
aiua-10886	35	23	ep111	ep111	PROPN
aiua-10886	35	24	,	,	PUNCT
aiua-10886	35	25	ready	ready	ADJ
aiua-10886	35	26	-	-	PUNCT
aiua-10886	35	27	to	to	ADP
aiua-10886	35	28	-	-	PUNCT
aiua-10886	35	29	use	use	VERB
aiua-10886	35	30	)	)	PUNCT
aiua-10886	35	31	.	.	PUNCT
aiua-10886	36	1	after	after	ADP
aiua-10886	36	2	heat	heat	NOUN
aiua-10886	36	3	-	-	PUNCT
aiua-10886	36	4	induced	induce	VERB
aiua-10886	36	5	epitope	epitope	NOUN
aiua-10886	36	6	retrieval	retrieval	NOUN
aiua-10886	36	7	and	and	CCONJ
aiua-10886	36	8	a	a	DET
aiua-10886	36	9	ph9	ph9	NOUN
aiua-10886	36	10	buffer	buffer	NOUN
aiua-10886	36	11	,	,	PUNCT
aiua-10886	36	12	the	the	DET
aiua-10886	36	13	sections	section	NOUN
aiua-10886	36	14	were	be	AUX
aiua-10886	36	15	incubated	incubate	VERB
aiua-10886	36	16	for	for	ADP
aiua-10886	36	17	1h	1h	NUM
aiua-10886	36	18	with	with	ADP
aiua-10886	36	19	the	the	DET
aiua-10886	36	20	antibody	antibody	NOUN
aiua-10886	36	21	and	and	CCONJ
aiua-10886	36	22	counterstained	counterstaine	VERB
aiua-10886	36	23	in	in	ADP
aiua-10886	36	24	hematoxylin	hematoxylin	PROPN
aiua-10886	36	25	.	.	PUNCT
aiua-10886	37	1	for	for	ADP
aiua-10886	37	2	anti	anti	ADJ
aiua-10886	37	3	-	-	ADJ
aiua-10886	37	4	pten	pten	ADJ
aiua-10886	37	5	antibody	antibody	NOUN
aiua-10886	37	6	,	,	PUNCT
aiua-10886	37	7	the	the	DET
aiua-10886	37	8	primary	primary	ADJ
aiua-10886	37	9	antibody	antibody	NOUN
aiua-10886	37	10	was	be	AUX
aiua-10886	37	11	obtained	obtain	VERB
aiua-10886	37	12	from	from	ADP
aiua-10886	37	13	dako	dako	PROPN
aiua-10886	37	14	[	[	X
aiua-10886	37	15	monoclonal	monoclonal	NOUN
aiua-10886	37	16	mouse	mouse	NOUN
aiua-10886	37	17	anti	anti	ADJ
aiua-10886	37	18	-	-	ADJ
aiua-10886	37	19	human	human	ADJ
aiua-10886	37	20	pten	pten	NOUN
aiua-10886	37	21	(	(	PUNCT
aiua-10886	37	22	concenctrate	concenctrate	NOUN
aiua-10886	37	23	)	)	PUNCT
aiua-10886	37	24	clone	clone	NOUN
aiua-10886	37	25	6h2.1	6h2.1	NOUN
aiua-10886	37	26	]	]	PUNCT
aiua-10886	37	27	.	.	PUNCT
aiua-10886	38	1	after	after	ADP
aiua-10886	38	2	heat	heat	NOUN
aiua-10886	38	3	-	-	PUNCT
aiua-10886	38	4	induced	induce	VERB
aiua-10886	38	5	epitope	epitope	NOUN
aiua-10886	38	6	retrieval	retrieval	NOUN
aiua-10886	38	7	and	and	CCONJ
aiua-10886	38	8	ph9	ph9	NOUN
aiua-10886	38	9	buffer	buffer	NOUN
aiua-10886	38	10	,	,	PUNCT
aiua-10886	38	11	the	the	DET
aiua-10886	38	12	sections	section	NOUN
aiua-10886	38	13	were	be	AUX
aiua-10886	38	14	incubated	incubate	VERB
aiua-10886	38	15	for	for	ADP
aiua-10886	38	16	1h	1h	NUM
aiua-10886	38	17	in	in	ADP
aiua-10886	38	18	1:100	1:100	NUM
aiua-10886	38	19	of	of	ADP
aiua-10886	38	20	the	the	DET
aiua-10886	38	21	primary	primary	ADJ
aiua-10886	38	22	antibody	antibody	NOUN
aiua-10886	38	23	,	,	PUNCT
aiua-10886	38	24	followed	follow	VERB
aiua-10886	38	25	by	by	ADP
aiua-10886	38	26	15min	15min	NOUN
aiua-10886	38	27	in	in	ADP
aiua-10886	38	28	linker	linker	NOUN
aiua-10886	38	29	.	.	PUNCT
aiua-10886	39	1	counterstain	counterstain	PROPN
aiua-10886	39	2	was	be	AUX
aiua-10886	39	3	performed	perform	VERB
aiua-10886	39	4	with	with	ADP
aiua-10886	39	5	hematoxylin	hematoxylin	PROPN
aiua-10886	39	6	.	.	PUNCT
aiua-10886	40	1	erg	erg	PROPN
aiua-10886	40	2	was	be	AUX
aiua-10886	40	3	considered	consider	VERB
aiua-10886	40	4	positive	positive	ADJ
aiua-10886	40	5	if	if	SCONJ
aiua-10886	40	6	at	at	ADV
aiua-10886	40	7	least	least	ADV
aiua-10886	40	8	20	20	NUM
aiua-10886	40	9	%	%	NOUN
aiua-10886	40	10	of	of	ADP
aiua-10886	40	11	the	the	DET
aiua-10886	40	12	evaluated	evaluate	VERB
aiua-10886	40	13	cells	cell	NOUN
aiua-10886	40	14	(	(	PUNCT
aiua-10886	40	15	neoplastic	neoplastic	ADJ
aiua-10886	40	16	or	or	CCONJ
aiua-10886	40	17	with	with	ADP
aiua-10886	40	18	hgpin	hgpin	NOUN
aiua-10886	40	19	)	)	PUNCT
aiua-10886	40	20	were	be	AUX
aiua-10886	40	21	stained	stain	VERB
aiua-10886	40	22	at	at	ADP
aiua-10886	40	23	least	least	ADJ
aiua-10886	40	24	with	with	ADP
aiua-10886	40	25	medium	medium	ADJ
aiua-10886	40	26	intensity	intensity	NOUN
aiua-10886	40	27	(	(	PUNCT
aiua-10886	40	28	figure	figure	NOUN
aiua-10886	40	29	1	1	NUM
aiua-10886	40	30	)	)	PUNCT
aiua-10886	40	31	.	.	PUNCT
aiua-10886	41	1	endothelial	endothelial	ADJ
aiua-10886	41	2	cells	cell	NOUN
aiua-10886	41	3	were	be	AUX
aiua-10886	41	4	used	use	VERB
aiua-10886	41	5	as	as	ADP
aiua-10886	41	6	positive	positive	ADJ
aiua-10886	41	7	control	control	NOUN
aiua-10886	41	8	.	.	PUNCT
aiua-10886	42	1	a	a	DET
aiua-10886	42	2	tissue	tissue	NOUN
aiua-10886	42	3	sample	sample	NOUN
aiua-10886	42	4	was	be	AUX
aiua-10886	42	5	considered	consider	VERB
aiua-10886	42	6	to	to	PART
aiua-10886	42	7	have	have	AUX
aiua-10886	42	8	pten	pten	VERB
aiua-10886	42	9	protein	protein	NOUN
aiua-10886	42	10	loss	loss	NOUN
aiua-10886	42	11	if	if	SCONJ
aiua-10886	42	12	the	the	DET
aiua-10886	42	13	intensity	intensity	NOUN
aiua-10886	42	14	of	of	ADP
aiua-10886	42	15	cytoplasmic	cytoplasmic	ADJ
aiua-10886	42	16	and	and	CCONJ
aiua-10886	42	17	nuclear	nuclear	ADJ
aiua-10886	42	18	staining	staining	NOUN
aiua-10886	42	19	was	be	AUX
aiua-10886	42	20	mild	mild	ADJ
aiua-10886	42	21	or	or	CCONJ
aiua-10886	42	22	entirely	entirely	ADV
aiua-10886	42	23	negative	negative	ADJ
aiua-10886	42	24	across	across	ADP
aiua-10886	42	25	>	>	X
aiua-10886	42	26	10	10	NUM
aiua-10886	42	27	%	%	NOUN
aiua-10886	42	28	of	of	ADP
aiua-10886	42	29	tumor	tumor	NOUN
aiua-10886	42	30	cells	cell	NOUN
aiua-10886	42	31	,	,	PUNCT
aiua-10886	42	32	compared	compare	VERB
aiua-10886	42	33	with	with	ADP
aiua-10886	42	34	surrounding	surround	VERB
aiua-10886	42	35	benign	benign	ADJ
aiua-10886	42	36	glands	gland	NOUN
aiua-10886	42	37	and/or	and/or	CCONJ
aiua-10886	42	38	stroma	stroma	NOUN
aiua-10886	42	39	,	,	PUNCT
aiua-10886	42	40	used	use	VERB
aiua-10886	42	41	as	as	ADP
aiua-10886	42	42	positive	positive	ADJ
aiua-10886	42	43	controls	control	NOUN
aiua-10886	42	44	for	for	ADP
aiua-10886	42	45	pten	pten	VERB
aiua-10886	42	46	protein	protein	NOUN
aiua-10886	42	47	expression	expression	NOUN
aiua-10886	42	48	.	.	PUNCT
aiua-10886	43	1	if	if	SCONJ
aiua-10886	43	2	the	the	DET
aiua-10886	43	3	neoplastic	neoplastic	ADJ
aiua-10886	43	4	cells	cell	NOUN
aiua-10886	43	5	showed	show	VERB
aiua-10886	43	6	pten	pten	VERB
aiua-10886	43	7	loss	loss	NOUN
aiua-10886	43	8	in	in	ADP
aiua-10886	43	9	10	10	NUM
aiua-10886	43	10	-	-	SYM
aiua-10886	43	11	90	90	NUM
aiua-10886	43	12	%	%	NOUN
aiua-10886	43	13	of	of	ADP
aiua-10886	43	14	neoplastic	neoplastic	ADJ
aiua-10886	43	15	cells	cell	NOUN
aiua-10886	43	16	,	,	PUNCT
aiua-10886	43	17	it	it	PRON
aiua-10886	43	18	was	be	AUX
aiua-10886	43	19	considered	consider	VERB
aiua-10886	43	20	heterogeneous	heterogeneous	ADJ
aiua-10886	43	21	pten	pten	ADJ
aiua-10886	43	22	protein	protein	NOUN
aiua-10886	43	23	loss	loss	NOUN
aiua-10886	43	24	.	.	PUNCT
aiua-10886	44	1	if	if	SCONJ
aiua-10886	44	2	neoplastic	neoplastic	ADJ
aiua-10886	44	3	cells	cell	NOUN
aiua-10886	44	4	showed	show	VERB
aiua-10886	44	5	pten	pten	VERB
aiua-10886	44	6	protein	protein	NOUN
aiua-10886	44	7	loss	loss	NOUN
aiua-10886	44	8	in	in	ADP
aiua-10886	44	9	>	>	X
aiua-10886	44	10	90	90	NUM
aiua-10886	44	11	%	%	NOUN
aiua-10886	44	12	,	,	PUNCT
aiua-10886	44	13	it	it	PRON
aiua-10886	44	14	was	be	AUX
aiua-10886	44	15	considered	consider	VERB
aiua-10886	44	16	homogeneous	homogeneous	ADJ
aiua-10886	44	17	pten	pten	ADJ
aiua-10886	44	18	loss	loss	NOUN
aiua-10886	44	19	.	.	PUNCT
aiua-10886	45	1	regarding	regard	VERB
aiua-10886	45	2	statistical	statistical	ADJ
aiua-10886	45	3	methodology	methodology	NOUN
aiua-10886	45	4	,	,	PUNCT
aiua-10886	45	5	continuous	continuous	ADJ
aiua-10886	45	6	variables	variable	NOUN
aiua-10886	45	7	were	be	AUX
aiua-10886	45	8	expressed	express	VERB
aiua-10886	45	9	using	use	VERB
aiua-10886	45	10	medians	median	NOUN
aiua-10886	45	11	,	,	PUNCT
aiua-10886	45	12	minimum	minimum	ADJ
aiua-10886	45	13	-	-	PUNCT
aiua-10886	45	14	maximum	maximum	ADJ
aiua-10886	45	15	values	value	NOUN
aiua-10886	45	16	and	and	CCONJ
aiua-10886	45	17	interquartile	interquartile	ADJ
aiua-10886	45	18	range	range	NOUN
aiua-10886	45	19	,	,	PUNCT
aiua-10886	45	20	while	while	SCONJ
aiua-10886	45	21	categorical	categorical	ADJ
aiua-10886	45	22	variables	variable	NOUN
aiua-10886	45	23	using	use	VERB
aiua-10886	45	24	numbers	number	NOUN
aiua-10886	45	25	and	and	CCONJ
aiua-10886	45	26	proportions	proportion	NOUN
aiua-10886	45	27	.	.	PUNCT
aiua-10886	46	1	fisher	fisher	PROPN
aiua-10886	46	2	’s	’s	PART
aiua-10886	46	3	exact	exact	ADJ
aiua-10886	46	4	test	test	NOUN
aiua-10886	46	5	or	or	CCONJ
aiua-10886	46	6	chi	chi	PROPN
aiua-10886	46	7	square	square	ADJ
aiua-10886	46	8	test	test	NOUN
aiua-10886	46	9	and	and	CCONJ
aiua-10886	46	10	kruskal	kruskal	PROPN
aiua-10886	46	11	-	-	PUNCT
aiua-10886	46	12	wallis	wallis	PROPN
aiua-10886	46	13	test	test	NOUN
aiua-10886	46	14	were	be	AUX
aiua-10886	46	15	used	use	VERB
aiua-10886	46	16	to	to	PART
aiua-10886	46	17	analyze	analyze	VERB
aiua-10886	46	18	data	datum	NOUN
aiua-10886	46	19	,	,	PUNCT
aiua-10886	46	20	since	since	SCONJ
aiua-10886	46	21	after	after	ADP
aiua-10886	46	22	testing	test	VERB
aiua-10886	46	23	for	for	ADP
aiua-10886	46	24	distributions	distribution	NOUN
aiua-10886	46	25	non	non	ADJ
aiua-10886	46	26	-	-	ADJ
aiua-10886	46	27	normality	normality	NOUN
aiua-10886	46	28	was	be	AUX
aiua-10886	46	29	detected	detect	VERB
aiua-10886	46	30	.	.	PUNCT
aiua-10886	47	1	when	when	SCONJ
aiua-10886	47	2	a	a	DET
aiua-10886	47	3	statistical	statistical	ADJ
aiua-10886	47	4	significance	significance	NOUN
aiua-10886	47	5	was	be	AUX
aiua-10886	47	6	noted	note	VERB
aiua-10886	47	7	,	,	PUNCT
aiua-10886	47	8	pairwise	pairwise	NOUN
aiua-10886	47	9	comparisons	comparison	NOUN
aiua-10886	47	10	were	be	AUX
aiua-10886	47	11	used	use	VERB
aiua-10886	47	12	to	to	PART
aiua-10886	47	13	detect	detect	VERB
aiua-10886	47	14	which	which	PRON
aiua-10886	47	15	exact	exact	ADJ
aiua-10886	47	16	groups	group	NOUN
aiua-10886	47	17	differ	differ	VERB
aiua-10886	47	18	.	.	PUNCT
aiua-10886	48	1	pairwise	pairwise	NOUN
aiua-10886	48	2	comparisons	comparison	NOUN
aiua-10886	48	3	were	be	AUX
aiua-10886	48	4	performed	perform	VERB
aiua-10886	48	5	whenever	whenever	SCONJ
aiua-10886	48	6	a	a	DET
aiua-10886	48	7	statistical	statistical	ADJ
aiua-10886	48	8	significance	significance	NOUN
aiua-10886	48	9	was	be	AUX
aiua-10886	48	10	detected	detect	VERB
aiua-10886	48	11	,	,	PUNCT
aiua-10886	48	12	using	use	VERB
aiua-10886	48	13	the	the	DET
aiua-10886	48	14	dunn	dunn	PROPN
aiua-10886	48	15	’s	’s	PART
aiua-10886	48	16	procedure	procedure	NOUN
aiua-10886	48	17	.	.	PUNCT
aiua-10886	49	1	statistical	statistical	ADJ
aiua-10886	49	2	significance	significance	NOUN
aiua-10886	49	3	was	be	AUX
aiua-10886	49	4	set	set	VERB
aiua-10886	49	5	at	at	ADP
aiua-10886	49	6	p	p	NOUN
aiua-10886	49	7	=	=	NOUN
aiua-10886	49	8	0.05	0.05	NUM
aiua-10886	49	9	.	.	PUNCT
aiua-10886	50	1	all	all	DET
aiua-10886	50	2	analyses	analysis	NOUN
aiua-10886	50	3	were	be	AUX
aiua-10886	50	4	done	do	VERB
aiua-10886	50	5	with	with	ADP
aiua-10886	50	6	ibm	ibm	PROPN
aiua-10886	50	7	spss	spss	PROPN
aiua-10886	50	8	statistics	statistic	NOUN
aiua-10886	50	9	25.0	25.0	NUM
aiua-10886	50	10	software	software	NOUN
aiua-10886	50	11	(	(	PUNCT
aiua-10886	50	12	spss	spss	PROPN
aiua-10886	50	13	inc	inc	PROPN
aiua-10886	50	14	.	.	PROPN
aiua-10886	50	15	,	,	PUNCT
aiua-10886	50	16	chicago	chicago	PROPN
aiua-10886	50	17	,	,	PUNCT
aiua-10886	50	18	il	il	PROPN
aiua-10886	50	19	.	.	PROPN
aiua-10886	50	20	)	)	PUNCT
aiua-10886	50	21	.	.	PUNCT
aiua-10886	51	1	results	result	NOUN
aiua-10886	51	2	median	median	ADJ
aiua-10886	51	3	age	age	NOUN
aiua-10886	51	4	was	be	AUX
aiua-10886	51	5	70	70	NUM
aiua-10886	51	6	years	year	NOUN
aiua-10886	51	7	and	and	CCONJ
aiua-10886	51	8	median	median	ADJ
aiua-10886	51	9	psa	psa	NOUN
aiua-10886	51	10	was	be	AUX
aiua-10886	51	11	7.3	7.3	NUM
aiua-10886	51	12	ng	ng	PROPN
aiua-10886	51	13	/	/	SYM
aiua-10886	51	14	dl	dl	PROPN
aiua-10886	51	15	.	.	PUNCT
aiua-10886	51	16	demographics	demographic	NOUN
aiua-10886	51	17	as	as	ADV
aiua-10886	51	18	well	well	ADV
aiua-10886	51	19	as	as	ADP
aiua-10886	51	20	clinical	clinical	ADJ
aiua-10886	51	21	and	and	CCONJ
aiua-10886	51	22	pathological	pathological	ADJ
aiua-10886	51	23	isup	isup	ADJ
aiua-10886	51	24	grade	grade	NOUN
aiua-10886	51	25	and	and	CCONJ
aiua-10886	51	26	tnm	tnm	PROPN
aiua-10886	51	27	stage	stage	NOUN
aiua-10886	51	28	are	be	AUX
aiua-10886	51	29	presented	present	VERB
aiua-10886	51	30	in	in	ADP
aiua-10886	51	31	table	table	NOUN
aiua-10886	51	32	1	1	NUM
aiua-10886	51	33	.	.	PUNCT
aiua-10886	52	1	pten	pten	NOUN
aiua-10886	52	2	status	status	NOUN
aiua-10886	52	3	was	be	AUX
aiua-10886	52	4	defined	define	VERB
aiua-10886	52	5	as	as	ADP
aiua-10886	52	6	homologous	homologous	ADJ
aiua-10886	52	7	loss	loss	NOUN
aiua-10886	52	8	in	in	ADP
aiua-10886	52	9	15	15	NUM
aiua-10886	52	10	patients	patient	NOUN
aiua-10886	52	11	,	,	PUNCT
aiua-10886	52	12	heterologous	heterologous	ADJ
aiua-10886	52	13	loss	loss	NOUN
aiua-10886	52	14	in	in	ADP
aiua-10886	52	15	43	43	NUM
aiua-10886	52	16	patients	patient	NOUN
aiua-10886	52	17	and	and	CCONJ
aiua-10886	52	18	as	as	ADV
aiua-10886	52	19	intact	intact	ADJ
aiua-10886	52	20	in	in	ADP
aiua-10886	52	21	16	16	NUM
aiua-10886	52	22	patients	patient	NOUN
aiua-10886	52	23	.	.	PUNCT
aiua-10886	53	1	erg	erg	PROPN
aiua-10886	53	2	rearrangement	rearrangement	PROPN
aiua-10886	53	3	was	be	AUX
aiua-10886	53	4	present	present	ADJ
aiua-10886	53	5	in	in	ADP
aiua-10886	53	6	29	29	NUM
aiua-10886	53	7	patients	patient	NOUN
aiua-10886	53	8	and	and	CCONJ
aiua-10886	53	9	absent	absent	ADJ
aiua-10886	53	10	in	in	ADP
aiua-10886	53	11	45	45	NUM
aiua-10886	53	12	.	.	PUNCT
aiua-10886	54	1	in	in	ADP
aiua-10886	54	2	terms	term	NOUN
aiua-10886	54	3	of	of	ADP
aiua-10886	54	4	correlation	correlation	NOUN
aiua-10886	54	5	of	of	ADP
aiua-10886	54	6	pten	pten	ADJ
aiua-10886	54	7	status	status	NOUN
aiua-10886	54	8	with	with	ADP
aiua-10886	54	9	isup	isup	ADJ
aiua-10886	54	10	grade	grade	NOUN
aiua-10886	54	11	,	,	PUNCT
aiua-10886	54	12	homogenous	homogenous	ADJ
aiua-10886	54	13	loss	loss	NOUN
aiua-10886	54	14	was	be	AUX
aiua-10886	54	15	associated	associate	VERB
aiua-10886	54	16	with	with	ADP
aiua-10886	54	17	higher	high	ADJ
aiua-10886	54	18	clinical	clinical	ADJ
aiua-10886	54	19	isup	isup	ADJ
aiua-10886	54	20	grade	grade	NOUN
aiua-10886	54	21	(	(	PUNCT
aiua-10886	54	22	p	p	NOUN
aiua-10886	54	23	=	=	NOUN
aiua-10886	54	24	0.018	0.018	NUM
aiua-10886	54	25	)	)	PUNCT
aiua-10886	54	26	while	while	SCONJ
aiua-10886	54	27	the	the	DET
aiua-10886	54	28	medians	median	NOUN
aiua-10886	54	29	of	of	ADP
aiua-10886	54	30	intact	intact	ADJ
aiua-10886	54	31	-	-	PUNCT
aiua-10886	54	32	homogeneous	homogeneous	ADJ
aiua-10886	54	33	groups	group	NOUN
aiua-10886	54	34	differed	differ	VERB
aiua-10886	54	35	significantly	significantly	ADV
aiua-10886	54	36	for	for	ADP
aiua-10886	54	37	median	median	ADJ
aiua-10886	54	38	isup	isup	ADJ
aiua-10886	54	39	pathology	pathology	NOUN
aiua-10886	54	40	grade	grade	NOUN
aiua-10886	54	41	(	(	PUNCT
aiua-10886	54	42	p	p	X
aiua-10886	54	43	=	=	NOUN
aiua-10886	54	44	0.022	0.022	NUM
aiua-10886	54	45	)	)	PUNCT
aiua-10886	54	46	(	(	PUNCT
aiua-10886	54	47	table	table	NOUN
aiua-10886	54	48	2	2	NUM
aiua-10886	54	49	)	)	PUNCT
aiua-10886	54	50	.	.	PUNCT
aiua-10886	55	1	on	on	ADP
aiua-10886	55	2	the	the	DET
aiua-10886	55	3	other	other	ADJ
aiua-10886	55	4	hand	hand	NOUN
aiua-10886	55	5	,	,	PUNCT
aiua-10886	55	6	no	no	DET
aiua-10886	55	7	statistical	statistical	ADJ
aiua-10886	55	8	significant	significant	ADJ
aiua-10886	55	9	association	association	NOUN
aiua-10886	55	10	table	table	NOUN
aiua-10886	55	11	1	1	NUM
aiua-10886	55	12	.	.	PUNCT
aiua-10886	56	1	patients	patient	NOUN
aiua-10886	56	2	’	'	PUNCT
aiua-10886	56	3	demographics	demographic	NOUN
aiua-10886	56	4	.	.	PUNCT
aiua-10886	57	1	number	number	NOUN
aiua-10886	57	2	of	of	ADP
aiua-10886	57	3	patients	patient	NOUN
aiua-10886	57	4	74	74	NUM
aiua-10886	57	5	age	age	NOUN
aiua-10886	57	6	(	(	PUNCT
aiua-10886	57	7	median	median	NOUN
aiua-10886	57	8	)	)	PUNCT
aiua-10886	57	9	70	70	NUM
aiua-10886	57	10	psa	psa	VERB
aiua-10886	57	11	7.3	7.3	NUM
aiua-10886	57	12	ng	ng	PROPN
aiua-10886	57	13	/	/	SYM
aiua-10886	57	14	dl	dl	PROPN
aiua-10886	57	15	clinical	clinical	ADJ
aiua-10886	57	16	isup	isup	NOUN
aiua-10886	57	17	(	(	PUNCT
aiua-10886	57	18	number	number	NOUN
aiua-10886	57	19	of	of	ADP
aiua-10886	57	20	patients	patient	NOUN
aiua-10886	57	21	)	)	PUNCT
aiua-10886	57	22	1	1	NUM
aiua-10886	57	23	23	23	NUM
aiua-10886	57	24	2	2	NUM
aiua-10886	57	25	17	17	NUM
aiua-10886	57	26	3	3	NUM
aiua-10886	57	27	20	20	NUM
aiua-10886	57	28	4	4	NUM
aiua-10886	57	29	7	7	NUM
aiua-10886	57	30	5	5	NUM
aiua-10886	57	31	7	7	NUM
aiua-10886	57	32	pathology	pathology	NOUN
aiua-10886	57	33	isup	isup	NOUN
aiua-10886	57	34	(	(	PUNCT
aiua-10886	57	35	number	number	NOUN
aiua-10886	57	36	of	of	ADP
aiua-10886	57	37	patients	patient	NOUN
aiua-10886	57	38	)	)	PUNCT
aiua-10886	57	39	1	1	NUM
aiua-10886	57	40	10	10	NUM
aiua-10886	57	41	2	2	NUM
aiua-10886	57	42	25	25	NUM
aiua-10886	57	43	3	3	NUM
aiua-10886	57	44	24	24	NUM
aiua-10886	57	45	4	4	NUM
aiua-10886	57	46	7	7	NUM
aiua-10886	57	47	5	5	NUM
aiua-10886	57	48	8	8	NUM
aiua-10886	57	49	pathology	pathology	NOUN
aiua-10886	57	50	tnm	tnm	PROPN
aiua-10886	57	51	pt2	pt2	PROPN
aiua-10886	57	52	50	50	NUM
aiua-10886	57	53	pt3a	pt3a	PROPN
aiua-10886	57	54	14	14	NUM
aiua-10886	57	55	pt3b	pt3b	NOUN
aiua-10886	57	56	10	10	NUM
aiua-10886	57	57	table	table	NOUN
aiua-10886	57	58	2	2	NUM
aiua-10886	57	59	.	.	PUNCT
aiua-10886	57	60	pten	pten	VERB
aiua-10886	57	61	status	status	NOUN
aiua-10886	57	62	correlation	correlation	NOUN
aiua-10886	57	63	with	with	ADP
aiua-10886	57	64	isupc	isupc	NOUN
aiua-10886	57	65	and	and	CCONJ
aiua-10886	57	66	isupp	isupp	ADJ
aiua-10886	57	67	.	.	PUNCT
aiua-10886	58	1	median	median	ADJ
aiua-10886	58	2	isupc	isupc	PROPN
aiua-10886	58	3	median	median	PROPN
aiua-10886	58	4	isupp	isupp	ADJ
aiua-10886	58	5	homogeneous	homogeneous	ADJ
aiua-10886	58	6	loss	loss	NOUN
aiua-10886	58	7	3	3	NUM
aiua-10886	58	8	3	3	NUM
aiua-10886	58	9	heterogeneous	heterogeneous	ADJ
aiua-10886	58	10	loss	loss	NOUN
aiua-10886	58	11	2	2	NUM
aiua-10886	58	12	3	3	NUM
aiua-10886	58	13	intact	intact	ADJ
aiua-10886	58	14	1	1	NUM
aiua-10886	58	15	2	2	NUM
aiua-10886	58	16	p	p	NOUN
aiua-10886	58	17	-	-	PUNCT
aiua-10886	58	18	value	value	NOUN
aiua-10886	58	19	0.018	0.018	NUM
aiua-10886	58	20	*	*	PUNCT
aiua-10886	58	21	0.022	0.022	PUNCT
aiua-10886	58	22	*	*	PUNCT
aiua-10886	59	1	*	*	PUNCT
aiua-10886	59	2	*	*	PUNCT
aiua-10886	59	3	using	use	VERB
aiua-10886	59	4	kruskall	kruskall	NOUN
aiua-10886	59	5	-	-	PUNCT
aiua-10886	59	6	wallis	wallis	PROPN
aiua-10886	59	7	h	h	PROPN
aiua-10886	59	8	test	test	NOUN
aiua-10886	59	9	,	,	PUNCT
aiua-10886	59	10	the	the	DET
aiua-10886	59	11	medians	median	NOUN
aiua-10886	59	12	of	of	ADP
aiua-10886	59	13	intact	intact	ADJ
aiua-10886	59	14	-	-	PUNCT
aiua-10886	59	15	homogeneous	homogeneous	ADJ
aiua-10886	59	16	groups	group	NOUN
aiua-10886	59	17	differed	differ	VERB
aiua-10886	59	18	significantly	significantly	ADV
aiua-10886	59	19	for	for	ADP
aiua-10886	59	20	median	median	ADJ
aiua-10886	59	21	isupc	isupc	NOUN
aiua-10886	59	22	grade	grade	NOUN
aiua-10886	59	23	.	.	PUNCT
aiua-10886	60	1	*	*	PUNCT
aiua-10886	60	2	*	*	PUNCT
aiua-10886	60	3	using	use	VERB
aiua-10886	60	4	kruskall	kruskall	NOUN
aiua-10886	60	5	-	-	PUNCT
aiua-10886	60	6	wallis	wallis	PROPN
aiua-10886	60	7	h	h	PROPN
aiua-10886	60	8	test	test	NOUN
aiua-10886	60	9	,	,	PUNCT
aiua-10886	60	10	the	the	DET
aiua-10886	60	11	medians	median	NOUN
aiua-10886	60	12	of	of	ADP
aiua-10886	60	13	intact	intact	ADJ
aiua-10886	60	14	-	-	PUNCT
aiua-10886	60	15	homogeneous	homogeneous	ADJ
aiua-10886	60	16	groups	group	NOUN
aiua-10886	60	17	differed	differ	VERB
aiua-10886	60	18	significantly	significantly	ADV
aiua-10886	60	19	for	for	ADP
aiua-10886	60	20	median	median	ADJ
aiua-10886	60	21	isupp	isupp	ADJ
aiua-10886	60	22	grade	grade	NOUN
aiua-10886	60	23	.	.	PUNCT
aiua-10886	61	1	figure	figure	NOUN
aiua-10886	61	2	1	1	NUM
aiua-10886	61	3	.	.	PUNCT
aiua-10886	62	1	positive	positive	ADJ
aiua-10886	62	2	erg	erg	NOUN
aiua-10886	62	3	staining	stain	VERB
aiua-10886	62	4	using	use	VERB
aiua-10886	62	5	anti	anti	ADJ
aiua-10886	62	6	-	-	ADJ
aiua-10886	62	7	human	human	ADJ
aiua-10886	62	8	erg	erg	NOUN
aiua-10886	62	9	antibody	antibody	NOUN
aiua-10886	62	10	.	.	PUNCT
aiua-10886	63	1	archivio	archivio	NOUN
aiua-10886	63	2	italiano	italiano	PROPN
aiua-10886	63	3	di	di	X
aiua-10886	63	4	urologia	urologia	PROPN
aiua-10886	63	5	e	e	PROPN
aiua-10886	63	6	andrologia	andrologia	PROPN
aiua-10886	63	7	2022	2022	NUM
aiua-10886	63	8	;	;	PUNCT
aiua-10886	63	9	94	94	NUM
aiua-10886	63	10	,	,	PUNCT
aiua-10886	63	11	4	4	NUM
aiua-10886	63	12	c.	c.	PROPN
aiua-10886	63	13	fragkoulis	fragkoulis	PROPN
aiua-10886	63	14	,	,	PUNCT
aiua-10886	63	15	i.	i.	PROPN
aiua-10886	63	16	glykas	glykas	PROPN
aiua-10886	63	17	,	,	PUNCT
aiua-10886	63	18	l.	l.	PROPN
aiua-10886	63	19	tzelves	tzelves	PROPN
aiua-10886	63	20	,	,	PUNCT
aiua-10886	63	21	et	et	PROPN
aiua-10886	63	22	al	al	PROPN
aiua-10886	63	23	.	.	PROPN
aiua-10886	63	24	392	392	NUM
aiua-10886	63	25	was	be	AUX
aiua-10886	63	26	present	present	ADJ
aiua-10886	63	27	regarding	regard	VERB
aiua-10886	63	28	the	the	DET
aiua-10886	63	29	presence	presence	NOUN
aiua-10886	63	30	of	of	ADP
aiua-10886	63	31	erg	erg	PROPN
aiua-10886	63	32	rearrangement	rearrangement	NOUN
aiua-10886	63	33	with	with	ADP
aiua-10886	63	34	either	either	CCONJ
aiua-10886	63	35	isupc	isupc	NOUN
aiua-10886	63	36	or	or	CCONJ
aiua-10886	63	37	isupp	isupp	ADJ
aiua-10886	63	38	(	(	PUNCT
aiua-10886	63	39	table3	table3	PROPN
aiua-10886	63	40	)	)	PUNCT
aiua-10886	63	41	.	.	PUNCT
aiua-10886	64	1	after	after	SCONJ
aiua-10886	64	2	a	a	DET
aiua-10886	64	3	median	median	NOUN
aiua-10886	64	4	follow	follow	VERB
aiua-10886	64	5	up	up	ADP
aiua-10886	64	6	of	of	ADP
aiua-10886	64	7	34	34	NUM
aiua-10886	64	8	months	month	NOUN
aiua-10886	64	9	,	,	PUNCT
aiua-10886	64	10	24	24	NUM
aiua-10886	64	11	patients	patient	NOUN
aiua-10886	64	12	developed	develop	VERB
aiua-10886	64	13	biochemical	biochemical	ADJ
aiua-10886	64	14	recurrence	recurrence	NOUN
aiua-10886	64	15	defined	define	VERB
aiua-10886	64	16	as	as	ADP
aiua-10886	64	17	psa	psa	NOUN
aiua-10886	64	18	levels	level	NOUN
aiua-10886	64	19	above	above	ADP
aiua-10886	64	20	0.2	0.2	NUM
aiua-10886	64	21	ng	ng	PROPN
aiua-10886	64	22	/	/	SYM
aiua-10886	64	23	dl	dl	PROPN
aiua-10886	64	24	.	.	PUNCT
aiua-10886	65	1	no	no	DET
aiua-10886	65	2	statistical	statistical	ADJ
aiua-10886	65	3	significant	significant	ADJ
aiua-10886	65	4	correlation	correlation	NOUN
aiua-10886	65	5	of	of	ADP
aiua-10886	65	6	erg	erg	PROPN
aiua-10886	65	7	status	status	NOUN
aiua-10886	65	8	with	with	ADP
aiua-10886	65	9	biochemical	biochemical	ADJ
aiua-10886	65	10	recurrence	recurrence	NOUN
aiua-10886	65	11	was	be	AUX
aiua-10886	65	12	noted	note	VERB
aiua-10886	65	13	(	(	PUNCT
aiua-10886	65	14	table	table	NOUN
aiua-10886	65	15	4	4	NUM
aiua-10886	65	16	)	)	PUNCT
aiua-10886	65	17	.	.	PUNCT
aiua-10886	66	1	on	on	ADP
aiua-10886	66	2	the	the	DET
aiua-10886	66	3	other	other	ADJ
aiua-10886	66	4	hand	hand	NOUN
aiua-10886	66	5	,	,	PUNCT
aiua-10886	66	6	both	both	CCONJ
aiua-10886	66	7	homogenous	homogenous	ADJ
aiua-10886	66	8	and	and	CCONJ
aiua-10886	66	9	heterogenous	heterogenous	ADJ
aiua-10886	66	10	loss	loss	NOUN
aiua-10886	66	11	was	be	AUX
aiua-10886	66	12	associated	associate	VERB
aiua-10886	66	13	with	with	ADP
aiua-10886	66	14	biochemical	biochemical	ADJ
aiua-10886	66	15	recurrence	recurrence	NOUN
aiua-10886	66	16	development	development	NOUN
aiua-10886	66	17	in	in	ADP
aiua-10886	66	18	a	a	DET
aiua-10886	66	19	statistically	statistically	ADV
aiua-10886	66	20	significant	significant	ADJ
aiua-10886	66	21	way	way	NOUN
aiua-10886	66	22	(	(	PUNCT
aiua-10886	66	23	table	table	NOUN
aiua-10886	66	24	5	5	NUM
aiua-10886	66	25	)	)	PUNCT
aiua-10886	66	26	.	.	PUNCT
aiua-10886	67	1	as	as	ADV
aiua-10886	67	2	far	far	ADV
aiua-10886	67	3	as	as	SCONJ
aiua-10886	67	4	it	it	PRON
aiua-10886	67	5	concerns	concern	VERB
aiua-10886	67	6	the	the	DET
aiua-10886	67	7	combination	combination	NOUN
aiua-10886	67	8	of	of	ADP
aiua-10886	67	9	pten	pten	ADJ
aiua-10886	67	10	loss	loss	NOUN
aiua-10886	67	11	with	with	ADP
aiua-10886	67	12	erg	erg	PROPN
aiua-10886	67	13	rearrangement	rearrangement	ADJ
aiua-10886	67	14	presence	presence	NOUN
aiua-10886	67	15	,	,	PUNCT
aiua-10886	67	16	a	a	DET
aiua-10886	67	17	trend	trend	NOUN
aiua-10886	67	18	in	in	ADP
aiua-10886	67	19	higher	high	ADJ
aiua-10886	67	20	isupc	isupc	NOUN
aiua-10886	67	21	and	and	CCONJ
aiua-10886	67	22	isupp	isupp	ADJ
aiua-10886	67	23	as	as	ADV
aiua-10886	67	24	well	well	ADV
aiua-10886	67	25	as	as	ADP
aiua-10886	67	26	biochemical	biochemical	ADJ
aiua-10886	67	27	recurrence	recurrence	NOUN
aiua-10886	67	28	development	development	NOUN
aiua-10886	67	29	was	be	AUX
aiua-10886	67	30	detected	detect	VERB
aiua-10886	67	31	,	,	PUNCT
aiua-10886	67	32	although	although	SCONJ
aiua-10886	67	33	in	in	ADP
aiua-10886	67	34	a	a	DET
aiua-10886	67	35	non	non	ADJ
aiua-10886	67	36	-	-	ADJ
aiua-10886	67	37	statistical	statistical	ADJ
aiua-10886	67	38	significant	significant	ADJ
aiua-10886	67	39	way	way	NOUN
aiua-10886	67	40	.	.	PUNCT
aiua-10886	68	1	among	among	ADP
aiua-10886	68	2	patients	patient	NOUN
aiua-10886	68	3	who	who	PRON
aiua-10886	68	4	presented	present	VERB
aiua-10886	68	5	with	with	ADP
aiua-10886	68	6	combined	combine	VERB
aiua-10886	68	7	pten	pten	VERB
aiua-10886	68	8	homogenous	homogenous	ADJ
aiua-10886	68	9	loss	loss	NOUN
aiua-10886	68	10	and	and	CCONJ
aiua-10886	68	11	erg	erg	NOUN
aiua-10886	68	12	rearrangement	rearrangement	NOUN
aiua-10886	68	13	,	,	PUNCT
aiua-10886	68	14	56	56	NUM
aiua-10886	68	15	%	%	NOUN
aiua-10886	68	16	presented	present	VERB
aiua-10886	68	17	with	with	ADP
aiua-10886	68	18	biochemical	biochemical	ADJ
aiua-10886	68	19	recurrence	recurrence	NOUN
aiua-10886	68	20	during	during	ADP
aiua-10886	68	21	follow	follow	VERB
aiua-10886	68	22	up	up	ADP
aiua-10886	68	23	.	.	PUNCT
aiua-10886	69	1	the	the	DET
aiua-10886	69	2	combination	combination	NOUN
aiua-10886	69	3	of	of	ADP
aiua-10886	69	4	pten	pten	ADJ
aiua-10886	69	5	homogenous	homogenous	ADJ
aiua-10886	69	6	loss	loss	NOUN
aiua-10886	69	7	combined	combine	VERB
aiua-10886	69	8	with	with	ADP
aiua-10886	69	9	no	no	DET
aiua-10886	69	10	erg	erg	PROPN
aiua-10886	69	11	rearrangement	rearrangement	NOUN
aiua-10886	69	12	also	also	ADV
aiua-10886	69	13	presented	present	VERB
aiua-10886	69	14	high	high	ADJ
aiua-10886	69	15	rates	rate	NOUN
aiua-10886	69	16	of	of	ADP
aiua-10886	69	17	biochemical	biochemical	ADJ
aiua-10886	69	18	failure	failure	NOUN
aiua-10886	69	19	(	(	PUNCT
aiua-10886	69	20	66	66	NUM
aiua-10886	69	21	%	%	NOUN
aiua-10886	69	22	)	)	PUNCT
aiua-10886	69	23	.	.	PUNCT
aiua-10886	70	1	nevertheless	nevertheless	ADV
aiua-10886	70	2	,	,	PUNCT
aiua-10886	70	3	this	this	DET
aiua-10886	70	4	group	group	NOUN
aiua-10886	70	5	consisted	consist	VERB
aiua-10886	70	6	only	only	ADV
aiua-10886	70	7	of	of	ADP
aiua-10886	70	8	6	6	NUM
aiua-10886	70	9	patients	patient	NOUN
aiua-10886	70	10	,	,	PUNCT
aiua-10886	70	11	thus	thus	ADV
aiua-10886	70	12	no	no	DET
aiua-10886	70	13	strong	strong	ADJ
aiua-10886	70	14	evidence	evidence	NOUN
aiua-10886	70	15	could	could	AUX
aiua-10886	70	16	be	be	AUX
aiua-10886	70	17	extracted	extract	VERB
aiua-10886	70	18	regarding	regard	VERB
aiua-10886	70	19	this	this	DET
aiua-10886	70	20	combination	combination	NOUN
aiua-10886	70	21	.	.	PUNCT
aiua-10886	71	1	discussion	discussion	NOUN
aiua-10886	71	2	it	it	PRON
aiua-10886	71	3	is	be	AUX
aiua-10886	71	4	nowadays	nowadays	ADV
aiua-10886	71	5	well	well	ADV
aiua-10886	71	6	established	establish	VERB
aiua-10886	71	7	that	that	SCONJ
aiua-10886	71	8	pca	pca	PROPN
aiua-10886	71	9	is	be	AUX
aiua-10886	71	10	a	a	DET
aiua-10886	71	11	disease	disease	NOUN
aiua-10886	71	12	presented	present	VERB
aiua-10886	71	13	with	with	ADP
aiua-10886	71	14	a	a	DET
aiua-10886	71	15	wide	wide	ADJ
aiua-10886	71	16	clinical	clinical	ADJ
aiua-10886	71	17	heterogeneity	heterogeneity	NOUN
aiua-10886	71	18	.	.	PUNCT
aiua-10886	72	1	spectrum	spectrum	NOUN
aiua-10886	72	2	includes	include	VERB
aiua-10886	72	3	from	from	ADP
aiua-10886	72	4	indolent	indolent	ADJ
aiua-10886	72	5	tumors	tumor	NOUN
aiua-10886	72	6	of	of	ADP
aiua-10886	72	7	low	low	ADJ
aiua-10886	72	8	clinical	clinical	ADJ
aiua-10886	72	9	significance	significance	NOUN
aiua-10886	72	10	to	to	ADP
aiua-10886	72	11	highly	highly	ADV
aiua-10886	72	12	aggressive	aggressive	ADJ
aiua-10886	72	13	tumors	tumor	NOUN
aiua-10886	72	14	of	of	ADP
aiua-10886	72	15	high	high	ADJ
aiua-10886	72	16	probability	probability	NOUN
aiua-10886	72	17	of	of	ADP
aiua-10886	72	18	biochemical	biochemical	ADJ
aiua-10886	72	19	recurrence	recurrence	NOUN
aiua-10886	72	20	after	after	ADP
aiua-10886	72	21	local	local	ADJ
aiua-10886	72	22	treatment	treatment	NOUN
aiua-10886	72	23	as	as	ADV
aiua-10886	72	24	well	well	ADV
aiua-10886	72	25	as	as	ADP
aiua-10886	72	26	severe	severe	ADJ
aiua-10886	72	27	metastatic	metastatic	ADJ
aiua-10886	72	28	potential	potential	NOUN
aiua-10886	72	29	.	.	PUNCT
aiua-10886	73	1	currently	currently	ADV
aiua-10886	73	2	,	,	PUNCT
aiua-10886	73	3	risk	risk	NOUN
aiua-10886	73	4	stratification	stratification	NOUN
aiua-10886	73	5	for	for	ADP
aiua-10886	73	6	biochemical	biochemical	ADJ
aiua-10886	73	7	recurrence	recurrence	NOUN
aiua-10886	73	8	development	development	NOUN
aiua-10886	73	9	after	after	ADP
aiua-10886	73	10	radical	radical	ADJ
aiua-10886	73	11	prostatectomy	prostatectomy	NOUN
aiua-10886	73	12	for	for	ADP
aiua-10886	73	13	patients	patient	NOUN
aiua-10886	73	14	with	with	ADP
aiua-10886	73	15	localized	localized	ADJ
aiua-10886	73	16	disease	disease	NOUN
aiua-10886	73	17	stratifies	stratify	VERB
aiua-10886	73	18	patients	patient	NOUN
aiua-10886	73	19	into	into	ADP
aiua-10886	73	20	three	three	NUM
aiua-10886	73	21	groups	group	NOUN
aiua-10886	73	22	based	base	VERB
aiua-10886	73	23	on	on	ADP
aiua-10886	73	24	psa	psa	PROPN
aiua-10886	73	25	,	,	PUNCT
aiua-10886	73	26	gleason	gleason	PROPN
aiua-10886	73	27	score	score	NOUN
aiua-10886	73	28	and	and	CCONJ
aiua-10886	73	29	tnm	tnm	PROPN
aiua-10886	73	30	status	status	NOUN
aiua-10886	73	31	(	(	PUNCT
aiua-10886	73	32	9	9	NUM
aiua-10886	73	33	)	)	PUNCT
aiua-10886	73	34	.	.	PUNCT
aiua-10886	74	1	to	to	PART
aiua-10886	74	2	further	far	ADV
aiua-10886	74	3	stratify	stratify	VERB
aiua-10886	74	4	patients	patient	NOUN
aiua-10886	74	5	according	accord	VERB
aiua-10886	74	6	to	to	ADP
aiua-10886	74	7	molecular	molecular	ADJ
aiua-10886	74	8	and	and	CCONJ
aiua-10886	74	9	genetic	genetic	ADJ
aiua-10886	74	10	profile	profile	NOUN
aiua-10886	74	11	,	,	PUNCT
aiua-10886	74	12	it	it	PRON
aiua-10886	74	13	is	be	AUX
aiua-10886	74	14	of	of	ADP
aiua-10886	74	15	great	great	ADJ
aiua-10886	74	16	interest	interest	NOUN
aiua-10886	74	17	to	to	PART
aiua-10886	74	18	develop	develop	VERB
aiua-10886	74	19	novel	novel	ADJ
aiua-10886	74	20	markers	marker	NOUN
aiua-10886	74	21	based	base	VERB
aiua-10886	74	22	in	in	ADP
aiua-10886	74	23	the	the	DET
aiua-10886	74	24	genomic	genomic	NOUN
aiua-10886	74	25	instability	instability	NOUN
aiua-10886	74	26	characterized	characterize	VERB
aiua-10886	74	27	by	by	ADP
aiua-10886	74	28	activation	activation	NOUN
aiua-10886	74	29	of	of	ADP
aiua-10886	74	30	oncogenes	oncogene	NOUN
aiua-10886	74	31	or	or	CCONJ
aiua-10886	74	32	deactivation	deactivation	NOUN
aiua-10886	74	33	of	of	ADP
aiua-10886	74	34	tumor	tumor	NOUN
aiua-10886	74	35	suppressor	suppressor	NOUN
aiua-10886	74	36	genes	gene	NOUN
aiua-10886	74	37	.	.	PUNCT
aiua-10886	75	1	pten	pten	NOUN
aiua-10886	75	2	is	be	AUX
aiua-10886	75	3	a	a	DET
aiua-10886	75	4	tumor	tumor	NOUN
aiua-10886	75	5	suppressor	suppressor	NOUN
aiua-10886	75	6	gene	gene	NOUN
aiua-10886	75	7	located	locate	VERB
aiua-10886	75	8	in	in	ADP
aiua-10886	75	9	chromosome	chromosome	NOUN
aiua-10886	75	10	12q23.3	12q23.3	NUM
aiua-10886	75	11	acting	act	VERB
aiua-10886	75	12	as	as	ADP
aiua-10886	75	13	a	a	DET
aiua-10886	75	14	regulator	regulator	NOUN
aiua-10886	75	15	of	of	ADP
aiua-10886	75	16	the	the	DET
aiua-10886	75	17	pi3	pi3	NOUN
aiua-10886	75	18	-	-	PUNCT
aiua-10886	75	19	k	k	NOUN
aiua-10886	75	20	-	-	NOUN
aiua-10886	75	21	akt	akt	NOUN
aiua-10886	75	22	molecular	molecular	ADJ
aiua-10886	75	23	pathway	pathway	NOUN
aiua-10886	75	24	(	(	PUNCT
aiua-10886	75	25	4	4	NUM
aiua-10886	75	26	)	)	PUNCT
aiua-10886	75	27	.	.	PUNCT
aiua-10886	76	1	the	the	DET
aiua-10886	76	2	pi3	pi3	NOUN
aiua-10886	76	3	-	-	PUNCT
aiua-10886	76	4	k	k	NOUN
aiua-10886	76	5	-	-	PUNCT
aiua-10886	76	6	akt	akt	NOUN
aiua-10886	76	7	pathway	pathway	NOUN
aiua-10886	76	8	,	,	PUNCT
aiua-10886	76	9	frequently	frequently	ADV
aiua-10886	76	10	upregulated	upregulate	VERB
aiua-10886	76	11	in	in	ADP
aiua-10886	76	12	pca	pca	NOUN
aiua-10886	76	13	patients	patient	NOUN
aiua-10886	76	14	,	,	PUNCT
aiua-10886	76	15	is	be	AUX
aiua-10886	76	16	an	an	DET
aiua-10886	76	17	important	important	ADJ
aiua-10886	76	18	intracellular	intracellular	ADJ
aiua-10886	76	19	molecular	molecular	ADJ
aiua-10886	76	20	pathway	pathway	NOUN
aiua-10886	76	21	regulating	regulate	VERB
aiua-10886	76	22	crucial	crucial	ADJ
aiua-10886	76	23	cellular	cellular	ADJ
aiua-10886	76	24	functions	function	NOUN
aiua-10886	76	25	including	include	VERB
aiua-10886	76	26	cell	cell	NOUN
aiua-10886	76	27	proliferation	proliferation	NOUN
aiua-10886	76	28	,	,	PUNCT
aiua-10886	76	29	growth	growth	NOUN
aiua-10886	76	30	,	,	PUNCT
aiua-10886	76	31	differentiation	differentiation	NOUN
aiua-10886	76	32	,	,	PUNCT
aiua-10886	76	33	cell	cell	NOUN
aiua-10886	76	34	cycle	cycle	NOUN
aiua-10886	76	35	progression	progression	NOUN
aiua-10886	76	36	,	,	PUNCT
aiua-10886	76	37	metabolism	metabolism	NOUN
aiua-10886	76	38	and	and	CCONJ
aiua-10886	76	39	survival	survival	NOUN
aiua-10886	76	40	(	(	PUNCT
aiua-10886	76	41	3	3	NUM
aiua-10886	76	42	)	)	PUNCT
aiua-10886	76	43	.	.	PUNCT
aiua-10886	77	1	several	several	ADJ
aiua-10886	77	2	growth	growth	NOUN
aiua-10886	77	3	factors	factor	NOUN
aiua-10886	77	4	including	include	VERB
aiua-10886	77	5	epidermal	epidermal	ADJ
aiua-10886	77	6	growth	growth	NOUN
aiua-10886	77	7	factor	factor	NOUN
aiua-10886	77	8	(	(	PUNCT
aiua-10886	77	9	egf	egf	PROPN
aiua-10886	77	10	)	)	PUNCT
aiua-10886	77	11	,	,	PUNCT
aiua-10886	77	12	platelet	platelet	NOUN
aiua-10886	77	13	derived	derived	ADJ
aiua-10886	77	14	growth	growth	NOUN
aiua-10886	77	15	factor	factor	NOUN
aiua-10886	77	16	(	(	PUNCT
aiua-10886	77	17	pdgf	pdgf	NOUN
aiua-10886	77	18	)	)	PUNCT
aiua-10886	77	19	and	and	CCONJ
aiua-10886	77	20	insulin	insulin	NOUN
aiua-10886	77	21	like	like	ADP
aiua-10886	77	22	growth	growth	NOUN
aiua-10886	77	23	factor	factor	NOUN
aiua-10886	77	24	(	(	PUNCT
aiua-10886	77	25	igf	igf	PROPN
aiua-10886	77	26	)	)	PUNCT
aiua-10886	77	27	initiate	initiate	VERB
aiua-10886	77	28	the	the	DET
aiua-10886	77	29	activation	activation	NOUN
aiua-10886	77	30	of	of	ADP
aiua-10886	77	31	the	the	DET
aiua-10886	77	32	pi3	pi3	NOUN
aiua-10886	77	33	-	-	PUNCT
aiua-10886	77	34	k	k	NOUN
aiua-10886	77	35	-	-	PUNCT
aiua-10886	77	36	akt	akt	NOUN
aiua-10886	77	37	pathway	pathway	NOUN
aiua-10886	77	38	by	by	ADP
aiua-10886	77	39	activating	activate	VERB
aiua-10886	77	40	tyrosine	tyrosine	ADJ
aiua-10886	77	41	kinase	kinase	NOUN
aiua-10886	77	42	receptors	receptor	NOUN
aiua-10886	77	43	promoting	promote	VERB
aiua-10886	77	44	the	the	DET
aiua-10886	77	45	phosphorylation	phosphorylation	NOUN
aiua-10886	77	46	of	of	ADP
aiua-10886	77	47	pi3k	pi3k	PROPN
aiua-10886	77	48	at	at	ADP
aiua-10886	77	49	the	the	DET
aiua-10886	77	50	cell	cell	NOUN
aiua-10886	77	51	membrane	membrane	NOUN
aiua-10886	77	52	level	level	NOUN
aiua-10886	77	53	.	.	PUNCT
aiua-10886	78	1	phosphorylated	phosphorylate	VERB
aiua-10886	78	2	pi3k	pi3k	PROPN
aiua-10886	78	3	becomes	become	VERB
aiua-10886	78	4	active	active	ADJ
aiua-10886	78	5	and	and	CCONJ
aiua-10886	78	6	promotes	promote	VERB
aiua-10886	78	7	the	the	DET
aiua-10886	78	8	conversion	conversion	NOUN
aiua-10886	78	9	of	of	ADP
aiua-10886	78	10	pip2	pip2	NOUN
aiua-10886	78	11	to	to	ADP
aiua-10886	78	12	pip3	pip3	PROPN
aiua-10886	78	13	.	.	PUNCT
aiua-10886	79	1	this	this	DET
aiua-10886	79	2	event	event	NOUN
aiua-10886	79	3	leads	lead	VERB
aiua-10886	79	4	to	to	ADP
aiua-10886	79	5	the	the	DET
aiua-10886	79	6	phosphorylation	phosphorylation	NOUN
aiua-10886	79	7	of	of	ADP
aiua-10886	79	8	akt	akt	PROPN
aiua-10886	79	9	mediated	mediate	VERB
aiua-10886	79	10	by	by	ADP
aiua-10886	79	11	pdk1	pdk1	PROPN
aiua-10886	79	12	(	(	PUNCT
aiua-10886	79	13	10	10	NUM
aiua-10886	79	14	)	)	PUNCT
aiua-10886	79	15	.	.	PUNCT
aiua-10886	80	1	akt	akt	PROPN
aiua-10886	80	2	plays	play	VERB
aiua-10886	80	3	an	an	DET
aiua-10886	80	4	important	important	ADJ
aiua-10886	80	5	role	role	NOUN
aiua-10886	80	6	in	in	ADP
aiua-10886	80	7	carcinogenesis	carcinogenesis	NOUN
aiua-10886	80	8	and	and	CCONJ
aiua-10886	80	9	tumor	tumor	NOUN
aiua-10886	80	10	progression	progression	NOUN
aiua-10886	80	11	mainly	mainly	ADV
aiua-10886	80	12	by	by	ADP
aiua-10886	80	13	interfering	interfere	VERB
aiua-10886	80	14	with	with	ADP
aiua-10886	80	15	antiapoptotic	antiapoptotic	ADJ
aiua-10886	80	16	pathways	pathway	NOUN
aiua-10886	80	17	(	(	PUNCT
aiua-10886	80	18	11	11	NUM
aiua-10886	80	19	)	)	PUNCT
aiua-10886	80	20	.	.	PUNCT
aiua-10886	81	1	moreover	moreover	ADV
aiua-10886	81	2	,	,	PUNCT
aiua-10886	81	3	it	it	PRON
aiua-10886	81	4	may	may	AUX
aiua-10886	81	5	influence	influence	VERB
aiua-10886	81	6	the	the	DET
aiua-10886	81	7	activity	activity	NOUN
aiua-10886	81	8	of	of	ADP
aiua-10886	81	9	tumor	tumor	NOUN
aiua-10886	81	10	suppressor	suppressor	NOUN
aiua-10886	81	11	gene	gene	NOUN
aiua-10886	81	12	p53	p53	NOUN
aiua-10886	81	13	(	(	PUNCT
aiua-10886	81	14	12	12	NUM
aiua-10886	81	15	)	)	PUNCT
aiua-10886	81	16	.	.	PUNCT
aiua-10886	82	1	akt	akt	PROPN
aiua-10886	82	2	also	also	ADV
aiua-10886	82	3	interacts	interact	VERB
aiua-10886	82	4	with	with	ADP
aiua-10886	82	5	the	the	DET
aiua-10886	82	6	androgen	androgen	NOUN
aiua-10886	82	7	receptor	receptor	NOUN
aiua-10886	82	8	promoting	promote	VERB
aiua-10886	82	9	nuclear	nuclear	ADJ
aiua-10886	82	10	translocation	translocation	NOUN
aiua-10886	82	11	in	in	ADP
aiua-10886	82	12	an	an	DET
aiua-10886	82	13	androgen	androgen	NOUN
aiua-10886	82	14	independent	independent	ADJ
aiua-10886	82	15	manner	manner	NOUN
aiua-10886	82	16	(	(	PUNCT
aiua-10886	82	17	13	13	NUM
aiua-10886	82	18	)	)	PUNCT
aiua-10886	82	19	.	.	PUNCT
aiua-10886	83	1	activated	activate	VERB
aiua-10886	83	2	akt	akt	PROPN
aiua-10886	83	3	has	have	VERB
aiua-10886	83	4	also	also	ADV
aiua-10886	83	5	a	a	DET
aiua-10886	83	6	profound	profound	ADJ
aiua-10886	83	7	role	role	NOUN
aiua-10886	83	8	in	in	ADP
aiua-10886	83	9	carcinogenesis	carcinogenesis	NOUN
aiua-10886	83	10	by	by	ADP
aiua-10886	83	11	promoting	promote	VERB
aiua-10886	83	12	cell	cell	NOUN
aiua-10886	83	13	growth	growth	NOUN
aiua-10886	83	14	and	and	CCONJ
aiua-10886	83	15	protein	protein	NOUN
aiua-10886	83	16	synthesis	synthesis	NOUN
aiua-10886	83	17	through	through	ADP
aiua-10886	83	18	the	the	DET
aiua-10886	83	19	regulation	regulation	NOUN
aiua-10886	83	20	of	of	ADP
aiua-10886	83	21	the	the	DET
aiua-10886	83	22	mammalian	mammalian	ADJ
aiua-10886	83	23	target	target	NOUN
aiua-10886	83	24	of	of	ADP
aiua-10886	83	25	rapamycin	rapamycin	NOUN
aiua-10886	83	26	(	(	PUNCT
aiua-10886	83	27	mtor	mtor	NOUN
aiua-10886	83	28	)	)	PUNCT
aiua-10886	83	29	pathway	pathway	NOUN
aiua-10886	83	30	(	(	PUNCT
aiua-10886	83	31	14	14	NUM
aiua-10886	83	32	)	)	PUNCT
aiua-10886	83	33	.	.	PUNCT
aiua-10886	84	1	pten	pten	VERB
aiua-10886	84	2	suppressor	suppressor	NOUN
aiua-10886	84	3	gene	gene	NOUN
aiua-10886	84	4	protein	protein	NOUN
aiua-10886	84	5	product	product	NOUN
aiua-10886	84	6	is	be	AUX
aiua-10886	84	7	a	a	DET
aiua-10886	84	8	dual	dual	ADJ
aiua-10886	84	9	lipid	lipid	NOUN
aiua-10886	84	10	phosphatase	phosphatase	NOUN
aiua-10886	84	11	which	which	PRON
aiua-10886	84	12	acts	act	VERB
aiua-10886	84	13	as	as	ADP
aiua-10886	84	14	a	a	DET
aiua-10886	84	15	negative	negative	ADJ
aiua-10886	84	16	regulator	regulator	NOUN
aiua-10886	84	17	of	of	ADP
aiua-10886	84	18	the	the	DET
aiua-10886	84	19	pi3	pi3	NOUN
aiua-10886	84	20	-	-	PUNCT
aiua-10886	84	21	kakt	kakt	NOUN
aiua-10886	84	22	pathway	pathway	NOUN
aiua-10886	84	23	.	.	PUNCT
aiua-10886	85	1	pten	pten	VERB
aiua-10886	85	2	protein	protein	NOUN
aiua-10886	85	3	removes	remove	VERB
aiua-10886	85	4	the	the	DET
aiua-10886	85	5	3	3	NUM
aiua-10886	85	6	-	-	NOUN
aiua-10886	85	7	phosphatase	phosphatase	NOUN
aiua-10886	85	8	from	from	ADP
aiua-10886	85	9	pip3	pip3	NOUN
aiua-10886	85	10	converting	convert	VERB
aiua-10886	85	11	it	it	PRON
aiua-10886	85	12	back	back	ADV
aiua-10886	85	13	to	to	ADP
aiua-10886	85	14	pip2	pip2	NOUN
aiua-10886	85	15	thus	thus	ADV
aiua-10886	85	16	inhibiting	inhibit	VERB
aiua-10886	85	17	the	the	DET
aiua-10886	85	18	phosphorylation	phosphorylation	NOUN
aiua-10886	85	19	of	of	ADP
aiua-10886	85	20	akt	akt	PROPN
aiua-10886	85	21	(	(	PUNCT
aiua-10886	85	22	4	4	NUM
aiua-10886	85	23	,	,	PUNCT
aiua-10886	85	24	10	10	NUM
aiua-10886	85	25	)	)	PUNCT
aiua-10886	85	26	.	.	PUNCT
aiua-10886	86	1	in	in	ADP
aiua-10886	86	2	addition	addition	NOUN
aiua-10886	86	3	,	,	PUNCT
aiua-10886	86	4	genomic	genomic	ADJ
aiua-10886	86	5	stability	stability	NOUN
aiua-10886	86	6	is	be	AUX
aiua-10886	86	7	also	also	ADV
aiua-10886	86	8	influenced	influence	VERB
aiua-10886	86	9	by	by	ADP
aiua-10886	86	10	pten	pten	VERB
aiua-10886	86	11	protein	protein	NOUN
aiua-10886	86	12	through	through	ADP
aiua-10886	86	13	involvement	involvement	NOUN
aiua-10886	86	14	with	with	ADP
aiua-10886	86	15	the	the	DET
aiua-10886	86	16	mapk	mapk	NOUN
aiua-10886	86	17	signaling	signal	VERB
aiua-10886	86	18	network	network	NOUN
aiua-10886	86	19	which	which	PRON
aiua-10886	86	20	affects	affect	VERB
aiua-10886	86	21	both	both	PRON
aiua-10886	86	22	directly	directly	ADV
aiua-10886	86	23	and	and	CCONJ
aiua-10886	86	24	indirectly	indirectly	ADV
aiua-10886	86	25	the	the	DET
aiua-10886	86	26	androgen	androgen	NOUN
aiua-10886	86	27	receptor	receptor	NOUN
aiua-10886	86	28	activity	activity	NOUN
aiua-10886	86	29	(	(	PUNCT
aiua-10886	86	30	14	14	NUM
aiua-10886	86	31	)	)	PUNCT
aiua-10886	86	32	.	.	PUNCT
aiua-10886	87	1	since	since	SCONJ
aiua-10886	87	2	pten	pten	NOUN
aiua-10886	87	3	is	be	AUX
aiua-10886	87	4	the	the	DET
aiua-10886	87	5	most	most	ADV
aiua-10886	87	6	commonly	commonly	ADV
aiua-10886	87	7	tumor	tumor	NOUN
aiua-10886	87	8	suppressor	suppressor	NOUN
aiua-10886	87	9	gene	gene	NOUN
aiua-10886	87	10	mutated	mutate	VERB
aiua-10886	87	11	in	in	ADP
aiua-10886	87	12	pca	pca	PROPN
aiua-10886	87	13	,	,	PUNCT
aiua-10886	87	14	pten	pten	VERB
aiua-10886	87	15	loss	loss	NOUN
aiua-10886	87	16	may	may	AUX
aiua-10886	87	17	act	act	VERB
aiua-10886	87	18	as	as	ADP
aiua-10886	87	19	a	a	DET
aiua-10886	87	20	prognostic	prognostic	ADJ
aiua-10886	87	21	marker	marker	NOUN
aiua-10886	87	22	associated	associate	VERB
aiua-10886	87	23	with	with	ADP
aiua-10886	87	24	poor	poor	ADJ
aiua-10886	87	25	oncological	oncological	ADJ
aiua-10886	87	26	outcomes	outcome	NOUN
aiua-10886	87	27	and	and	CCONJ
aiua-10886	87	28	may	may	AUX
aiua-10886	87	29	facilitate	facilitate	VERB
aiua-10886	87	30	the	the	DET
aiua-10886	87	31	selection	selection	NOUN
aiua-10886	87	32	of	of	ADP
aiua-10886	87	33	patients	patient	NOUN
aiua-10886	87	34	who	who	PRON
aiua-10886	87	35	are	be	AUX
aiua-10886	87	36	more	more	ADV
aiua-10886	87	37	likely	likely	ADJ
aiua-10886	87	38	to	to	PART
aiua-10886	87	39	benefit	benefit	VERB
aiua-10886	87	40	from	from	ADP
aiua-10886	87	41	intensive	intensive	ADJ
aiua-10886	87	42	definite	definite	ADJ
aiua-10886	87	43	treatment	treatment	NOUN
aiua-10886	87	44	modalities	modality	NOUN
aiua-10886	87	45	(	(	PUNCT
aiua-10886	87	46	15	15	NUM
aiua-10886	87	47	)	)	PUNCT
aiua-10886	87	48	.	.	PUNCT
aiua-10886	88	1	pten	pten	ADJ
aiua-10886	88	2	mutations	mutation	NOUN
aiua-10886	88	3	are	be	AUX
aiua-10886	88	4	more	more	ADV
aiua-10886	88	5	frequently	frequently	ADV
aiua-10886	88	6	encountered	encounter	VERB
aiua-10886	88	7	in	in	ADP
aiua-10886	88	8	metastasis	metastasis	NOUN
aiua-10886	88	9	providing	provide	VERB
aiua-10886	88	10	further	further	ADJ
aiua-10886	88	11	evidence	evidence	NOUN
aiua-10886	88	12	that	that	PRON
aiua-10886	88	13	pten	pten	VERB
aiua-10886	88	14	loss	loss	NOUN
aiua-10886	88	15	is	be	AUX
aiua-10886	88	16	associated	associate	VERB
aiua-10886	88	17	with	with	ADP
aiua-10886	88	18	the	the	DET
aiua-10886	88	19	disease	disease	NOUN
aiua-10886	88	20	progression	progression	NOUN
aiua-10886	88	21	(	(	PUNCT
aiua-10886	88	22	16	16	NUM
aiua-10886	88	23	)	)	PUNCT
aiua-10886	88	24	.	.	PUNCT
aiua-10886	89	1	more	more	ADV
aiua-10886	89	2	specifically	specifically	ADV
aiua-10886	89	3	,	,	PUNCT
aiua-10886	89	4	pten	pten	ADJ
aiua-10886	89	5	deletion	deletion	NOUN
aiua-10886	89	6	is	be	AUX
aiua-10886	89	7	associated	associate	VERB
aiua-10886	89	8	with	with	ADP
aiua-10886	89	9	higher	high	ADJ
aiua-10886	89	10	disease	disease	NOUN
aiua-10886	89	11	stage	stage	NOUN
aiua-10886	89	12	among	among	ADP
aiua-10886	89	13	patients	patient	NOUN
aiua-10886	89	14	with	with	ADP
aiua-10886	89	15	gleason	gleason	PROPN
aiua-10886	89	16	score	score	VERB
aiua-10886	89	17	7	7	NUM
aiua-10886	89	18	(	(	PUNCT
aiua-10886	89	19	17	17	NUM
aiua-10886	89	20	)	)	PUNCT
aiua-10886	89	21	.	.	PUNCT
aiua-10886	90	1	a	a	DET
aiua-10886	90	2	metaanalysis	metaanalysis	NOUN
aiua-10886	90	3	involving	involve	VERB
aiua-10886	90	4	26	26	NUM
aiua-10886	90	5	published	publish	VERB
aiua-10886	90	6	studies	study	NOUN
aiua-10886	90	7	with	with	ADP
aiua-10886	90	8	a	a	DET
aiua-10886	90	9	total	total	NOUN
aiua-10886	90	10	of	of	ADP
aiua-10886	90	11	8097	8097	NUM
aiua-10886	90	12	patients	patient	NOUN
aiua-10886	90	13	presented	present	VERB
aiua-10886	90	14	that	that	SCONJ
aiua-10886	90	15	intact	intact	ADJ
aiua-10886	90	16	pten	pten	NOUN
aiua-10886	90	17	status	status	NOUN
aiua-10886	90	18	results	result	VERB
aiua-10886	90	19	in	in	ADP
aiua-10886	90	20	less	less	ADV
aiua-10886	90	21	aggressive	aggressive	ADJ
aiua-10886	90	22	disease	disease	NOUN
aiua-10886	90	23	and	and	CCONJ
aiua-10886	90	24	lower	low	ADJ
aiua-10886	90	25	gleason	gleason	PROPN
aiua-10886	90	26	score	score	NOUN
aiua-10886	90	27	(	(	PUNCT
aiua-10886	90	28	18	18	NUM
aiua-10886	90	29	)	)	PUNCT
aiua-10886	90	30	.	.	PUNCT
aiua-10886	91	1	results	result	NOUN
aiua-10886	91	2	from	from	ADP
aiua-10886	91	3	a	a	DET
aiua-10886	91	4	multicenter	multicenter	ADJ
aiua-10886	91	5	analysis	analysis	NOUN
aiua-10886	91	6	support	support	NOUN
aiua-10886	91	7	that	that	PRON
aiua-10886	91	8	pten	pten	VERB
aiua-10886	91	9	deletion	deletion	NOUN
aiua-10886	91	10	is	be	AUX
aiua-10886	91	11	strongly	strongly	ADV
aiua-10886	91	12	associated	associate	VERB
aiua-10886	91	13	with	with	ADP
aiua-10886	91	14	seminal	seminal	ADJ
aiua-10886	91	15	vesicle	vesicle	NOUN
aiua-10886	91	16	involvement	involvement	NOUN
aiua-10886	91	17	as	as	ADV
aiua-10886	91	18	well	well	ADV
aiua-10886	91	19	as	as	ADP
aiua-10886	91	20	extracapsular	extracapsular	ADJ
aiua-10886	91	21	extension	extension	NOUN
aiua-10886	91	22	(	(	PUNCT
aiua-10886	91	23	19	19	NUM
aiua-10886	91	24	)	)	PUNCT
aiua-10886	91	25	.	.	PUNCT
aiua-10886	92	1	furthermore	furthermore	ADV
aiua-10886	92	2	,	,	PUNCT
aiua-10886	92	3	homologous	homologous	ADJ
aiua-10886	92	4	,	,	PUNCT
aiua-10886	92	5	and	and	CCONJ
aiua-10886	92	6	heterologous	heterologous	ADJ
aiua-10886	92	7	pten	pten	NOUN
aiua-10886	92	8	loss	loss	NOUN
aiua-10886	92	9	is	be	AUX
aiua-10886	92	10	associated	associate	VERB
aiua-10886	92	11	with	with	ADP
aiua-10886	92	12	greater	great	ADJ
aiua-10886	92	13	risk	risk	NOUN
aiua-10886	92	14	of	of	ADP
aiua-10886	92	15	biochemical	biochemical	ADJ
aiua-10886	92	16	recurrence	recurrence	NOUN
aiua-10886	92	17	compared	compare	VERB
aiua-10886	92	18	with	with	ADP
aiua-10886	92	19	no	no	DET
aiua-10886	92	20	pten	pten	ADJ
aiua-10886	92	21	loss	loss	NOUN
aiua-10886	92	22	(	(	PUNCT
aiua-10886	92	23	20	20	NUM
aiua-10886	92	24	,	,	PUNCT
aiua-10886	92	25	21	21	NUM
aiua-10886	92	26	)	)	PUNCT
aiua-10886	92	27	.	.	PUNCT
aiua-10886	93	1	in	in	ADP
aiua-10886	93	2	a	a	DET
aiua-10886	93	3	meta	meta	ADJ
aiua-10886	93	4	-	-	PUNCT
aiua-10886	93	5	analysis	analysis	NOUN
aiua-10886	93	6	including	include	VERB
aiua-10886	93	7	2,154	2,154	NUM
aiua-10886	93	8	cases	case	NOUN
aiua-10886	93	9	with	with	ADP
aiua-10886	93	10	positive	positive	ADJ
aiua-10886	93	11	expression	expression	NOUN
aiua-10886	93	12	of	of	ADP
aiua-10886	93	13	pten	pten	NOUN
aiua-10886	93	14	and	and	CCONJ
aiua-10886	93	15	1.006	1.006	NUM
aiua-10886	93	16	pten	pten	NOUN
aiua-10886	93	17	deletion	deletion	NOUN
aiua-10886	93	18	cases	case	NOUN
aiua-10886	93	19	,	,	PUNCT
aiua-10886	93	20	pten	pten	VERB
aiua-10886	93	21	positive	positive	ADJ
aiua-10886	93	22	expression	expression	NOUN
aiua-10886	93	23	was	be	AUX
aiua-10886	93	24	associated	associate	VERB
aiua-10886	93	25	with	with	ADP
aiua-10886	93	26	prolonged	prolonged	ADJ
aiua-10886	93	27	biochemical	biochemical	ADJ
aiua-10886	93	28	free	free	ADJ
aiua-10886	93	29	survival	survival	NOUN
aiua-10886	93	30	(	(	PUNCT
aiua-10886	93	31	22	22	NUM
aiua-10886	93	32	)	)	PUNCT
aiua-10886	93	33	.	.	PUNCT
aiua-10886	94	1	nevertheless	nevertheless	ADV
aiua-10886	94	2	,	,	PUNCT
aiua-10886	94	3	patients	patient	NOUN
aiua-10886	94	4	with	with	ADP
aiua-10886	94	5	homologous	homologous	ADJ
aiua-10886	94	6	pten	pten	NOUN
aiua-10886	94	7	loss	loss	NOUN
aiua-10886	94	8	present	present	ADJ
aiua-10886	94	9	worst	bad	ADJ
aiua-10886	94	10	prognosis	prognosis	NOUN
aiua-10886	94	11	in	in	ADP
aiua-10886	94	12	terms	term	NOUN
aiua-10886	94	13	of	of	ADP
aiua-10886	94	14	biochemical	biochemical	ADJ
aiua-10886	94	15	free	free	ADJ
aiua-10886	94	16	survival	survival	NOUN
aiua-10886	94	17	(	(	PUNCT
aiua-10886	94	18	23	23	NUM
aiua-10886	94	19	)	)	PUNCT
aiua-10886	94	20	.	.	PUNCT
aiua-10886	95	1	lotan	lotan	PROPN
aiua-10886	95	2	et	et	PROPN
aiua-10886	95	3	al	al	PROPN
aiua-10886	95	4	.	.	PROPN
aiua-10886	95	5	,	,	PUNCT
aiua-10886	95	6	presented	present	VERB
aiua-10886	95	7	data	datum	NOUN
aiua-10886	95	8	supporting	support	VERB
aiua-10886	95	9	that	that	SCONJ
aiua-10886	95	10	only	only	ADJ
aiua-10886	95	11	homologous	homologous	ADJ
aiua-10886	95	12	pten	pten	NOUN
aiua-10886	95	13	loss	loss	NOUN
aiua-10886	95	14	is	be	AUX
aiua-10886	95	15	associated	associate	VERB
aiua-10886	95	16	with	with	ADP
aiua-10886	95	17	worst	bad	ADJ
aiua-10886	95	18	biotable	biotable	ADJ
aiua-10886	95	19	3	3	NUM
aiua-10886	95	20	.	.	PUNCT
aiua-10886	95	21	erg	erg	PROPN
aiua-10886	95	22	status	status	NOUN
aiua-10886	95	23	and	and	CCONJ
aiua-10886	95	24	correlation	correlation	NOUN
aiua-10886	95	25	with	with	ADP
aiua-10886	95	26	isupc	isupc	NOUN
aiua-10886	95	27	and	and	CCONJ
aiua-10886	95	28	isupp	isupp	ADJ
aiua-10886	95	29	.	.	PUNCT
aiua-10886	96	1	median	median	ADJ
aiua-10886	96	2	isupc	isupc	NOUN
aiua-10886	96	3	median	median	NOUN
aiua-10886	96	4	isupp	isupp	ADJ
aiua-10886	96	5	erg	erg	PROPN
aiua-10886	96	6	(	(	PUNCT
aiua-10886	96	7	+	+	NOUN
aiua-10886	96	8	)	)	PUNCT
aiua-10886	96	9	2	2	NUM
aiua-10886	96	10	3	3	NUM
aiua-10886	96	11	erg	erg	X
aiua-10886	96	12	(	(	PUNCT
aiua-10886	96	13	-	-	PUNCT
aiua-10886	96	14	)	)	SYM
aiua-10886	96	15	2	2	NUM
aiua-10886	96	16	3	3	NUM
aiua-10886	96	17	p	p	NOUN
aiua-10886	96	18	-	-	PUNCT
aiua-10886	96	19	value	value	NOUN
aiua-10886	96	20	0.836	0.836	NUM
aiua-10886	96	21	0.993	0.993	NUM
aiua-10886	96	22	table	table	NOUN
aiua-10886	96	23	4	4	NUM
aiua-10886	96	24	.	.	PUNCT
aiua-10886	96	25	biochemical	biochemical	ADJ
aiua-10886	96	26	recurrence	recurrence	NOUN
aiua-10886	96	27	and	and	CCONJ
aiua-10886	96	28	erg	erg	PROPN
aiua-10886	96	29	status	status	NOUN
aiua-10886	96	30	(	(	PUNCT
aiua-10886	96	31	chi	chi	ADJ
aiua-10886	96	32	-	-	PUNCT
aiua-10886	96	33	square	square	ADJ
aiua-10886	96	34	test	test	NOUN
aiua-10886	96	35	)	)	PUNCT
aiua-10886	96	36	.	.	PUNCT
aiua-10886	97	1	no	no	DET
aiua-10886	97	2	biochemical	biochemical	ADJ
aiua-10886	97	3	recurrence	recurrence	NOUN
aiua-10886	97	4	biochemical	biochemical	ADJ
aiua-10886	97	5	recurrence	recurrence	NOUN
aiua-10886	97	6	p	p	NOUN
aiua-10886	97	7	-	-	PUNCT
aiua-10886	97	8	value	value	NOUN
aiua-10886	97	9	(	(	PUNCT
aiua-10886	97	10	%	%	NOUN
aiua-10886	97	11	)	)	PUNCT
aiua-10886	97	12	(	(	PUNCT
aiua-10886	97	13	%	%	INTJ
aiua-10886	97	14	)	)	PUNCT
aiua-10886	97	15	negative	negative	ADJ
aiua-10886	97	16	erg	erg	PROPN
aiua-10886	97	17	29	29	NUM
aiua-10886	97	18	(	(	PUNCT
aiua-10886	97	19	64.4	64.4	NUM
aiua-10886	97	20	)	)	PUNCT
aiua-10886	97	21	16	16	NUM
aiua-10886	97	22	(	(	PUNCT
aiua-10886	97	23	35.6	35.6	NUM
aiua-10886	97	24	)	)	PUNCT
aiua-10886	97	25	0.475	0.475	NUM
aiua-10886	97	26	positive	positive	ADJ
aiua-10886	97	27	erg	erg	PROPN
aiua-10886	97	28	21	21	NUM
aiua-10886	97	29	(	(	PUNCT
aiua-10886	97	30	72.4	72.4	NUM
aiua-10886	97	31	)	)	SYM
aiua-10886	97	32	8	8	NUM
aiua-10886	97	33	(	(	PUNCT
aiua-10886	97	34	27.6	27.6	NUM
aiua-10886	97	35	)	)	PUNCT
aiua-10886	97	36	table	table	NOUN
aiua-10886	97	37	5	5	NUM
aiua-10886	97	38	.	.	PUNCT
aiua-10886	97	39	biochemical	biochemical	ADJ
aiua-10886	97	40	recurrence	recurrence	NOUN
aiua-10886	97	41	and	and	CCONJ
aiua-10886	97	42	pten	pten	VERB
aiua-10886	97	43	status	status	NOUN
aiua-10886	97	44	(	(	PUNCT
aiua-10886	97	45	chi	chi	ADJ
aiua-10886	97	46	-	-	PUNCT
aiua-10886	97	47	square	square	ADJ
aiua-10886	97	48	test	test	NOUN
aiua-10886	97	49	)	)	PUNCT
aiua-10886	97	50	.	.	PUNCT
aiua-10886	98	1	no	no	DET
aiua-10886	98	2	biochemical	biochemical	ADJ
aiua-10886	98	3	recurrence	recurrence	NOUN
aiua-10886	98	4	biochemical	biochemical	ADJ
aiua-10886	98	5	recurrence	recurrence	NOUN
aiua-10886	98	6	p	p	NOUN
aiua-10886	98	7	-	-	PUNCT
aiua-10886	98	8	value	value	NOUN
aiua-10886	98	9	(	(	PUNCT
aiua-10886	98	10	%	%	NOUN
aiua-10886	98	11	)	)	PUNCT
aiua-10886	98	12	(	(	PUNCT
aiua-10886	98	13	%	%	INTJ
aiua-10886	98	14	)	)	PUNCT
aiua-10886	98	15	heterogeneous	heterogeneous	ADJ
aiua-10886	98	16	loss	loss	NOUN
aiua-10886	98	17	31	31	NUM
aiua-10886	98	18	(	(	PUNCT
aiua-10886	98	19	72.1	72.1	NUM
aiua-10886	98	20	)	)	PUNCT
aiua-10886	98	21	12(27.9	12(27.9	NUM
aiua-10886	98	22	)	)	PUNCT
aiua-10886	98	23	0.031	0.031	NUM
aiua-10886	98	24	homogeneous	homogeneous	ADJ
aiua-10886	98	25	loss	loss	NOUN
aiua-10886	98	26	6	6	NUM
aiua-10886	98	27	(	(	PUNCT
aiua-10886	98	28	40	40	NUM
aiua-10886	98	29	)	)	PUNCT
aiua-10886	98	30	9	9	NUM
aiua-10886	98	31	(	(	PUNCT
aiua-10886	98	32	60	60	NUM
aiua-10886	98	33	)	)	PUNCT
aiua-10886	98	34	intact	intact	ADJ
aiua-10886	98	35	13	13	NUM
aiua-10886	98	36	(	(	PUNCT
aiua-10886	98	37	81.3	81.3	NUM
aiua-10886	98	38	)	)	PUNCT
aiua-10886	98	39	3	3	NUM
aiua-10886	98	40	(	(	PUNCT
aiua-10886	98	41	18.7	18.7	NUM
aiua-10886	98	42	)	)	PUNCT
aiua-10886	98	43	393archivio	393archivio	PROPN
aiua-10886	98	44	italiano	italiano	NOUN
aiua-10886	98	45	di	di	X
aiua-10886	98	46	urologia	urologia	PROPN
aiua-10886	98	47	e	e	PROPN
aiua-10886	98	48	andrologia	andrologia	PROPN
aiua-10886	98	49	2022	2022	NUM
aiua-10886	98	50	;	;	PUNCT
aiua-10886	98	51	94	94	NUM
aiua-10886	98	52	,	,	PUNCT
aiua-10886	98	53	4	4	NUM
aiua-10886	98	54	erg	erg	ADV
aiua-10886	98	55	and	and	CCONJ
aiua-10886	98	56	pten	pten	VERB
aiua-10886	98	57	status	status	NOUN
aiua-10886	98	58	in	in	ADP
aiua-10886	98	59	prostate	prostate	NOUN
aiua-10886	98	60	cancer	cancer	NOUN
aiua-10886	98	61	chemical	chemical	PROPN
aiua-10886	98	62	free	free	ADJ
aiua-10886	98	63	survival	survival	NOUN
aiua-10886	98	64	,	,	PUNCT
aiua-10886	98	65	while	while	SCONJ
aiua-10886	98	66	heterogenous	heterogenous	ADJ
aiua-10886	98	67	loss	loss	NOUN
aiua-10886	98	68	has	have	VERB
aiua-10886	98	69	the	the	DET
aiua-10886	98	70	same	same	ADJ
aiua-10886	98	71	impact	impact	NOUN
aiua-10886	98	72	as	as	SCONJ
aiua-10886	98	73	pten	pten	VERB
aiua-10886	98	74	intact	intact	ADJ
aiua-10886	98	75	status	status	NOUN
aiua-10886	98	76	(	(	PUNCT
aiua-10886	98	77	24	24	NUM
aiua-10886	98	78	)	)	PUNCT
aiua-10886	98	79	.	.	PUNCT
aiua-10886	99	1	as	as	ADV
aiua-10886	99	2	far	far	ADV
aiua-10886	99	3	as	as	SCONJ
aiua-10886	99	4	it	it	PRON
aiua-10886	99	5	concerns	concern	VERB
aiua-10886	99	6	lymph	lymph	VERB
aiua-10886	99	7	node	node	NOUN
aiua-10886	99	8	involvement	involvement	NOUN
aiua-10886	99	9	,	,	PUNCT
aiua-10886	99	10	it	it	PRON
aiua-10886	99	11	is	be	AUX
aiua-10886	99	12	more	more	ADV
aiua-10886	99	13	frequently	frequently	ADV
aiua-10886	99	14	encountered	encounter	VERB
aiua-10886	99	15	in	in	ADP
aiua-10886	99	16	patients	patient	NOUN
aiua-10886	99	17	with	with	ADP
aiua-10886	99	18	pten	pten	ADJ
aiua-10886	99	19	deletion	deletion	NOUN
aiua-10886	99	20	(	(	PUNCT
aiua-10886	99	21	25	25	NUM
aiua-10886	99	22	)	)	PUNCT
aiua-10886	99	23	.	.	PUNCT
aiua-10886	100	1	ets	et	NOUN
aiua-10886	100	2	related	relate	VERB
aiua-10886	100	3	gene	gene	NOUN
aiua-10886	100	4	(	(	PUNCT
aiua-10886	100	5	erg	erg	X
aiua-10886	100	6	)	)	PUNCT
aiua-10886	100	7	is	be	AUX
aiua-10886	100	8	an	an	DET
aiua-10886	100	9	oncogene	oncogene	NOUN
aiua-10886	100	10	member	member	NOUN
aiua-10886	100	11	of	of	ADP
aiua-10886	100	12	the	the	DET
aiua-10886	100	13	ets	ets	PROPN
aiua-10886	100	14	gene	gene	NOUN
aiua-10886	100	15	family	family	NOUN
aiua-10886	100	16	located	locate	VERB
aiua-10886	100	17	in	in	ADP
aiua-10886	100	18	chromosome	chromosome	NOUN
aiua-10886	100	19	21q22.5	21q22.5	NUM
aiua-10886	100	20	.	.	PUNCT
aiua-10886	101	1	it	it	PRON
aiua-10886	101	2	encodes	encode	VERB
aiua-10886	101	3	erg	erg	NOUN
aiua-10886	101	4	protein	protein	NOUN
aiua-10886	101	5	which	which	PRON
aiua-10886	101	6	is	be	AUX
aiua-10886	101	7	involved	involve	VERB
aiua-10886	101	8	in	in	ADP
aiua-10886	101	9	pca	pca	NOUN
aiua-10886	101	10	carcinogenesis	carcinogenesis	NOUN
aiua-10886	101	11	and	and	CCONJ
aiua-10886	101	12	progression	progression	NOUN
aiua-10886	101	13	as	as	ADP
aiua-10886	101	14	a	a	DET
aiua-10886	101	15	fusion	fusion	NOUN
aiua-10886	101	16	protein	protein	NOUN
aiua-10886	101	17	with	with	ADP
aiua-10886	101	18	transmembrane	transmembrane	ADJ
aiua-10886	101	19	protease	protease	NOUN
aiua-10886	101	20	,	,	PUNCT
aiua-10886	101	21	serine	serine	NOUN
aiua-10886	101	22	2	2	NUM
aiua-10886	101	23	(	(	PUNCT
aiua-10886	101	24	tmprss2	tmprss2	ADV
aiua-10886	101	25	)	)	PUNCT
aiua-10886	101	26	,	,	PUNCT
aiua-10886	101	27	a	a	DET
aiua-10886	101	28	protein	protein	NOUN
aiua-10886	101	29	encoded	encode	VERB
aiua-10886	101	30	by	by	ADP
aiua-10886	101	31	tmprss2	tmprss2	ADP
aiua-10886	101	32	gene	gene	NOUN
aiua-10886	101	33	located	locate	VERB
aiua-10886	101	34	in	in	ADP
aiua-10886	101	35	21q22.3	21q22.3	NUM
aiua-10886	101	36	(	(	PUNCT
aiua-10886	101	37	5	5	NUM
aiua-10886	101	38	,	,	PUNCT
aiua-10886	101	39	6	6	NUM
aiua-10886	101	40	)	)	PUNCT
aiua-10886	101	41	.	.	PUNCT
aiua-10886	102	1	tmprss2	tmprss2	ADP
aiua-10886	102	2	:	:	PUNCT
aiua-10886	102	3	erg	erg	NOUN
aiua-10886	102	4	fusion	fusion	NOUN
aiua-10886	102	5	is	be	AUX
aiua-10886	102	6	the	the	DET
aiua-10886	102	7	most	most	ADV
aiua-10886	102	8	common	common	ADJ
aiua-10886	102	9	ets	et	NOUN
aiua-10886	102	10	family	family	NOUN
aiua-10886	102	11	rearrangement	rearrangement	NOUN
aiua-10886	102	12	and	and	CCONJ
aiua-10886	102	13	is	be	AUX
aiua-10886	102	14	detected	detect	VERB
aiua-10886	102	15	in	in	ADP
aiua-10886	102	16	50	50	NUM
aiua-10886	102	17	%	%	NOUN
aiua-10886	102	18	of	of	ADP
aiua-10886	102	19	pca	pca	NOUN
aiua-10886	102	20	patients	patient	NOUN
aiua-10886	102	21	(	(	PUNCT
aiua-10886	102	22	26	26	NUM
aiua-10886	102	23	)	)	PUNCT
aiua-10886	102	24	.	.	PUNCT
aiua-10886	103	1	such	such	ADJ
aiua-10886	103	2	rearrangement	rearrangement	NOUN
aiua-10886	103	3	leads	lead	VERB
aiua-10886	103	4	to	to	ADP
aiua-10886	103	5	neoplastic	neoplastic	ADJ
aiua-10886	103	6	phenotype	phenotype	NOUN
aiua-10886	103	7	by	by	ADP
aiua-10886	103	8	overexpressing	overexpresse	VERB
aiua-10886	103	9	transcription	transcription	NOUN
aiua-10886	103	10	factors	factor	NOUN
aiua-10886	103	11	which	which	PRON
aiua-10886	103	12	are	be	AUX
aiua-10886	103	13	important	important	ADJ
aiua-10886	103	14	from	from	ADP
aiua-10886	103	15	the	the	DET
aiua-10886	103	16	first	first	ADJ
aiua-10886	103	17	step	step	NOUN
aiua-10886	103	18	of	of	ADP
aiua-10886	103	19	carcinogenesis	carcinogenesis	NOUN
aiua-10886	103	20	(	(	PUNCT
aiua-10886	103	21	27	27	NUM
aiua-10886	103	22	)	)	PUNCT
aiua-10886	103	23	.	.	PUNCT
aiua-10886	104	1	erg	erg	PROPN
aiua-10886	104	2	rearrangement	rearrangement	NOUN
aiua-10886	104	3	is	be	AUX
aiua-10886	104	4	encountered	encounter	VERB
aiua-10886	104	5	rarely	rarely	ADV
aiua-10886	104	6	in	in	ADP
aiua-10886	104	7	indolent	indolent	ADJ
aiua-10886	104	8	pca	pca	NOUN
aiua-10886	104	9	tumors	tumor	NOUN
aiua-10886	104	10	and	and	CCONJ
aiua-10886	104	11	it	it	PRON
aiua-10886	104	12	is	be	AUX
aiua-10886	104	13	usually	usually	ADV
aiua-10886	104	14	associated	associate	VERB
aiua-10886	104	15	with	with	ADP
aiua-10886	104	16	more	more	ADV
aiua-10886	104	17	advanced	advanced	ADJ
aiua-10886	104	18	stage	stage	NOUN
aiua-10886	104	19	with	with	ADP
aiua-10886	104	20	either	either	CCONJ
aiua-10886	104	21	extracapsular	extracapsular	ADJ
aiua-10886	104	22	extension	extension	NOUN
aiua-10886	104	23	or	or	CCONJ
aiua-10886	104	24	seminal	seminal	ADJ
aiua-10886	104	25	vesicles	vesicle	NOUN
aiua-10886	104	26	involvement	involvement	NOUN
aiua-10886	104	27	(	(	PUNCT
aiua-10886	104	28	28	28	NUM
aiua-10886	104	29	,	,	PUNCT
aiua-10886	104	30	29	29	NUM
aiua-10886	104	31	)	)	PUNCT
aiua-10886	104	32	.	.	PUNCT
aiua-10886	105	1	furthermore	furthermore	ADV
aiua-10886	105	2	,	,	PUNCT
aiua-10886	105	3	it	it	PRON
aiua-10886	105	4	presents	present	VERB
aiua-10886	105	5	an	an	DET
aiua-10886	105	6	independent	independent	ADJ
aiua-10886	105	7	prognostic	prognostic	ADJ
aiua-10886	105	8	value	value	NOUN
aiua-10886	105	9	regarding	regard	VERB
aiua-10886	105	10	both	both	CCONJ
aiua-10886	105	11	biochemical	biochemical	ADJ
aiua-10886	105	12	and	and	CCONJ
aiua-10886	105	13	clinical	clinical	ADJ
aiua-10886	105	14	recurrence	recurrence	NOUN
aiua-10886	105	15	,	,	PUNCT
aiua-10886	105	16	especially	especially	ADV
aiua-10886	105	17	among	among	ADP
aiua-10886	105	18	grade	grade	NOUN
aiua-10886	105	19	group	group	NOUN
aiua-10886	105	20	4	4	NUM
aiua-10886	105	21	or	or	CCONJ
aiua-10886	105	22	5	5	NUM
aiua-10886	105	23	patients	patient	NOUN
aiua-10886	105	24	(	(	PUNCT
aiua-10886	105	25	30	30	NUM
aiua-10886	105	26	)	)	PUNCT
aiua-10886	105	27	.	.	PUNCT
aiua-10886	106	1	among	among	ADP
aiua-10886	106	2	patients	patient	NOUN
aiua-10886	106	3	with	with	ADP
aiua-10886	106	4	localized	localized	ADJ
aiua-10886	106	5	pca	pca	NOUN
aiua-10886	106	6	treated	treat	VERB
aiua-10886	106	7	with	with	ADP
aiua-10886	106	8	radical	radical	ADJ
aiua-10886	106	9	prostatectomy	prostatectomy	NOUN
aiua-10886	106	10	,	,	PUNCT
aiua-10886	106	11	tmprss2	tmprss2	ADV
aiua-10886	106	12	-	-	PUNCT
aiua-10886	106	13	erg	erg	NOUN
aiua-10886	106	14	fusion	fusion	NOUN
aiua-10886	106	15	was	be	AUX
aiua-10886	106	16	associated	associate	VERB
aiua-10886	106	17	with	with	ADP
aiua-10886	106	18	higher	high	ADJ
aiua-10886	106	19	tumor	tumor	NOUN
aiua-10886	106	20	stage	stage	NOUN
aiua-10886	106	21	but	but	CCONJ
aiua-10886	106	22	not	not	PART
aiua-10886	106	23	with	with	ADP
aiua-10886	106	24	other	other	ADJ
aiua-10886	106	25	oncological	oncological	ADJ
aiua-10886	106	26	parameters	parameter	NOUN
aiua-10886	106	27	(	(	PUNCT
aiua-10886	106	28	31	31	NUM
aiua-10886	106	29	)	)	PUNCT
aiua-10886	106	30	.	.	PUNCT
aiua-10886	107	1	on	on	ADP
aiua-10886	107	2	the	the	DET
aiua-10886	107	3	other	other	ADJ
aiua-10886	107	4	hand	hand	NOUN
aiua-10886	107	5	,	,	PUNCT
aiua-10886	107	6	lee	lee	PROPN
aiua-10886	107	7	et	et	PROPN
aiua-10886	107	8	al	al	PROPN
aiua-10886	107	9	.	.	PROPN
aiua-10886	107	10	demonstrated	demonstrate	VERB
aiua-10886	107	11	that	that	SCONJ
aiua-10886	107	12	positive	positive	ADJ
aiua-10886	107	13	erg	erg	NOUN
aiua-10886	107	14	status	status	NOUN
aiua-10886	107	15	is	be	AUX
aiua-10886	107	16	frequently	frequently	ADV
aiua-10886	107	17	present	present	ADJ
aiua-10886	107	18	among	among	ADP
aiua-10886	107	19	patients	patient	NOUN
aiua-10886	107	20	with	with	ADP
aiua-10886	107	21	perineural	perineural	ADJ
aiua-10886	107	22	invasion	invasion	NOUN
aiua-10886	107	23	or	or	CCONJ
aiua-10886	107	24	positive	positive	ADJ
aiua-10886	107	25	apical	apical	ADJ
aiua-10886	107	26	margins	margin	NOUN
aiua-10886	107	27	(	(	PUNCT
aiua-10886	107	28	32	32	NUM
aiua-10886	107	29	)	)	PUNCT
aiua-10886	107	30	.	.	PUNCT
aiua-10886	108	1	quite	quite	ADV
aiua-10886	108	2	interesting	interesting	ADJ
aiua-10886	108	3	is	be	AUX
aiua-10886	108	4	the	the	DET
aiua-10886	108	5	fact	fact	NOUN
aiua-10886	108	6	that	that	SCONJ
aiua-10886	108	7	erg	erg	PROPN
aiua-10886	108	8	status	status	NOUN
aiua-10886	108	9	among	among	ADP
aiua-10886	108	10	pca	pca	NOUN
aiua-10886	108	11	patients	patient	NOUN
aiua-10886	108	12	is	be	AUX
aiua-10886	108	13	characterized	characterize	VERB
aiua-10886	108	14	by	by	ADP
aiua-10886	108	15	racial	racial	ADJ
aiua-10886	108	16	disparities	disparity	NOUN
aiua-10886	108	17	.	.	PUNCT
aiua-10886	109	1	highest	high	ADJ
aiua-10886	109	2	frequencies	frequency	NOUN
aiua-10886	109	3	of	of	ADP
aiua-10886	109	4	erg	erg	PROPN
aiua-10886	109	5	rearrangements	rearrangement	NOUN
aiua-10886	109	6	are	be	AUX
aiua-10886	109	7	encountered	encounter	VERB
aiua-10886	109	8	among	among	ADP
aiua-10886	109	9	caucasian	caucasian	ADJ
aiua-10886	109	10	descents	descent	NOUN
aiua-10886	109	11	,	,	PUNCT
aiua-10886	109	12	lower	low	ADJ
aiua-10886	109	13	frequencies	frequency	NOUN
aiua-10886	109	14	among	among	ADP
aiua-10886	109	15	african	african	ADJ
aiua-10886	109	16	americans	americans	PROPN
aiua-10886	109	17	and	and	CCONJ
aiua-10886	109	18	even	even	ADV
aiua-10886	109	19	lower	low	ADJ
aiua-10886	109	20	prevalence	prevalence	NOUN
aiua-10886	109	21	among	among	ADP
aiua-10886	109	22	asian	asian	ADJ
aiua-10886	109	23	men	man	NOUN
aiua-10886	109	24	.	.	PUNCT
aiua-10886	110	1	in	in	ADP
aiua-10886	110	2	asian	asian	ADJ
aiua-10886	110	3	cohorts	cohort	NOUN
aiua-10886	110	4	,	,	PUNCT
aiua-10886	110	5	erg	erg	X
aiua-10886	110	6	positive	positive	ADJ
aiua-10886	110	7	status	status	NOUN
aiua-10886	110	8	was	be	AUX
aiua-10886	110	9	more	more	ADV
aiua-10886	110	10	frequent	frequent	ADJ
aiua-10886	110	11	in	in	ADP
aiua-10886	110	12	low	low	ADJ
aiua-10886	110	13	gleason	gleason	PROPN
aiua-10886	110	14	score	score	NOUN
aiua-10886	110	15	and	and	CCONJ
aiua-10886	110	16	low	low	ADJ
aiua-10886	110	17	stage	stage	NOUN
aiua-10886	110	18	patients	patient	NOUN
aiua-10886	110	19	in	in	ADP
aiua-10886	110	20	contrast	contrast	NOUN
aiua-10886	110	21	with	with	ADP
aiua-10886	110	22	western	western	ADJ
aiua-10886	110	23	cohorts	cohort	NOUN
aiua-10886	110	24	(	(	PUNCT
aiua-10886	110	25	33	33	NUM
aiua-10886	110	26	)	)	PUNCT
aiua-10886	110	27	.	.	PUNCT
aiua-10886	111	1	as	as	SCONJ
aiua-10886	111	2	tmprss2	tmprss2	NOUN
aiua-10886	111	3	-	-	PUNCT
aiua-10886	111	4	erg	erg	NOUN
aiua-10886	111	5	fusion	fusion	NOUN
aiua-10886	111	6	is	be	AUX
aiua-10886	111	7	not	not	PART
aiua-10886	111	8	a	a	DET
aiua-10886	111	9	frequent	frequent	ADJ
aiua-10886	111	10	genomic	genomic	NOUN
aiua-10886	111	11	alteration	alteration	NOUN
aiua-10886	111	12	among	among	ADP
aiua-10886	111	13	asian	asian	ADJ
aiua-10886	111	14	pca	pca	NOUN
aiua-10886	111	15	patients	patient	NOUN
aiua-10886	111	16	it	it	PRON
aiua-10886	111	17	has	have	VERB
aiua-10886	111	18	limited	limit	VERB
aiua-10886	111	19	significance	significance	NOUN
aiua-10886	111	20	in	in	ADP
aiua-10886	111	21	clinical	clinical	ADJ
aiua-10886	111	22	practices	practice	NOUN
aiua-10886	111	23	in	in	ADP
aiua-10886	111	24	asian	asian	ADJ
aiua-10886	111	25	populations	population	NOUN
aiua-10886	111	26	(	(	PUNCT
aiua-10886	111	27	34	34	NUM
aiua-10886	111	28	)	)	PUNCT
aiua-10886	111	29	.	.	PUNCT
aiua-10886	112	1	in	in	ADP
aiua-10886	112	2	a	a	DET
aiua-10886	112	3	metaanalysis	metaanalysis	NOUN
aiua-10886	112	4	including	include	VERB
aiua-10886	112	5	6744	6744	NUM
aiua-10886	112	6	patients	patient	NOUN
aiua-10886	112	7	,	,	PUNCT
aiua-10886	112	8	liu	liu	PROPN
aiua-10886	112	9	et	et	PROPN
aiua-10886	112	10	al	al	PROPN
aiua-10886	112	11	.	.	PROPN
aiua-10886	112	12	conclude	conclude	VERB
aiua-10886	112	13	that	that	SCONJ
aiua-10886	112	14	erg	erg	PROPN
aiua-10886	112	15	status	status	NOUN
aiua-10886	112	16	is	be	AUX
aiua-10886	112	17	not	not	PART
aiua-10886	112	18	correlated	correlate	VERB
aiua-10886	112	19	with	with	ADP
aiua-10886	112	20	biochemical	biochemical	ADJ
aiua-10886	112	21	free	free	ADJ
aiua-10886	112	22	survival	survival	NOUN
aiua-10886	112	23	or	or	CCONJ
aiua-10886	112	24	recurrence	recurrence	NOUN
aiua-10886	112	25	free	free	ADJ
aiua-10886	112	26	survival	survival	NOUN
aiua-10886	112	27	(	(	PUNCT
aiua-10886	112	28	35	35	NUM
aiua-10886	112	29	)	)	PUNCT
aiua-10886	112	30	.	.	PUNCT
aiua-10886	113	1	in	in	ADP
aiua-10886	113	2	non	non	ADJ
aiua-10886	113	3	-	-	ADJ
aiua-10886	113	4	surgical	surgical	ADJ
aiua-10886	113	5	cohorts	cohort	NOUN
aiua-10886	113	6	,	,	PUNCT
aiua-10886	113	7	erg	erg	NOUN
aiua-10886	113	8	expression	expression	NOUN
aiua-10886	113	9	is	be	AUX
aiua-10886	113	10	associated	associate	VERB
aiua-10886	113	11	with	with	ADP
aiua-10886	113	12	advanced	advanced	ADJ
aiua-10886	113	13	stage	stage	NOUN
aiua-10886	113	14	,	,	PUNCT
aiua-10886	113	15	higher	high	ADJ
aiua-10886	113	16	probability	probability	NOUN
aiua-10886	113	17	of	of	ADP
aiua-10886	113	18	metastasis	metastasis	PRON
aiua-10886	113	19	as	as	ADV
aiua-10886	113	20	well	well	ADV
aiua-10886	113	21	as	as	ADP
aiua-10886	113	22	increased	increase	VERB
aiua-10886	113	23	mortality	mortality	NOUN
aiua-10886	113	24	(	(	PUNCT
aiua-10886	113	25	36	36	NUM
aiua-10886	113	26	)	)	PUNCT
aiua-10886	113	27	.	.	PUNCT
aiua-10886	114	1	as	as	ADV
aiua-10886	114	2	far	far	ADV
aiua-10886	114	3	as	as	SCONJ
aiua-10886	114	4	it	it	PRON
aiua-10886	114	5	concerns	concern	VERB
aiua-10886	114	6	immunohistochemistry	immunohistochemistry	ADV
aiua-10886	114	7	as	as	ADP
aiua-10886	114	8	a	a	DET
aiua-10886	114	9	method	method	NOUN
aiua-10886	114	10	of	of	ADP
aiua-10886	114	11	pten	pten	NOUN
aiua-10886	114	12	and	and	CCONJ
aiua-10886	114	13	erg	erg	PROPN
aiua-10886	114	14	status	status	NOUN
aiua-10886	114	15	evaluation	evaluation	NOUN
aiua-10886	114	16	,	,	PUNCT
aiua-10886	114	17	the	the	DET
aiua-10886	114	18	technique	technique	NOUN
aiua-10886	114	19	presents	present	VERB
aiua-10886	114	20	100	100	NUM
aiua-10886	114	21	%	%	NOUN
aiua-10886	114	22	sensitivity	sensitivity	NOUN
aiua-10886	114	23	and	and	CCONJ
aiua-10886	114	24	97.8	97.8	NUM
aiua-10886	114	25	%	%	NOUN
aiua-10886	114	26	specificity	specificity	NOUN
aiua-10886	114	27	for	for	ADP
aiua-10886	114	28	detecting	detect	VERB
aiua-10886	114	29	pten	pten	ADJ
aiua-10886	114	30	genomic	genomic	NOUN
aiua-10886	114	31	alterations	alteration	NOUN
aiua-10886	114	32	(	(	PUNCT
aiua-10886	114	33	37	37	NUM
aiua-10886	114	34	)	)	PUNCT
aiua-10886	114	35	.	.	PUNCT
aiua-10886	115	1	although	although	SCONJ
aiua-10886	115	2	most	most	ADJ
aiua-10886	115	3	studies	study	NOUN
aiua-10886	115	4	use	use	VERB
aiua-10886	115	5	fish	fish	NOUN
aiua-10886	115	6	in	in	ADP
aiua-10886	115	7	order	order	NOUN
aiua-10886	115	8	to	to	PART
aiua-10886	115	9	detect	detect	VERB
aiua-10886	115	10	pten	pten	ADJ
aiua-10886	115	11	alterations	alteration	NOUN
aiua-10886	115	12	,	,	PUNCT
aiua-10886	115	13	immunohistochemistry	immunohistochemistry	NOUN
aiua-10886	115	14	using	use	VERB
aiua-10886	115	15	commercially	commercially	ADV
aiua-10886	115	16	available	available	ADJ
aiua-10886	115	17	antibodies	antibody	NOUN
aiua-10886	115	18	is	be	AUX
aiua-10886	115	19	a	a	DET
aiua-10886	115	20	validated	validate	VERB
aiua-10886	115	21	method	method	NOUN
aiua-10886	115	22	with	with	ADP
aiua-10886	115	23	similar	similar	ADJ
aiua-10886	115	24	results	result	NOUN
aiua-10886	115	25	as	as	ADP
aiua-10886	115	26	high	high	ADJ
aiua-10886	115	27	concordance	concordance	NOUN
aiua-10886	115	28	is	be	AUX
aiua-10886	115	29	present	present	ADJ
aiua-10886	115	30	between	between	ADP
aiua-10886	115	31	the	the	DET
aiua-10886	115	32	two	two	NUM
aiua-10886	115	33	methods	method	NOUN
aiua-10886	115	34	(	(	PUNCT
aiua-10886	115	35	38	38	NUM
aiua-10886	115	36	,	,	PUNCT
aiua-10886	115	37	39	39	NUM
aiua-10886	115	38	)	)	PUNCT
aiua-10886	115	39	.	.	PUNCT
aiua-10886	116	1	characterization	characterization	NOUN
aiua-10886	116	2	of	of	ADP
aiua-10886	116	3	erg	erg	PROPN
aiua-10886	116	4	status	status	NOUN
aiua-10886	116	5	by	by	ADP
aiua-10886	116	6	immunohistochemistry	immunohistochemistry	NOUN
aiua-10886	116	7	in	in	ADP
aiua-10886	116	8	prostate	prostate	NOUN
aiua-10886	116	9	tissue	tissue	NOUN
aiua-10886	116	10	has	have	VERB
aiua-10886	116	11	also	also	ADV
aiua-10886	116	12	an	an	DET
aiua-10886	116	13	excellent	excellent	ADJ
aiua-10886	116	14	correlation	correlation	NOUN
aiua-10886	116	15	with	with	ADP
aiua-10886	116	16	fish	fish	NOUN
aiua-10886	116	17	and	and	CCONJ
aiua-10886	116	18	is	be	AUX
aiua-10886	116	19	validated	validate	VERB
aiua-10886	116	20	method	method	NOUN
aiua-10886	116	21	to	to	PART
aiua-10886	116	22	be	be	AUX
aiua-10886	116	23	used	use	VERB
aiua-10886	116	24	in	in	ADP
aiua-10886	116	25	clinical	clinical	ADJ
aiua-10886	116	26	practice	practice	NOUN
aiua-10886	116	27	(	(	PUNCT
aiua-10886	116	28	40	40	NUM
aiua-10886	116	29	)	)	PUNCT
aiua-10886	116	30	.	.	PUNCT
aiua-10886	117	1	erg	erg	NOUN
aiua-10886	117	2	fusion	fusion	NOUN
aiua-10886	117	3	protein	protein	NOUN
aiua-10886	117	4	is	be	AUX
aiua-10886	117	5	often	often	ADV
aiua-10886	117	6	accompanied	accompany	VERB
aiua-10886	117	7	by	by	ADP
aiua-10886	117	8	pten	pten	VERB
aiua-10886	117	9	loss	loss	NOUN
aiua-10886	117	10	,	,	PUNCT
aiua-10886	117	11	a	a	DET
aiua-10886	117	12	condition	condition	NOUN
aiua-10886	117	13	which	which	PRON
aiua-10886	117	14	further	far	ADV
aiua-10886	117	15	up	up	ADV
aiua-10886	117	16	regulates	regulate	VERB
aiua-10886	117	17	the	the	DET
aiua-10886	117	18	akt	akt	PROPN
aiua-10886	117	19	pathway	pathway	NOUN
aiua-10886	117	20	leading	lead	VERB
aiua-10886	117	21	to	to	ADP
aiua-10886	117	22	more	more	ADV
aiua-10886	117	23	aggressive	aggressive	ADJ
aiua-10886	117	24	cancer	cancer	NOUN
aiua-10886	117	25	progression	progression	NOUN
aiua-10886	117	26	(	(	PUNCT
aiua-10886	117	27	41	41	NUM
aiua-10886	117	28	)	)	PUNCT
aiua-10886	117	29	.	.	PUNCT
aiua-10886	118	1	early	early	ADV
aiua-10886	118	2	in	in	ADP
aiua-10886	118	3	the	the	DET
aiua-10886	118	4	carcinogenesis	carcinogenesis	NOUN
aiua-10886	118	5	process	process	NOUN
aiua-10886	118	6	,	,	PUNCT
aiua-10886	118	7	pten	pten	VERB
aiua-10886	118	8	loss	loss	NOUN
aiua-10886	118	9	and	and	CCONJ
aiua-10886	118	10	subsequent	subsequent	ADJ
aiua-10886	118	11	low	low	ADJ
aiua-10886	118	12	pten	pten	NOUN
aiua-10886	118	13	protein	protein	NOUN
aiua-10886	118	14	results	result	NOUN
aiua-10886	118	15	in	in	ADP
aiua-10886	118	16	genomic	genomic	ADJ
aiua-10886	118	17	instability	instability	NOUN
aiua-10886	118	18	.	.	PUNCT
aiua-10886	119	1	such	such	ADJ
aiua-10886	119	2	instability	instability	NOUN
aiua-10886	119	3	may	may	AUX
aiua-10886	119	4	provoke	provoke	VERB
aiua-10886	119	5	erg	erg	NOUN
aiua-10886	119	6	fusion	fusion	NOUN
aiua-10886	119	7	and	and	CCONJ
aiua-10886	119	8	thus	thus	ADV
aiua-10886	119	9	a	a	DET
aiua-10886	119	10	synergistic	synergistic	ADJ
aiua-10886	119	11	action	action	NOUN
aiua-10886	119	12	in	in	ADP
aiua-10886	119	13	akt	akt	PROPN
aiua-10886	119	14	pathway	pathway	NOUN
aiua-10886	119	15	leading	lead	VERB
aiua-10886	119	16	to	to	ADP
aiua-10886	119	17	poor	poor	ADJ
aiua-10886	119	18	prognosis	prognosis	NOUN
aiua-10886	119	19	(	(	PUNCT
aiua-10886	119	20	10	10	NUM
aiua-10886	119	21	,	,	PUNCT
aiua-10886	119	22	41	41	NUM
aiua-10886	119	23	)	)	PUNCT
aiua-10886	119	24	.	.	PUNCT
aiua-10886	120	1	regarding	regard	VERB
aiua-10886	120	2	the	the	DET
aiua-10886	120	3	relationship	relationship	NOUN
aiua-10886	120	4	between	between	ADP
aiua-10886	120	5	pten	pten	NOUN
aiua-10886	120	6	and	and	CCONJ
aiua-10886	120	7	erg	erg	X
aiua-10886	120	8	status	status	NOUN
aiua-10886	120	9	in	in	ADP
aiua-10886	120	10	terms	term	NOUN
aiua-10886	120	11	of	of	ADP
aiua-10886	120	12	oncological	oncological	ADJ
aiua-10886	120	13	results	result	NOUN
aiua-10886	120	14	,	,	PUNCT
aiua-10886	120	15	brady	brady	PROPN
aiua-10886	120	16	et	et	PROPN
aiua-10886	120	17	al	al	PROPN
aiua-10886	120	18	.	.	PROPN
aiua-10886	120	19	presented	present	VERB
aiua-10886	120	20	that	that	SCONJ
aiua-10886	120	21	combined	combine	VERB
aiua-10886	120	22	loss	loss	NOUN
aiua-10886	120	23	of	of	ADP
aiua-10886	120	24	pten	pten	NOUN
aiua-10886	120	25	with	with	ADP
aiua-10886	120	26	negative	negative	ADJ
aiua-10886	120	27	erg	erg	NOUN
aiua-10886	120	28	expression	expression	NOUN
aiua-10886	120	29	leads	lead	VERB
aiua-10886	120	30	to	to	ADP
aiua-10886	120	31	a	a	DET
aiua-10886	120	32	trend	trend	NOUN
aiua-10886	120	33	over	over	ADP
aiua-10886	120	34	immediate	immediate	ADJ
aiua-10886	120	35	recurrence	recurrence	NOUN
aiua-10886	120	36	after	after	ADP
aiua-10886	120	37	surgery	surgery	NOUN
aiua-10886	120	38	but	but	CCONJ
aiua-10886	120	39	not	not	PART
aiua-10886	120	40	in	in	ADP
aiua-10886	120	41	a	a	DET
aiua-10886	120	42	statistically	statistically	ADV
aiua-10886	120	43	significant	significant	ADJ
aiua-10886	120	44	way	way	NOUN
aiua-10886	120	45	(	(	PUNCT
aiua-10886	120	46	42	42	NUM
aiua-10886	120	47	)	)	PUNCT
aiua-10886	120	48	.	.	PUNCT
aiua-10886	121	1	on	on	ADP
aiua-10886	121	2	the	the	DET
aiua-10886	121	3	other	other	ADJ
aiua-10886	121	4	hand	hand	NOUN
aiua-10886	121	5	,	,	PUNCT
aiua-10886	121	6	mehra	mehra	PROPN
aiua-10886	121	7	et	et	PROPN
aiua-10886	121	8	al	al	PROPN
aiua-10886	121	9	.	.	PROPN
aiua-10886	121	10	concluded	conclude	VERB
aiua-10886	121	11	that	that	SCONJ
aiua-10886	121	12	patients	patient	NOUN
aiua-10886	121	13	who	who	PRON
aiua-10886	121	14	exhibited	exhibit	VERB
aiua-10886	121	15	erg	erg	PROPN
aiua-10886	121	16	rearrangement	rearrangement	NOUN
aiua-10886	121	17	and	and	CCONJ
aiua-10886	121	18	loss	loss	NOUN
aiua-10886	121	19	of	of	ADP
aiua-10886	121	20	pten	pten	NOUN
aiua-10886	121	21	had	have	VERB
aiua-10886	121	22	no	no	DET
aiua-10886	121	23	significant	significant	ADJ
aiua-10886	121	24	difference	difference	NOUN
aiua-10886	121	25	in	in	ADP
aiua-10886	121	26	time	time	NOUN
aiua-10886	121	27	to	to	ADP
aiua-10886	121	28	recurrence	recurrence	NOUN
aiua-10886	121	29	compared	compare	VERB
aiua-10886	121	30	to	to	ADP
aiua-10886	121	31	patients	patient	NOUN
aiua-10886	121	32	with	with	ADP
aiua-10886	121	33	wild	wild	ADJ
aiua-10886	121	34	-	-	PUNCT
aiua-10886	121	35	type	type	NOUN
aiua-10886	121	36	erg	erg	NOUN
aiua-10886	121	37	and	and	CCONJ
aiua-10886	121	38	loss	loss	NOUN
aiua-10886	121	39	of	of	ADP
aiua-10886	121	40	pten	pten	NOUN
aiua-10886	121	41	(	(	PUNCT
aiua-10886	121	42	21	21	NUM
aiua-10886	121	43	)	)	PUNCT
aiua-10886	121	44	.	.	PUNCT
aiua-10886	122	1	a	a	DET
aiua-10886	122	2	proposed	propose	VERB
aiua-10886	122	3	method	method	NOUN
aiua-10886	122	4	for	for	ADP
aiua-10886	122	5	risk	risk	NOUN
aiua-10886	122	6	stratification	stratification	NOUN
aiua-10886	122	7	in	in	ADP
aiua-10886	122	8	a	a	DET
aiua-10886	122	9	non	non	ADJ
aiua-10886	122	10	-	-	ADJ
aiua-10886	122	11	surgical	surgical	ADJ
aiua-10886	122	12	cohort	cohort	NOUN
aiua-10886	122	13	including	include	VERB
aiua-10886	122	14	patients	patient	NOUN
aiua-10886	122	15	treated	treat	VERB
aiua-10886	122	16	with	with	ADP
aiua-10886	122	17	androgen	androgen	NOUN
aiua-10886	122	18	deprivation	deprivation	NOUN
aiua-10886	122	19	therapy	therapy	NOUN
aiua-10886	122	20	suggests	suggest	VERB
aiua-10886	122	21	that	that	SCONJ
aiua-10886	122	22	worst	bad	ADJ
aiua-10886	122	23	clinical	clinical	ADJ
aiua-10886	122	24	outcome	outcome	NOUN
aiua-10886	122	25	is	be	AUX
aiua-10886	122	26	among	among	ADP
aiua-10886	122	27	patients	patient	NOUN
aiua-10886	122	28	with	with	ADP
aiua-10886	122	29	decreased	decrease	VERB
aiua-10886	122	30	pten	pten	ADJ
aiua-10886	122	31	intensity	intensity	NOUN
aiua-10886	122	32	without	without	ADP
aiua-10886	122	33	erg	erg	PROPN
aiua-10886	122	34	positivity	positivity	NOUN
aiua-10886	122	35	.	.	PUNCT
aiua-10886	123	1	patients	patient	NOUN
aiua-10886	123	2	with	with	ADP
aiua-10886	123	3	positive	positive	ADJ
aiua-10886	123	4	erg	erg	NOUN
aiua-10886	123	5	expression	expression	NOUN
aiua-10886	123	6	presented	present	VERB
aiua-10886	123	7	intermediate	intermediate	ADJ
aiua-10886	123	8	risk	risk	NOUN
aiua-10886	123	9	for	for	ADP
aiua-10886	123	10	lethal	lethal	ADJ
aiua-10886	123	11	disease	disease	NOUN
aiua-10886	123	12	regardless	regardless	ADV
aiua-10886	123	13	pten	pten	VERB
aiua-10886	123	14	status	status	NOUN
aiua-10886	123	15	(	(	PUNCT
aiua-10886	123	16	43	43	NUM
aiua-10886	123	17	)	)	PUNCT
aiua-10886	123	18	.	.	PUNCT
aiua-10886	124	1	in	in	ADP
aiua-10886	124	2	an	an	DET
aiua-10886	124	3	analysis	analysis	NOUN
aiua-10886	124	4	of	of	ADP
aiua-10886	124	5	80	80	NUM
aiua-10886	124	6	pca	pca	NOUN
aiua-10886	124	7	patients	patient	NOUN
aiua-10886	124	8	no	no	DET
aiua-10886	124	9	patient	patient	NOUN
aiua-10886	124	10	with	with	ADP
aiua-10886	124	11	low	low	ADJ
aiua-10886	124	12	grade	grade	NOUN
aiua-10886	124	13	disease	disease	NOUN
aiua-10886	124	14	bared	bare	VERB
aiua-10886	124	15	concurrent	concurrent	ADJ
aiua-10886	124	16	tmprss2	tmprss2	NOUN
aiua-10886	124	17	-	-	PUNCT
aiua-10886	124	18	erg	erg	NOUN
aiua-10886	124	19	fusion	fusion	NOUN
aiua-10886	124	20	and	and	CCONJ
aiua-10886	124	21	pten	pten	VERB
aiua-10886	124	22	loss	loss	NOUN
aiua-10886	124	23	(	(	PUNCT
aiua-10886	124	24	44	44	NUM
aiua-10886	124	25	)	)	PUNCT
aiua-10886	124	26	.	.	PUNCT
aiua-10886	125	1	in	in	ADP
aiua-10886	125	2	a	a	DET
aiua-10886	125	3	large	large	ADJ
aiua-10886	125	4	radical	radical	ADJ
aiua-10886	125	5	prostatectomy	prostatectomy	NOUN
aiua-10886	125	6	cohort	cohort	NOUN
aiua-10886	125	7	including	include	VERB
aiua-10886	125	8	815	815	NUM
aiua-10886	125	9	patients	patient	NOUN
aiua-10886	125	10	,	,	PUNCT
aiua-10886	125	11	loss	loss	NOUN
aiua-10886	125	12	of	of	ADP
aiua-10886	125	13	pten	pten	NOUN
aiua-10886	125	14	in	in	ADP
aiua-10886	125	15	erg	erg	PROPN
aiua-10886	125	16	negative	negative	ADJ
aiua-10886	125	17	patients	patient	NOUN
aiua-10886	125	18	was	be	AUX
aiua-10886	125	19	predictive	predictive	ADJ
aiua-10886	125	20	of	of	ADP
aiua-10886	125	21	secondary	secondary	ADJ
aiua-10886	125	22	therapies	therapy	NOUN
aiua-10886	125	23	as	as	ADV
aiua-10886	125	24	well	well	ADV
aiua-10886	125	25	as	as	ADP
aiua-10886	125	26	shorter	short	ADJ
aiua-10886	125	27	disease	disease	NOUN
aiua-10886	125	28	specific	specific	ADJ
aiua-10886	125	29	survival	survival	NOUN
aiua-10886	125	30	(	(	PUNCT
aiua-10886	125	31	45	45	NUM
aiua-10886	125	32	)	)	PUNCT
aiua-10886	125	33	.	.	PUNCT
aiua-10886	126	1	it	it	PRON
aiua-10886	126	2	is	be	AUX
aiua-10886	126	3	quite	quite	ADV
aiua-10886	126	4	clear	clear	ADJ
aiua-10886	126	5	that	that	SCONJ
aiua-10886	126	6	although	although	SCONJ
aiua-10886	126	7	great	great	ADJ
aiua-10886	126	8	interest	interest	NOUN
aiua-10886	126	9	exists	exist	VERB
aiua-10886	126	10	in	in	ADP
aiua-10886	126	11	determining	determine	VERB
aiua-10886	126	12	the	the	DET
aiua-10886	126	13	role	role	NOUN
aiua-10886	126	14	of	of	ADP
aiua-10886	126	15	combined	combine	VERB
aiua-10886	126	16	pten	pten	ADJ
aiua-10886	126	17	status	status	NOUN
aiua-10886	126	18	with	with	ADP
aiua-10886	126	19	erg	erg	NOUN
aiua-10886	126	20	fusion	fusion	NOUN
aiua-10886	126	21	no	no	DET
aiua-10886	126	22	solid	solid	ADJ
aiua-10886	126	23	conclusions	conclusion	NOUN
aiua-10886	126	24	can	can	AUX
aiua-10886	126	25	be	be	AUX
aiua-10886	126	26	made	make	VERB
aiua-10886	126	27	as	as	SCONJ
aiua-10886	126	28	data	datum	NOUN
aiua-10886	126	29	remain	remain	VERB
aiua-10886	126	30	conflicting	conflicting	ADJ
aiua-10886	126	31	(	(	PUNCT
aiua-10886	126	32	46	46	NUM
aiua-10886	126	33	,	,	PUNCT
aiua-10886	126	34	47	47	NUM
aiua-10886	126	35	)	)	PUNCT
aiua-10886	126	36	.	.	PUNCT
aiua-10886	127	1	to	to	ADP
aiua-10886	127	2	our	our	PRON
aiua-10886	127	3	knowledge	knowledge	NOUN
aiua-10886	127	4	this	this	PRON
aiua-10886	127	5	is	be	AUX
aiua-10886	127	6	the	the	DET
aiua-10886	127	7	first	first	ADJ
aiua-10886	127	8	study	study	NOUN
aiua-10886	127	9	evaluating	evaluate	VERB
aiua-10886	127	10	the	the	DET
aiua-10886	127	11	role	role	NOUN
aiua-10886	127	12	of	of	ADP
aiua-10886	127	13	individual	individual	ADJ
aiua-10886	127	14	pten	pten	NOUN
aiua-10886	127	15	and	and	CCONJ
aiua-10886	127	16	erg	erg	X
aiua-10886	127	17	status	status	NOUN
aiua-10886	127	18	and	and	CCONJ
aiua-10886	127	19	their	their	PRON
aiua-10886	127	20	possible	possible	ADJ
aiua-10886	127	21	combination	combination	NOUN
aiua-10886	127	22	regarding	regard	VERB
aiua-10886	127	23	oncological	oncological	ADJ
aiua-10886	127	24	results	result	NOUN
aiua-10886	127	25	in	in	ADP
aiua-10886	127	26	men	man	NOUN
aiua-10886	127	27	who	who	PRON
aiua-10886	127	28	underwent	undergo	VERB
aiua-10886	127	29	radical	radical	ADJ
aiua-10886	127	30	prostatectomy	prostatectomy	NOUN
aiua-10886	127	31	.	.	PUNCT
aiua-10886	128	1	disadvantages	disadvantage	NOUN
aiua-10886	128	2	of	of	ADP
aiua-10886	128	3	the	the	DET
aiua-10886	128	4	present	present	ADJ
aiua-10886	128	5	study	study	NOUN
aiua-10886	128	6	include	include	VERB
aiua-10886	128	7	the	the	DET
aiua-10886	128	8	relatively	relatively	ADV
aiua-10886	128	9	low	low	ADJ
aiua-10886	128	10	sample	sample	NOUN
aiua-10886	128	11	which	which	PRON
aiua-10886	128	12	underpowered	underpowered	ADJ
aiua-10886	128	13	statistical	statistical	ADJ
aiua-10886	128	14	analysis	analysis	NOUN
aiua-10886	128	15	and	and	CCONJ
aiua-10886	128	16	the	the	DET
aiua-10886	128	17	fact	fact	NOUN
aiua-10886	128	18	that	that	PRON
aiua-10886	128	19	pten	pten	VERB
aiua-10886	128	20	and	and	CCONJ
aiua-10886	128	21	erg	erg	PROPN
aiua-10886	128	22	status	status	NOUN
aiua-10886	128	23	was	be	AUX
aiua-10886	128	24	examined	examine	VERB
aiua-10886	128	25	only	only	ADV
aiua-10886	128	26	by	by	ADP
aiua-10886	128	27	immunohistochemistry	immunohistochemistry	NOUN
aiua-10886	128	28	and	and	CCONJ
aiua-10886	128	29	not	not	PART
aiua-10886	128	30	by	by	ADP
aiua-10886	128	31	fish	fish	NOUN
aiua-10886	128	32	.	.	PUNCT
aiua-10886	129	1	conclusions	conclusion	NOUN
aiua-10886	129	2	homogenous	homogenous	ADJ
aiua-10886	129	3	and	and	CCONJ
aiua-10886	129	4	heterogenous	heterogenous	ADJ
aiua-10886	129	5	pten	pten	NOUN
aiua-10886	129	6	loss	loss	NOUN
aiua-10886	129	7	was	be	AUX
aiua-10886	129	8	associated	associate	VERB
aiua-10886	129	9	with	with	ADP
aiua-10886	129	10	biochemical	biochemical	ADJ
aiua-10886	129	11	recurrence	recurrence	NOUN
aiua-10886	129	12	in	in	ADP
aiua-10886	129	13	pca	pca	NOUN
aiua-10886	129	14	patients	patient	NOUN
aiua-10886	129	15	treated	treat	VERB
aiua-10886	129	16	with	with	ADP
aiua-10886	129	17	radical	radical	ADJ
aiua-10886	129	18	prostatectomy	prostatectomy	NOUN
aiua-10886	129	19	.	.	PUNCT
aiua-10886	130	1	no	no	DET
aiua-10886	130	2	association	association	NOUN
aiua-10886	130	3	of	of	ADP
aiua-10886	130	4	erg	erg	PROPN
aiua-10886	130	5	status	status	NOUN
aiua-10886	130	6	and	and	CCONJ
aiua-10886	130	7	biochemical	biochemical	ADJ
aiua-10886	130	8	recurrence	recurrence	NOUN
aiua-10886	130	9	was	be	AUX
aiua-10886	130	10	noted	note	VERB
aiua-10886	130	11	.	.	PUNCT
aiua-10886	131	1	the	the	DET
aiua-10886	131	2	combination	combination	NOUN
aiua-10886	131	3	of	of	ADP
aiua-10886	131	4	pten	pten	ADJ
aiua-10886	131	5	loss	loss	NOUN
aiua-10886	131	6	and	and	CCONJ
aiua-10886	131	7	erg	erg	PROPN
aiua-10886	131	8	rearrangement	rearrangement	PROPN
aiua-10886	131	9	presented	present	VERB
aiua-10886	131	10	a	a	DET
aiua-10886	131	11	trend	trend	NOUN
aiua-10886	131	12	for	for	ADP
aiua-10886	131	13	higher	high	ADJ
aiua-10886	131	14	isupc	isupc	NOUN
aiua-10886	131	15	and	and	CCONJ
aiua-10886	131	16	isupp	isupp	ADJ
aiua-10886	131	17	as	as	ADV
aiua-10886	131	18	well	well	ADV
aiua-10886	131	19	as	as	ADP
aiua-10886	131	20	biochemical	biochemical	ADJ
aiua-10886	131	21	recurrence	recurrence	NOUN
aiua-10886	131	22	but	but	CCONJ
aiua-10886	131	23	not	not	PART
aiua-10886	131	24	in	in	ADP
aiua-10886	131	25	a	a	DET
aiua-10886	131	26	statistically	statistically	ADV
aiua-10886	131	27	significant	significant	ADJ
aiua-10886	131	28	way	way	NOUN
aiua-10886	131	29	.	.	PUNCT
aiua-10886	132	1	references	reference	NOUN
aiua-10886	132	2	1	1	NUM
aiua-10886	132	3	.	.	PUNCT
aiua-10886	132	4	culp	culp	PROPN
aiua-10886	132	5	mb	mb	PROPN
aiua-10886	132	6	,	,	PUNCT
aiua-10886	132	7	soerjomataram	soerjomataram	PROPN
aiua-10886	132	8	i	i	PROPN
aiua-10886	132	9	,	,	PUNCT
aiua-10886	132	10	efstathiou	efstathiou	PROPN
aiua-10886	132	11	ja	ja	PROPN
aiua-10886	132	12	,	,	PUNCT
aiua-10886	132	13	et	et	PROPN
aiua-10886	132	14	al	al	PROPN
aiua-10886	132	15	.	.	PUNCT
aiua-10886	133	1	recent	recent	ADJ
aiua-10886	133	2	global	global	ADJ
aiua-10886	133	3	patterns	pattern	NOUN
aiua-10886	133	4	in	in	ADP
aiua-10886	133	5	prostate	prostate	NOUN
aiua-10886	133	6	cancer	cancer	NOUN
aiua-10886	133	7	incidence	incidence	NOUN
aiua-10886	133	8	and	and	CCONJ
aiua-10886	133	9	mortality	mortality	NOUN
aiua-10886	133	10	rates	rate	NOUN
aiua-10886	133	11	.	.	PUNCT
aiua-10886	134	1	eur	eur	PROPN
aiua-10886	134	2	urol	urol	PROPN
aiua-10886	134	3	.	.	PUNCT
aiua-10886	134	4	2020	2020	NUM
aiua-10886	134	5	;	;	PUNCT
aiua-10886	134	6	77:38	77:38	NUM
aiua-10886	134	7	-	-	SYM
aiua-10886	134	8	52	52	NUM
aiua-10886	134	9	.	.	PUNCT
aiua-10886	135	1	2	2	NUM
aiua-10886	135	2	.	.	PUNCT
aiua-10886	135	3	hoag	hoag	PROPN
aiua-10886	135	4	j	j	PROPN
aiua-10886	135	5	,	,	PUNCT
aiua-10886	135	6	barbieri	barbieri	PROPN
aiua-10886	135	7	c.	c.	PROPN
aiua-10886	135	8	clinical	clinical	ADJ
aiua-10886	135	9	variability	variability	NOUN
aiua-10886	135	10	and	and	CCONJ
aiua-10886	135	11	molecular	molecular	ADJ
aiua-10886	135	12	heterogeneity	heterogeneity	NOUN
aiua-10886	135	13	in	in	ADP
aiua-10886	135	14	prostate	prostate	NOUN
aiua-10886	135	15	cancer	cancer	NOUN
aiua-10886	135	16	.	.	PUNCT
aiua-10886	136	1	asian	asian	PROPN
aiua-10886	136	2	j	j	PROPN
aiua-10886	136	3	androl	androl	PROPN
aiua-10886	136	4	2016	2016	NUM
aiua-10886	136	5	;	;	PUNCT
aiua-10886	136	6	18:543	18:543	NUM
aiua-10886	136	7	-	-	SYM
aiua-10886	136	8	548	548	NUM
aiua-10886	136	9	.	.	PUNCT
aiua-10886	137	1	3	3	X
aiua-10886	137	2	.	.	X
aiua-10886	137	3	de	de	PROPN
aiua-10886	137	4	velasco	velasco	PROPN
aiua-10886	137	5	ma	ma	PROPN
aiua-10886	137	6	,	,	PUNCT
aiua-10886	137	7	uemura	uemura	PROPN
aiua-10886	137	8	h.	h.	PROPN
aiua-10886	137	9	preclinical	preclinical	ADJ
aiua-10886	137	10	remodeling	remodeling	NOUN
aiua-10886	137	11	of	of	ADP
aiua-10886	137	12	human	human	ADJ
aiua-10886	137	13	prostate	prostate	NOUN
aiua-10886	137	14	cancer	cancer	NOUN
aiua-10886	137	15	through	through	ADP
aiua-10886	137	16	the	the	DET
aiua-10886	137	17	pten	pten	NOUN
aiua-10886	137	18	/	/	SYM
aiua-10886	137	19	akt	akt	PROPN
aiua-10886	137	20	pathway	pathway	NOUN
aiua-10886	137	21	.	.	PUNCT
aiua-10886	138	1	adv	adv	PROPN
aiua-10886	138	2	urol	urol	PROPN
aiua-10886	138	3	.	.	PUNCT
aiua-10886	138	4	2012	2012	NUM
aiua-10886	138	5	;	;	PUNCT
aiua-10886	138	6	2012:419348	2012:419348	NUM
aiua-10886	138	7	.	.	NOUN
aiua-10886	138	8	4	4	X
aiua-10886	138	9	.	.	X
aiua-10886	139	1	hopkins	hopkins	PROPN
aiua-10886	139	2	bd	bd	PROPN
aiua-10886	139	3	,	,	PUNCT
aiua-10886	139	4	parsons	parson	NOUN
aiua-10886	139	5	re	re	VERB
aiua-10886	139	6	.	.	PUNCT
aiua-10886	140	1	molecular	molecular	ADJ
aiua-10886	140	2	pathways	pathway	NOUN
aiua-10886	140	3	:	:	PUNCT
aiua-10886	140	4	intercellular	intercellular	ADJ
aiua-10886	140	5	pten	pten	NOUN
aiua-10886	140	6	and	and	CCONJ
aiua-10886	140	7	the	the	DET
aiua-10886	140	8	potential	potential	NOUN
aiua-10886	140	9	of	of	ADP
aiua-10886	140	10	pten	pten	ADJ
aiua-10886	140	11	restoration	restoration	NOUN
aiua-10886	140	12	therapy	therapy	NOUN
aiua-10886	140	13	.	.	PUNCT
aiua-10886	141	1	clin	clin	PROPN
aiua-10886	141	2	cancer	cancer	NOUN
aiua-10886	141	3	res	re	NOUN
aiua-10886	141	4	.	.	PUNCT
aiua-10886	141	5	2014	2014	NUM
aiua-10886	141	6	;	;	PUNCT
aiua-10886	141	7	20:5379	20:5379	NUM
aiua-10886	141	8	-	-	SYM
aiua-10886	141	9	83	83	NUM
aiua-10886	141	10	.	.	PUNCT
aiua-10886	142	1	5	5	NUM
aiua-10886	142	2	.	.	X
aiua-10886	142	3	park	park	PROPN
aiua-10886	142	4	k	k	PROPN
aiua-10886	142	5	,	,	PUNCT
aiua-10886	142	6	tomlins	tomlins	PROPN
aiua-10886	142	7	sa	sa	PROPN
aiua-10886	142	8	,	,	PUNCT
aiua-10886	142	9	mudaliar	mudaliar	PROPN
aiua-10886	142	10	km	km	PROPN
aiua-10886	142	11	,	,	PUNCT
aiua-10886	142	12	et	et	PROPN
aiua-10886	142	13	al	al	PROPN
aiua-10886	142	14	.	.	PUNCT
aiua-10886	142	15	antibody	antibody	NOUN
aiua-10886	142	16	-	-	PUNCT
aiua-10886	142	17	based	base	VERB
aiua-10886	142	18	detection	detection	NOUN
aiua-10886	142	19	of	of	ADP
aiua-10886	142	20	erg	erg	PROPN
aiua-10886	142	21	rearrangement	rearrangement	ADJ
aiua-10886	142	22	-	-	PUNCT
aiua-10886	142	23	positive	positive	ADJ
aiua-10886	142	24	prostate	prostate	NOUN
aiua-10886	142	25	cancer	cancer	NOUN
aiua-10886	142	26	.	.	PUNCT
aiua-10886	143	1	neoplasia	neoplasia	NOUN
aiua-10886	143	2	.	.	PUNCT
aiua-10886	144	1	2010	2010	NUM
aiua-10886	144	2	;	;	PUNCT
aiua-10886	144	3	12:590	12:590	NUM
aiua-10886	144	4	-	-	SYM
aiua-10886	144	5	8	8	NUM
aiua-10886	144	6	.	.	PUNCT
aiua-10886	145	1	archivio	archivio	NOUN
aiua-10886	145	2	italiano	italiano	X
aiua-10886	145	3	di	di	X
aiua-10886	145	4	urologia	urologia	PROPN
aiua-10886	145	5	e	e	PROPN
aiua-10886	145	6	andrologia	andrologia	PROPN
aiua-10886	145	7	2022	2022	NUM
aiua-10886	145	8	;	;	PUNCT
aiua-10886	145	9	94	94	NUM
aiua-10886	145	10	,	,	PUNCT
aiua-10886	145	11	4	4	NUM
aiua-10886	145	12	c.	c.	PROPN
aiua-10886	145	13	fragkoulis	fragkoulis	PROPN
aiua-10886	145	14	,	,	PUNCT
aiua-10886	145	15	i.	i.	PROPN
aiua-10886	145	16	glykas	glykas	PROPN
aiua-10886	145	17	,	,	PUNCT
aiua-10886	145	18	l.	l.	PROPN
aiua-10886	145	19	tzelves	tzelves	PROPN
aiua-10886	145	20	,	,	PUNCT
aiua-10886	145	21	et	et	PROPN
aiua-10886	145	22	al	al	PROPN
aiua-10886	145	23	.	.	PROPN
aiua-10886	145	24	394	394	NUM
aiua-10886	145	25	6	6	NUM
aiua-10886	145	26	.	.	PUNCT
aiua-10886	146	1	van	van	PROPN
aiua-10886	146	2	leenders	leenders	PROPN
aiua-10886	146	3	gj	gj	PROPN
aiua-10886	146	4	,	,	PUNCT
aiua-10886	146	5	boormans	boorman	VERB
aiua-10886	146	6	jl	jl	PROPN
aiua-10886	146	7	,	,	PUNCT
aiua-10886	146	8	vissers	visser	NOUN
aiua-10886	146	9	cj	cj	PROPN
aiua-10886	146	10	,	,	PUNCT
aiua-10886	146	11	et	et	PROPN
aiua-10886	146	12	al	al	PROPN
aiua-10886	146	13	.	.	PUNCT
aiua-10886	147	1	antibody	antibody	NOUN
aiua-10886	147	2	epr3864	epr3864	NOUN
aiua-10886	147	3	is	be	AUX
aiua-10886	147	4	specific	specific	ADJ
aiua-10886	147	5	for	for	ADP
aiua-10886	147	6	erg	erg	PROPN
aiua-10886	147	7	genomic	genomic	ADJ
aiua-10886	147	8	fusions	fusion	NOUN
aiua-10886	147	9	in	in	ADP
aiua-10886	147	10	prostate	prostate	NOUN
aiua-10886	147	11	cancer	cancer	NOUN
aiua-10886	147	12	:	:	PUNCT
aiua-10886	147	13	implications	implication	NOUN
aiua-10886	147	14	for	for	ADP
aiua-10886	147	15	pathological	pathological	ADJ
aiua-10886	147	16	practice	practice	NOUN
aiua-10886	147	17	.	.	PUNCT
aiua-10886	148	1	mod	mod	PROPN
aiua-10886	148	2	pathol	pathol	PROPN
aiua-10886	148	3	.	.	PUNCT
aiua-10886	149	1	2011	2011	NUM
aiua-10886	149	2	;	;	PUNCT
aiua-10886	149	3	24:1128	24:1128	X
aiua-10886	149	4	-	-	SYM
aiua-10886	149	5	38	38	NUM
aiua-10886	149	6	.	.	PUNCT
aiua-10886	150	1	7	7	X
aiua-10886	150	2	.	.	X
aiua-10886	150	3	demichelis	demichelis	PROPN
aiua-10886	150	4	f	f	PROPN
aiua-10886	150	5	,	,	PUNCT
aiua-10886	150	6	rubin	rubin	PROPN
aiua-10886	150	7	m.	m.	PROPN
aiua-10886	151	1	tmprss2	tmprss2	PROPN
aiua-10886	151	2	:	:	PUNCT
aiua-10886	151	3	erg	erg	PROPN
aiua-10886	151	4	gene	gene	NOUN
aiua-10886	151	5	fusion	fusion	NOUN
aiua-10886	151	6	associated	associate	VERB
aiua-10886	151	7	with	with	ADP
aiua-10886	151	8	lethal	lethal	ADJ
aiua-10886	151	9	prostate	prostate	NOUN
aiua-10886	151	10	cancer	cancer	NOUN
aiua-10886	151	11	in	in	ADP
aiua-10886	151	12	a	a	DET
aiua-10886	151	13	watchful	watchful	ADJ
aiua-10886	151	14	waiting	waiting	NOUN
aiua-10886	151	15	cohort	cohort	NOUN
aiua-10886	151	16	.	.	PUNCT
aiua-10886	152	1	oncogene	oncogene	NOUN
aiua-10886	152	2	2007	2007	NUM
aiua-10886	152	3	;	;	PUNCT
aiua-10886	152	4	26:4596	26:4596	NUM
aiua-10886	152	5	-	-	SYM
aiua-10886	152	6	4599	4599	NUM
aiua-10886	152	7	.	.	PUNCT
aiua-10886	153	1	8	8	NUM
aiua-10886	153	2	.	.	X
aiua-10886	153	3	yoshimoto	yoshimoto	PROPN
aiua-10886	153	4	m	m	PROPN
aiua-10886	153	5	,	,	PUNCT
aiua-10886	153	6	joshua	joshua	PROPN
aiua-10886	153	7	am	am	PROPN
aiua-10886	153	8	,	,	PUNCT
aiua-10886	153	9	cunha	cunha	PROPN
aiua-10886	153	10	iw	iw	PROPN
aiua-10886	153	11	,	,	PUNCT
aiua-10886	153	12	et	et	PROPN
aiua-10886	153	13	al	al	PROPN
aiua-10886	153	14	.	.	PROPN
aiua-10886	153	15	absence	absence	NOUN
aiua-10886	153	16	of	of	ADP
aiua-10886	153	17	tmprss2	tmprss2	ADP
aiua-10886	153	18	:	:	PUNCT
aiua-10886	153	19	erg	erg	PROPN
aiua-10886	153	20	fusions	fusion	NOUN
aiua-10886	153	21	and	and	CCONJ
aiua-10886	153	22	pten	pten	VERB
aiua-10886	153	23	losses	loss	NOUN
aiua-10886	153	24	in	in	ADP
aiua-10886	153	25	prostate	prostate	NOUN
aiua-10886	153	26	cancer	cancer	NOUN
aiua-10886	153	27	is	be	AUX
aiua-10886	153	28	associated	associate	VERB
aiua-10886	153	29	with	with	ADP
aiua-10886	153	30	a	a	DET
aiua-10886	153	31	favorable	favorable	ADJ
aiua-10886	153	32	outcome	outcome	NOUN
aiua-10886	153	33	.	.	PUNCT
aiua-10886	154	1	mod	mod	PROPN
aiua-10886	154	2	pathol	pathol	PROPN
aiua-10886	154	3	.	.	PUNCT
aiua-10886	154	4	2008	2008	NUM
aiua-10886	154	5	;	;	PUNCT
aiua-10886	154	6	21:1451	21:1451	NUM
aiua-10886	154	7	-	-	SYM
aiua-10886	154	8	60	60	NUM
aiua-10886	154	9	.	.	PUNCT
aiua-10886	155	1	9	9	NUM
aiua-10886	155	2	.	.	X
aiua-10886	155	3	cooperberg	cooperberg	PROPN
aiua-10886	155	4	mr	mr	PROPN
aiua-10886	155	5	,	,	PUNCT
aiua-10886	155	6	pasta	pasta	NOUN
aiua-10886	155	7	dj	dj	PROPN
aiua-10886	155	8	,	,	PUNCT
aiua-10886	155	9	elkin	elkin	PROPN
aiua-10886	155	10	ep	ep	PROPN
aiua-10886	155	11	,	,	PUNCT
aiua-10886	155	12	et	et	PROPN
aiua-10886	155	13	al	al	PROPN
aiua-10886	155	14	.	.	PUNCT
aiua-10886	156	1	the	the	DET
aiua-10886	156	2	university	university	PROPN
aiua-10886	156	3	of	of	ADP
aiua-10886	156	4	california	california	PROPN
aiua-10886	156	5	,	,	PUNCT
aiua-10886	156	6	san	san	PROPN
aiua-10886	156	7	francisco	francisco	PROPN
aiua-10886	156	8	cancer	cancer	NOUN
aiua-10886	156	9	of	of	ADP
aiua-10886	156	10	the	the	DET
aiua-10886	156	11	prostate	prostate	NOUN
aiua-10886	156	12	risk	risk	NOUN
aiua-10886	156	13	assessment	assessment	NOUN
aiua-10886	156	14	score	score	NOUN
aiua-10886	156	15	:	:	PUNCT
aiua-10886	156	16	a	a	DET
aiua-10886	156	17	straightforward	straightforward	ADJ
aiua-10886	156	18	and	and	CCONJ
aiua-10886	156	19	reliable	reliable	ADJ
aiua-10886	156	20	preoperative	preoperative	ADJ
aiua-10886	156	21	predictor	predictor	NOUN
aiua-10886	156	22	of	of	ADP
aiua-10886	156	23	disease	disease	NOUN
aiua-10886	156	24	recurrence	recurrence	NOUN
aiua-10886	156	25	after	after	ADP
aiua-10886	156	26	radical	radical	ADJ
aiua-10886	156	27	prostatectomy	prostatectomy	NOUN
aiua-10886	156	28	.	.	PUNCT
aiua-10886	157	1	j	j	PROPN
aiua-10886	157	2	urol	urol	PROPN
aiua-10886	157	3	.	.	PUNCT
aiua-10886	157	4	2005	2005	NUM
aiua-10886	157	5	;	;	PUNCT
aiua-10886	157	6	173:1938	173:1938	NUM
aiua-10886	157	7	-	-	SYM
aiua-10886	157	8	42	42	NUM
aiua-10886	157	9	.	.	PUNCT
aiua-10886	158	1	10	10	NUM
aiua-10886	158	2	.	.	PUNCT
aiua-10886	159	1	phin	phin	PROPN
aiua-10886	159	2	s	s	PROPN
aiua-10886	159	3	,	,	PUNCT
aiua-10886	159	4	moore	moore	PROPN
aiua-10886	159	5	mw	mw	PROPN
aiua-10886	159	6	,	,	PUNCT
aiua-10886	159	7	cotter	cotter	PROPN
aiua-10886	159	8	pd	pd	PROPN
aiua-10886	159	9	.	.	PUNCT
aiua-10886	160	1	genomic	genomic	ADJ
aiua-10886	160	2	rearrangements	rearrangement	NOUN
aiua-10886	160	3	of	of	ADP
aiua-10886	160	4	pten	pten	NOUN
aiua-10886	160	5	in	in	ADP
aiua-10886	160	6	prostate	prostate	NOUN
aiua-10886	160	7	cancer	cancer	NOUN
aiua-10886	160	8	.	.	PUNCT
aiua-10886	161	1	front	front	ADJ
aiua-10886	161	2	oncol	oncol	ADJ
aiua-10886	161	3	.	.	PUNCT
aiua-10886	162	1	2013	2013	NUM
aiua-10886	162	2	;	;	PUNCT
aiua-10886	162	3	3:240	3:240	NUM
aiua-10886	162	4	.	.	NOUN
aiua-10886	163	1	11	11	NUM
aiua-10886	163	2	.	.	PUNCT
aiua-10886	164	1	brunet	brunet	PROPN
aiua-10886	164	2	a	a	PRON
aiua-10886	164	3	,	,	PUNCT
aiua-10886	164	4	bonni	bonni	PROPN
aiua-10886	164	5	a	a	PRON
aiua-10886	164	6	,	,	PUNCT
aiua-10886	164	7	zigmond	zigmond	PROPN
aiua-10886	164	8	mj	mj	PROPN
aiua-10886	164	9	,	,	PUNCT
aiua-10886	164	10	et	et	PROPN
aiua-10886	164	11	al	al	PROPN
aiua-10886	164	12	.	.	PUNCT
aiua-10886	165	1	akt	akt	PROPN
aiua-10886	165	2	promotes	promote	VERB
aiua-10886	165	3	cell	cell	NOUN
aiua-10886	165	4	survival	survival	NOUN
aiua-10886	165	5	by	by	ADP
aiua-10886	165	6	phosphorylating	phosphorylate	VERB
aiua-10886	165	7	and	and	CCONJ
aiua-10886	165	8	inhibiting	inhibit	VERB
aiua-10886	165	9	a	a	DET
aiua-10886	165	10	forkhead	forkhead	NOUN
aiua-10886	165	11	transcription	transcription	NOUN
aiua-10886	165	12	factor	factor	NOUN
aiua-10886	165	13	.	.	PUNCT
aiua-10886	166	1	cell	cell	NOUN
aiua-10886	166	2	.	.	PUNCT
aiua-10886	167	1	1999	1999	NUM
aiua-10886	167	2	;	;	PUNCT
aiua-10886	167	3	96:857	96:857	NUM
aiua-10886	167	4	-	-	SYM
aiua-10886	167	5	68	68	NUM
aiua-10886	167	6	.	.	PUNCT
aiua-10886	167	7	12	12	NUM
aiua-10886	167	8	.	.	PUNCT
aiua-10886	167	9	mayo	mayo	PROPN
aiua-10886	167	10	ld	ld	PROPN
aiua-10886	167	11	,	,	PUNCT
aiua-10886	167	12	donner	donner	PROPN
aiua-10886	167	13	db	db	PROPN
aiua-10886	167	14	.	.	PUNCT
aiua-10886	168	1	a	a	DET
aiua-10886	168	2	phosphatidylinositol	phosphatidylinositol	NOUN
aiua-10886	168	3	3	3	NUM
aiua-10886	168	4	-	-	PUNCT
aiua-10886	168	5	kinase	kinase	NOUN
aiua-10886	168	6	/	/	SYM
aiua-10886	168	7	akt	akt	PROPN
aiua-10886	168	8	pathway	pathway	NOUN
aiua-10886	168	9	promotes	promote	VERB
aiua-10886	168	10	translocation	translocation	NOUN
aiua-10886	168	11	of	of	ADP
aiua-10886	168	12	mdm2	mdm2	PROPN
aiua-10886	168	13	from	from	ADP
aiua-10886	168	14	the	the	DET
aiua-10886	168	15	cytoplasm	cytoplasm	NOUN
aiua-10886	168	16	to	to	ADP
aiua-10886	168	17	the	the	DET
aiua-10886	168	18	nucleus	nucleus	NOUN
aiua-10886	168	19	.	.	PUNCT
aiua-10886	169	1	proc	proc	PROPN
aiua-10886	169	2	natl	natl	PROPN
aiua-10886	169	3	acad	acad	PROPN
aiua-10886	169	4	sci	sci	PROPN
aiua-10886	169	5	u	u	PROPN
aiua-10886	169	6	s	s	NOUN
aiua-10886	169	7	a.	a.	NOUN
aiua-10886	169	8	2001	2001	NUM
aiua-10886	169	9	;	;	PUNCT
aiua-10886	169	10	98:11598	98:11598	NUM
aiua-10886	169	11	-	-	SYM
aiua-10886	169	12	603	603	NUM
aiua-10886	169	13	.	.	PUNCT
aiua-10886	169	14	13	13	NUM
aiua-10886	169	15	.	.	PUNCT
aiua-10886	170	1	navarro	navarro	PROPN
aiua-10886	170	2	d	d	PROPN
aiua-10886	170	3	,	,	PUNCT
aiua-10886	170	4	luzardo	luzardo	PROPN
aiua-10886	170	5	op	op	NOUN
aiua-10886	170	6	,	,	PUNCT
aiua-10886	170	7	fernández	fernández	PROPN
aiua-10886	170	8	l	l	PROPN
aiua-10886	170	9	,	,	PUNCT
aiua-10886	170	10	et	et	PROPN
aiua-10886	170	11	al	al	PROPN
aiua-10886	170	12	.	.	PROPN
aiua-10886	170	13	transition	transition	NOUN
aiua-10886	170	14	to	to	ADP
aiua-10886	170	15	androgen	androgen	NOUN
aiua-10886	170	16	-	-	PUNCT
aiua-10886	170	17	independence	independence	NOUN
aiua-10886	170	18	in	in	ADP
aiua-10886	170	19	prostate	prostate	NOUN
aiua-10886	170	20	cancer	cancer	NOUN
aiua-10886	170	21	.	.	PUNCT
aiua-10886	171	1	j	j	PROPN
aiua-10886	171	2	steroid	steroid	PROPN
aiua-10886	171	3	biochem	biochem	PROPN
aiua-10886	171	4	mol	mol	ADP
aiua-10886	171	5	biol	biol	PROPN
aiua-10886	171	6	.	.	PUNCT
aiua-10886	172	1	2002	2002	NUM
aiua-10886	172	2	;	;	PUNCT
aiua-10886	172	3	81:191	81:191	X
aiua-10886	172	4	-	-	PUNCT
aiua-10886	172	5	201	201	NUM
aiua-10886	172	6	.	.	PUNCT
aiua-10886	173	1	14	14	NUM
aiua-10886	173	2	.	.	PUNCT
aiua-10886	173	3	papatsoris	papatsoris	PROPN
aiua-10886	173	4	ag	ag	PROPN
aiua-10886	173	5	,	,	PUNCT
aiua-10886	173	6	karamouzis	karamouzis	PROPN
aiua-10886	173	7	mv	mv	PROPN
aiua-10886	173	8	,	,	PUNCT
aiua-10886	173	9	papavassiliou	papavassiliou	PROPN
aiua-10886	173	10	ag	ag	PROPN
aiua-10886	173	11	.	.	PUNCT
aiua-10886	174	1	the	the	DET
aiua-10886	174	2	power	power	NOUN
aiua-10886	174	3	and	and	CCONJ
aiua-10886	174	4	promise	promise	NOUN
aiua-10886	174	5	of	of	ADP
aiua-10886	174	6	"	"	PUNCT
aiua-10886	174	7	rewiring	rewire	VERB
aiua-10886	174	8	"	"	PUNCT
aiua-10886	174	9	the	the	DET
aiua-10886	174	10	mitogen	mitogen	NOUN
aiua-10886	174	11	-	-	PUNCT
aiua-10886	174	12	activated	activate	VERB
aiua-10886	174	13	protein	protein	NOUN
aiua-10886	174	14	kinase	kinase	NOUN
aiua-10886	174	15	network	network	NOUN
aiua-10886	174	16	in	in	ADP
aiua-10886	174	17	prostate	prostate	NOUN
aiua-10886	174	18	cancer	cancer	NOUN
aiua-10886	174	19	therapeutics	therapeutic	NOUN
aiua-10886	174	20	.	.	PUNCT
aiua-10886	175	1	mol	mol	ADP
aiua-10886	175	2	cancer	cancer	NOUN
aiua-10886	175	3	ther	ther	ADV
aiua-10886	175	4	.	.	PUNCT
aiua-10886	176	1	2007	2007	NUM
aiua-10886	176	2	;	;	PUNCT
aiua-10886	176	3	6:811	6:811	NUM
aiua-10886	176	4	-	-	SYM
aiua-10886	176	5	9	9	NUM
aiua-10886	176	6	.	.	NOUN
aiua-10886	176	7	15	15	NUM
aiua-10886	176	8	.	.	PUNCT
aiua-10886	177	1	jamaspishvili	jamaspishvili	PROPN
aiua-10886	177	2	t	t	PROPN
aiua-10886	177	3	,	,	PUNCT
aiua-10886	177	4	berman	berman	PROPN
aiua-10886	177	5	dm	dm	PROPN
aiua-10886	177	6	,	,	PUNCT
aiua-10886	177	7	ross	ross	PROPN
aiua-10886	177	8	ae	ae	PROPN
aiua-10886	177	9	,	,	PUNCT
aiua-10886	177	10	et	et	PROPN
aiua-10886	177	11	al	al	PROPN
aiua-10886	177	12	.	.	PUNCT
aiua-10886	178	1	clinical	clinical	ADJ
aiua-10886	178	2	implications	implication	NOUN
aiua-10886	178	3	of	of	ADP
aiua-10886	178	4	pten	pten	ADJ
aiua-10886	178	5	loss	loss	NOUN
aiua-10886	178	6	in	in	ADP
aiua-10886	178	7	prostate	prostate	NOUN
aiua-10886	178	8	cancer	cancer	NOUN
aiua-10886	178	9	.	.	PUNCT
aiua-10886	179	1	nature	nature	NOUN
aiua-10886	179	2	reviews	review	VERB
aiua-10886	179	3	urology	urology	NOUN
aiua-10886	179	4	.	.	PUNCT
aiua-10886	180	1	2018	2018	NUM
aiua-10886	180	2	;	;	PUNCT
aiua-10886	180	3	15:222	15:222	NUM
aiua-10886	180	4	-	-	SYM
aiua-10886	180	5	234	234	NUM
aiua-10886	180	6	.	.	PUNCT
aiua-10886	181	1	16	16	NUM
aiua-10886	181	2	.	.	PUNCT
aiua-10886	182	1	dong	dong	PROPN
aiua-10886	182	2	jt	jt	PROPN
aiua-10886	182	3	,	,	PUNCT
aiua-10886	182	4	li	li	PROPN
aiua-10886	182	5	cl	cl	PROPN
aiua-10886	182	6	,	,	PUNCT
aiua-10886	182	7	sipe	sipe	PROPN
aiua-10886	182	8	tw	tw	PROPN
aiua-10886	182	9	,	,	PUNCT
aiua-10886	182	10	frierson	frierson	PROPN
aiua-10886	182	11	hf	hf	PROPN
aiua-10886	182	12	jr	jr	PROPN
aiua-10886	182	13	.	.	PUNCT
aiua-10886	182	14	mutations	mutation	NOUN
aiua-10886	182	15	of	of	ADP
aiua-10886	182	16	pten	pten	NOUN
aiua-10886	182	17	/	/	SYM
aiua-10886	182	18	mmac1	mmac1	NOUN
aiua-10886	182	19	in	in	ADP
aiua-10886	182	20	primary	primary	ADJ
aiua-10886	182	21	prostate	prostate	NOUN
aiua-10886	182	22	cancers	cancer	NOUN
aiua-10886	182	23	from	from	ADP
aiua-10886	182	24	chinese	chinese	ADJ
aiua-10886	182	25	patients	patient	NOUN
aiua-10886	182	26	.	.	PUNCT
aiua-10886	183	1	clin	clin	PROPN
aiua-10886	183	2	cancer	cancer	NOUN
aiua-10886	183	3	res	re	NOUN
aiua-10886	183	4	.	.	PUNCT
aiua-10886	183	5	2001	2001	NUM
aiua-10886	183	6	;	;	PUNCT
aiua-10886	183	7	7:304	7:304	X
aiua-10886	183	8	-	-	SYM
aiua-10886	183	9	8	8	NUM
aiua-10886	183	10	.	.	PUNCT
aiua-10886	183	11	17	17	NUM
aiua-10886	183	12	.	.	PUNCT
aiua-10886	184	1	patel	patel	PROPN
aiua-10886	184	2	dm	dm	PROPN
aiua-10886	184	3	,	,	PUNCT
aiua-10886	184	4	varma	varma	PROPN
aiua-10886	184	5	pk	pk	PROPN
aiua-10886	184	6	,	,	PUNCT
aiua-10886	184	7	kazi	kazi	PROPN
aiua-10886	184	8	mm	mm	PROPN
aiua-10886	184	9	,	,	PUNCT
aiua-10886	184	10	et	et	PROPN
aiua-10886	184	11	al	al	PROPN
aiua-10886	184	12	.	.	PROPN
aiua-10886	184	13	assessment	assessment	NOUN
aiua-10886	184	14	of	of	ADP
aiua-10886	184	15	pten	pten	ADJ
aiua-10886	184	16	gene	gene	NOUN
aiua-10886	184	17	loss	loss	NOUN
aiua-10886	184	18	as	as	ADP
aiua-10886	184	19	a	a	DET
aiua-10886	184	20	possible	possible	ADJ
aiua-10886	184	21	prognostic	prognostic	ADJ
aiua-10886	184	22	marker	marker	NOUN
aiua-10886	184	23	for	for	ADP
aiua-10886	184	24	prostate	prostate	NOUN
aiua-10886	184	25	cancer	cancer	NOUN
aiua-10886	184	26	.	.	PUNCT
aiua-10886	185	1	j	j	PROPN
aiua-10886	185	2	assoc	assoc	PROPN
aiua-10886	185	3	genet	genet	PROPN
aiua-10886	185	4	technol	technol	PROPN
aiua-10886	185	5	.	.	PUNCT
aiua-10886	185	6	2022	2022	NUM
aiua-10886	185	7	;	;	PUNCT
aiua-10886	185	8	48:63	48:63	NUM
aiua-10886	185	9	-	-	SYM
aiua-10886	185	10	67	67	NUM
aiua-10886	185	11	.	.	PUNCT
aiua-10886	185	12	18	18	NUM
aiua-10886	185	13	.	.	PUNCT
aiua-10886	186	1	gao	gao	PROPN
aiua-10886	186	2	t	t	PROPN
aiua-10886	186	3	,	,	PUNCT
aiua-10886	186	4	mei	mei	PROPN
aiua-10886	186	5	y	y	PROPN
aiua-10886	186	6	,	,	PUNCT
aiua-10886	186	7	sun	sun	PROPN
aiua-10886	186	8	h	h	PROPN
aiua-10886	186	9	,	,	PUNCT
aiua-10886	186	10	et	et	PROPN
aiua-10886	186	11	al	al	PROPN
aiua-10886	186	12	.	.	PUNCT
aiua-10886	187	1	the	the	DET
aiua-10886	187	2	association	association	NOUN
aiua-10886	187	3	of	of	ADP
aiua-10886	187	4	phosphatase	phosphatase	NOUN
aiua-10886	187	5	and	and	CCONJ
aiua-10886	187	6	tensin	tensin	PROPN
aiua-10886	187	7	homolog	homolog	PROPN
aiua-10886	187	8	(	(	PUNCT
aiua-10886	187	9	pten	pten	NOUN
aiua-10886	187	10	)	)	PUNCT
aiua-10886	187	11	deletion	deletion	NOUN
aiua-10886	187	12	and	and	CCONJ
aiua-10886	187	13	prostate	prostate	NOUN
aiua-10886	187	14	cancer	cancer	NOUN
aiua-10886	187	15	risk	risk	NOUN
aiua-10886	187	16	:	:	PUNCT
aiua-10886	187	17	a	a	DET
aiua-10886	187	18	metaanalysis	metaanalysis	NOUN
aiua-10886	187	19	.	.	PUNCT
aiua-10886	187	20	biomed	biome	VERB
aiua-10886	187	21	pharmacother	pharmacother	ADJ
aiua-10886	187	22	.	.	PUNCT
aiua-10886	188	1	2016	2016	NUM
aiua-10886	188	2	;	;	PUNCT
aiua-10886	188	3	83:114	83:114	NUM
aiua-10886	188	4	-	-	SYM
aiua-10886	188	5	121	121	NUM
aiua-10886	188	6	.	.	PUNCT
aiua-10886	189	1	19	19	NUM
aiua-10886	189	2	.	.	PUNCT
aiua-10886	190	1	troyer	troyer	PROPN
aiua-10886	190	2	da	da	PROPN
aiua-10886	190	3	,	,	PUNCT
aiua-10886	190	4	jamaspishvili	jamaspishvili	PROPN
aiua-10886	190	5	t	t	PROPN
aiua-10886	190	6	,	,	PUNCT
aiua-10886	190	7	wei	wei	PROPN
aiua-10886	190	8	w	w	PROPN
aiua-10886	190	9	,	,	PUNCT
aiua-10886	190	10	et	et	PROPN
aiua-10886	190	11	al	al	PROPN
aiua-10886	190	12	.	.	PUNCT
aiua-10886	191	1	a	a	DET
aiua-10886	191	2	multicenter	multicenter	ADJ
aiua-10886	191	3	study	study	NOUN
aiua-10886	191	4	shows	show	NOUN
aiua-10886	191	5	pten	pten	VERB
aiua-10886	191	6	deletion	deletion	NOUN
aiua-10886	191	7	is	be	AUX
aiua-10886	191	8	strongly	strongly	ADV
aiua-10886	191	9	associated	associate	VERB
aiua-10886	191	10	with	with	ADP
aiua-10886	191	11	seminal	seminal	ADJ
aiua-10886	191	12	vesicle	vesicle	NOUN
aiua-10886	191	13	involvement	involvement	NOUN
aiua-10886	191	14	and	and	CCONJ
aiua-10886	191	15	extracapsular	extracapsular	ADJ
aiua-10886	191	16	extension	extension	NOUN
aiua-10886	191	17	in	in	ADP
aiua-10886	191	18	localized	localized	ADJ
aiua-10886	191	19	prostate	prostate	NOUN
aiua-10886	191	20	cancer	cancer	NOUN
aiua-10886	191	21	.	.	PUNCT
aiua-10886	192	1	prostate	prostate	NOUN
aiua-10886	192	2	.	.	PUNCT
aiua-10886	193	1	2015	2015	NUM
aiua-10886	193	2	;	;	PUNCT
aiua-10886	194	1	75:1206	75:1206	NUM
aiua-10886	194	2	-	-	SYM
aiua-10886	194	3	15	15	NUM
aiua-10886	194	4	.	.	NOUN
aiua-10886	194	5	20	20	NUM
aiua-10886	194	6	.	.	PUNCT
aiua-10886	195	1	jamaspishvili	jamaspishvili	PROPN
aiua-10886	195	2	t	t	PROPN
aiua-10886	195	3	,	,	PUNCT
aiua-10886	195	4	patel	patel	PROPN
aiua-10886	195	5	pg	pg	PROPN
aiua-10886	195	6	,	,	PUNCT
aiua-10886	195	7	niu	niu	PROPN
aiua-10886	195	8	y	y	PROPN
aiua-10886	195	9	,	,	PUNCT
aiua-10886	195	10	et	et	PROPN
aiua-10886	195	11	al	al	PROPN
aiua-10886	195	12	.	.	PUNCT
aiua-10886	195	13	risk	risk	NOUN
aiua-10886	195	14	stratification	stratification	NOUN
aiua-10886	195	15	of	of	ADP
aiua-10886	195	16	prostate	prostate	NOUN
aiua-10886	195	17	cancer	cancer	NOUN
aiua-10886	195	18	through	through	ADP
aiua-10886	195	19	quantitative	quantitative	ADJ
aiua-10886	195	20	assessment	assessment	NOUN
aiua-10886	195	21	of	of	ADP
aiua-10886	195	22	pten	pten	ADJ
aiua-10886	195	23	loss	loss	NOUN
aiua-10886	195	24	(	(	PUNCT
aiua-10886	195	25	qpten	qpten	NOUN
aiua-10886	195	26	)	)	PUNCT
aiua-10886	195	27	.	.	PUNCT
aiua-10886	196	1	j	j	PROPN
aiua-10886	196	2	natl	natl	PROPN
aiua-10886	196	3	cancer	cancer	PROPN
aiua-10886	196	4	inst	inst	PROPN
aiua-10886	196	5	.	.	PUNCT
aiua-10886	197	1	2020	2020	NUM
aiua-10886	197	2	;	;	PUNCT
aiua-10886	197	3	112:1098	112:1098	PROPN
aiua-10886	197	4	-	-	SYM
aiua-10886	197	5	1104	1104	NUM
aiua-10886	197	6	.	.	PUNCT
aiua-10886	198	1	21	21	NUM
aiua-10886	198	2	.	.	PUNCT
aiua-10886	199	1	mehra	mehra	PROPN
aiua-10886	199	2	r	r	PROPN
aiua-10886	199	3	,	,	PUNCT
aiua-10886	199	4	salami	salami	PROPN
aiua-10886	199	5	ss	ss	PROPN
aiua-10886	199	6	,	,	PUNCT
aiua-10886	199	7	lonigro	lonigro	ADJ
aiua-10886	199	8	r	r	PROPN
aiua-10886	199	9	,	,	PUNCT
aiua-10886	199	10	et	et	PROPN
aiua-10886	199	11	al	al	PROPN
aiua-10886	199	12	.	.	PROPN
aiua-10886	199	13	association	association	PROPN
aiua-10886	199	14	of	of	ADP
aiua-10886	199	15	erg	erg	PROPN
aiua-10886	199	16	/	/	SYM
aiua-10886	199	17	pten	pten	ADJ
aiua-10886	199	18	status	status	NOUN
aiua-10886	199	19	with	with	ADP
aiua-10886	199	20	biochemical	biochemical	ADJ
aiua-10886	199	21	recurrence	recurrence	NOUN
aiua-10886	199	22	after	after	ADP
aiua-10886	199	23	radical	radical	ADJ
aiua-10886	199	24	prostatectomy	prostatectomy	NOUN
aiua-10886	199	25	for	for	ADP
aiua-10886	199	26	clinically	clinically	ADV
aiua-10886	199	27	localized	localize	VERB
aiua-10886	199	28	prostate	prostate	NOUN
aiua-10886	199	29	cancer	cancer	NOUN
aiua-10886	199	30	.	.	PUNCT
aiua-10886	200	1	med	med	PROPN
aiua-10886	200	2	oncol	oncol	ADJ
aiua-10886	200	3	.	.	PUNCT
aiua-10886	201	1	2018	2018	NUM
aiua-10886	201	2	;	;	PUNCT
aiua-10886	201	3	35:152	35:152	NUM
aiua-10886	201	4	.	.	PUNCT
aiua-10886	202	1	22	22	NUM
aiua-10886	202	2	.	.	PUNCT
aiua-10886	203	1	xie	xie	PROPN
aiua-10886	203	2	h	h	PROPN
aiua-10886	203	3	,	,	PUNCT
aiua-10886	203	4	xie	xie	PROPN
aiua-10886	203	5	b	b	PROPN
aiua-10886	203	6	,	,	PUNCT
aiua-10886	203	7	liu	liu	PROPN
aiua-10886	203	8	c	c	PROPN
aiua-10886	203	9	,	,	PUNCT
aiua-10886	203	10	wang	wang	PROPN
aiua-10886	203	11	j	j	PROPN
aiua-10886	203	12	,	,	PUNCT
aiua-10886	203	13	xu	xu	PROPN
aiua-10886	203	14	y.	y.	PROPN
aiua-10886	203	15	association	association	PROPN
aiua-10886	203	16	of	of	ADP
aiua-10886	203	17	pten	pten	ADJ
aiua-10886	203	18	expression	expression	NOUN
aiua-10886	203	19	with	with	ADP
aiua-10886	203	20	biochemical	biochemical	ADJ
aiua-10886	203	21	recurrence	recurrence	NOUN
aiua-10886	203	22	in	in	ADP
aiua-10886	203	23	prostate	prostate	NOUN
aiua-10886	203	24	cancer	cancer	NOUN
aiua-10886	203	25	:	:	PUNCT
aiua-10886	203	26	results	result	NOUN
aiua-10886	203	27	based	base	VERB
aiua-10886	203	28	on	on	ADP
aiua-10886	203	29	previous	previous	ADJ
aiua-10886	203	30	reports	report	NOUN
aiua-10886	203	31	.	.	PUNCT
aiua-10886	204	1	onco	onco	NOUN
aiua-10886	204	2	targets	target	NOUN
aiua-10886	204	3	ther	ther	ADV
aiua-10886	204	4	.	.	PUNCT
aiua-10886	205	1	2017	2017	NUM
aiua-10886	205	2	;	;	PUNCT
aiua-10886	205	3	10:5089	10:5089	NUM
aiua-10886	205	4	-	-	SYM
aiua-10886	205	5	5097	5097	NUM
aiua-10886	205	6	.	.	PUNCT
aiua-10886	206	1	23	23	NUM
aiua-10886	206	2	.	.	PUNCT
aiua-10886	207	1	geybels	geybel	NOUN
aiua-10886	207	2	ms	ms	PROPN
aiua-10886	207	3	,	,	PUNCT
aiua-10886	207	4	fang	fang	PROPN
aiua-10886	207	5	m	m	PROPN
aiua-10886	207	6	,	,	PUNCT
aiua-10886	207	7	wright	wright	PROPN
aiua-10886	207	8	jl	jl	PROPN
aiua-10886	207	9	,	,	PUNCT
aiua-10886	207	10	et	et	PROPN
aiua-10886	207	11	al	al	PROPN
aiua-10886	207	12	.	.	PROPN
aiua-10886	207	13	pten	pten	PROPN
aiua-10886	207	14	loss	loss	NOUN
aiua-10886	207	15	is	be	AUX
aiua-10886	207	16	associated	associate	VERB
aiua-10886	207	17	with	with	ADP
aiua-10886	207	18	prostate	prostate	NOUN
aiua-10886	207	19	cancer	cancer	NOUN
aiua-10886	207	20	recurrence	recurrence	NOUN
aiua-10886	207	21	and	and	CCONJ
aiua-10886	207	22	alterations	alteration	NOUN
aiua-10886	207	23	in	in	ADP
aiua-10886	207	24	tumor	tumor	NOUN
aiua-10886	207	25	dna	dna	PROPN
aiua-10886	207	26	methylation	methylation	NOUN
aiua-10886	207	27	profiles	profile	NOUN
aiua-10886	207	28	.	.	PUNCT
aiua-10886	208	1	oncotarget	oncotarget	NOUN
aiua-10886	208	2	.	.	PUNCT
aiua-10886	209	1	2017	2017	NUM
aiua-10886	209	2	;	;	PUNCT
aiua-10886	209	3	8:84338	8:84338	NUM
aiua-10886	209	4	-	-	NOUN
aiua-10886	209	5	84348	84348	NUM
aiua-10886	209	6	.	.	PUNCT
aiua-10886	210	1	24	24	NUM
aiua-10886	210	2	.	.	PUNCT
aiua-10886	211	1	lotan	lotan	PROPN
aiua-10886	211	2	tl	tl	PROPN
aiua-10886	211	3	,	,	PUNCT
aiua-10886	211	4	wei	wei	PROPN
aiua-10886	211	5	w	w	PROPN
aiua-10886	211	6	,	,	PUNCT
aiua-10886	211	7	morais	morais	PROPN
aiua-10886	211	8	cl	cl	PROPN
aiua-10886	211	9	,	,	PUNCT
aiua-10886	211	10	et	et	PROPN
aiua-10886	211	11	al	al	PROPN
aiua-10886	211	12	.	.	PROPN
aiua-10886	211	13	pten	pten	PROPN
aiua-10886	211	14	loss	loss	NOUN
aiua-10886	211	15	as	as	SCONJ
aiua-10886	211	16	determined	determine	VERB
aiua-10886	211	17	by	by	ADP
aiua-10886	211	18	clinical	clinical	ADJ
aiua-10886	211	19	-	-	PUNCT
aiua-10886	211	20	grade	grade	NOUN
aiua-10886	211	21	immunohistochemistry	immunohistochemistry	NOUN
aiua-10886	211	22	assay	assay	NOUN
aiua-10886	211	23	is	be	AUX
aiua-10886	211	24	associated	associate	VERB
aiua-10886	211	25	with	with	ADP
aiua-10886	211	26	worse	bad	ADJ
aiua-10886	211	27	recurrence	recurrence	NOUN
aiua-10886	211	28	-	-	PUNCT
aiua-10886	211	29	free	free	ADJ
aiua-10886	211	30	survival	survival	NOUN
aiua-10886	211	31	in	in	ADP
aiua-10886	211	32	prostate	prostate	NOUN
aiua-10886	211	33	cancer	cancer	NOUN
aiua-10886	211	34	.	.	PUNCT
aiua-10886	212	1	eur	eur	PROPN
aiua-10886	212	2	urol	urol	PROPN
aiua-10886	212	3	focus	focus	NOUN
aiua-10886	212	4	.	.	PUNCT
aiua-10886	213	1	2016	2016	NUM
aiua-10886	213	2	;	;	PUNCT
aiua-10886	213	3	2:180	2:180	NUM
aiua-10886	213	4	-	-	SYM
aiua-10886	213	5	188	188	NUM
aiua-10886	213	6	.	.	PUNCT
aiua-10886	214	1	25	25	NUM
aiua-10886	214	2	.	.	X
aiua-10886	214	3	switlyk	switlyk	PROPN
aiua-10886	214	4	md	md	PROPN
aiua-10886	214	5	,	,	PUNCT
aiua-10886	214	6	salberg	salberg	PROPN
aiua-10886	214	7	ub	ub	PROPN
aiua-10886	214	8	,	,	PUNCT
aiua-10886	214	9	geier	geier	NOUN
aiua-10886	214	10	om	om	PROPN
aiua-10886	214	11	,	,	PUNCT
aiua-10886	214	12	et	et	PROPN
aiua-10886	214	13	al	al	PROPN
aiua-10886	214	14	.	.	PROPN
aiua-10886	214	15	pten	pten	VERB
aiua-10886	214	16	expression	expression	NOUN
aiua-10886	214	17	in	in	ADP
aiua-10886	214	18	prostate	prostate	NOUN
aiua-10886	214	19	cancer	cancer	NOUN
aiua-10886	214	20	:	:	PUNCT
aiua-10886	214	21	relationship	relationship	NOUN
aiua-10886	214	22	with	with	ADP
aiua-10886	214	23	clinicopathologic	clinicopathologic	ADJ
aiua-10886	214	24	features	feature	NOUN
aiua-10886	214	25	and	and	CCONJ
aiua-10886	214	26	multiparametric	multiparametric	ADJ
aiua-10886	214	27	mri	mri	NOUN
aiua-10886	214	28	findings	finding	NOUN
aiua-10886	214	29	.	.	PUNCT
aiua-10886	215	1	ajr	ajr	PROPN
aiua-10886	215	2	am	be	AUX
aiua-10886	215	3	j	j	PROPN
aiua-10886	215	4	roentgenol	roentgenol	NOUN
aiua-10886	215	5	.	.	PUNCT
aiua-10886	216	1	2019	2019	NUM
aiua-10886	216	2	;	;	PUNCT
aiua-10886	217	1	19:1	19:1	X
aiua-10886	217	2	-	-	SYM
aiua-10886	217	3	9	9	NUM
aiua-10886	217	4	.	.	NOUN
aiua-10886	217	5	26	26	NUM
aiua-10886	217	6	.	.	PUNCT
aiua-10886	218	1	pettersson	pettersson	PROPN
aiua-10886	218	2	a	a	PRON
aiua-10886	218	3	,	,	PUNCT
aiua-10886	218	4	graff	graff	X
aiua-10886	218	5	re	re	PROPN
aiua-10886	218	6	,	,	PUNCT
aiua-10886	218	7	bauer	bauer	PROPN
aiua-10886	218	8	sr	sr	PROPN
aiua-10886	218	9	,	,	PUNCT
aiua-10886	218	10	et	et	PROPN
aiua-10886	218	11	al	al	PROPN
aiua-10886	218	12	.	.	PUNCT
aiua-10886	219	1	the	the	DET
aiua-10886	219	2	tmprss2	tmprss2	PROPN
aiua-10886	219	3	:	:	PUNCT
aiua-10886	219	4	erg	erg	NOUN
aiua-10886	219	5	rearrangement	rearrangement	NOUN
aiua-10886	219	6	,	,	PUNCT
aiua-10886	219	7	erg	erg	NOUN
aiua-10886	219	8	expression	expression	NOUN
aiua-10886	219	9	,	,	PUNCT
aiua-10886	219	10	and	and	CCONJ
aiua-10886	219	11	prostate	prostate	NOUN
aiua-10886	219	12	cancer	cancer	NOUN
aiua-10886	219	13	outcomes	outcome	NOUN
aiua-10886	219	14	:	:	PUNCT
aiua-10886	219	15	a	a	DET
aiua-10886	219	16	cohort	cohort	NOUN
aiua-10886	219	17	study	study	NOUN
aiua-10886	219	18	and	and	CCONJ
aiua-10886	219	19	meta	meta	ADJ
aiua-10886	219	20	-	-	PUNCT
aiua-10886	219	21	analysis	analysis	NOUN
aiua-10886	219	22	.	.	PUNCT
aiua-10886	220	1	cancer	cancer	NOUN
aiua-10886	220	2	epidemiol	epidemiol	PROPN
aiua-10886	220	3	biomarkers	biomarkers	PROPN
aiua-10886	220	4	prev	prev	NOUN
aiua-10886	220	5	.	.	PUNCT
aiua-10886	220	6	2012	2012	NUM
aiua-10886	220	7	;	;	PUNCT
aiua-10886	221	1	21:1497	21:1497	NUM
aiua-10886	221	2	-	-	SYM
aiua-10886	221	3	509	509	NUM
aiua-10886	221	4	.	.	PUNCT
aiua-10886	222	1	27	27	NUM
aiua-10886	222	2	.	.	PUNCT
aiua-10886	223	1	park	park	PROPN
aiua-10886	223	2	k	k	PROPN
aiua-10886	223	3	,	,	PUNCT
aiua-10886	223	4	tomlins	tomlins	PROPN
aiua-10886	223	5	sa	sa	PROPN
aiua-10886	223	6	,	,	PUNCT
aiua-10886	223	7	mudaliar	mudaliar	PROPN
aiua-10886	223	8	km	km	PROPN
aiua-10886	223	9	,	,	PUNCT
aiua-10886	223	10	et	et	PROPN
aiua-10886	223	11	al	al	PROPN
aiua-10886	223	12	.	.	PUNCT
aiua-10886	223	13	antibody	antibody	NOUN
aiua-10886	223	14	-	-	PUNCT
aiua-10886	223	15	based	base	VERB
aiua-10886	223	16	detection	detection	NOUN
aiua-10886	223	17	of	of	ADP
aiua-10886	223	18	erg	erg	PROPN
aiua-10886	223	19	rearrangement	rearrangement	ADJ
aiua-10886	223	20	-	-	PUNCT
aiua-10886	223	21	positive	positive	ADJ
aiua-10886	223	22	prostate	prostate	NOUN
aiua-10886	223	23	cancer	cancer	NOUN
aiua-10886	223	24	.	.	PUNCT
aiua-10886	224	1	neoplasia	neoplasia	NOUN
aiua-10886	224	2	.	.	PUNCT
aiua-10886	225	1	2010	2010	NUM
aiua-10886	225	2	;	;	PUNCT
aiua-10886	225	3	12:590	12:590	NUM
aiua-10886	225	4	-	-	SYM
aiua-10886	225	5	8	8	NUM
aiua-10886	225	6	.	.	NOUN
aiua-10886	225	7	28	28	NUM
aiua-10886	225	8	.	.	PUNCT
aiua-10886	226	1	krstanoski	krstanoski	PROPN
aiua-10886	226	2	z	z	PROPN
aiua-10886	226	3	,	,	PUNCT
aiua-10886	226	4	vokac	vokac	PROPN
aiua-10886	226	5	nk	nk	PROPN
aiua-10886	226	6	,	,	PUNCT
aiua-10886	226	7	zagorac	zagorac	PROPN
aiua-10886	226	8	a	a	PROPN
aiua-10886	226	9	,	,	PUNCT
aiua-10886	226	10	et	et	PROPN
aiua-10886	226	11	al	al	PROPN
aiua-10886	226	12	.	.	PUNCT
aiua-10886	227	1	tmprss2	tmprss2	PROPN
aiua-10886	227	2	:	:	PUNCT
aiua-10886	227	3	erg	erg	PROPN
aiua-10886	227	4	gene	gene	NOUN
aiua-10886	227	5	aberrations	aberration	NOUN
aiua-10886	227	6	may	may	AUX
aiua-10886	227	7	provide	provide	VERB
aiua-10886	227	8	insight	insight	NOUN
aiua-10886	227	9	into	into	ADP
aiua-10886	227	10	pt	pt	NOUN
aiua-10886	227	11	stage	stage	NOUN
aiua-10886	227	12	in	in	ADP
aiua-10886	227	13	prostate	prostate	NOUN
aiua-10886	227	14	cancer	cancer	NOUN
aiua-10886	227	15	.	.	PUNCT
aiua-10886	228	1	bmc	bmc	PROPN
aiua-10886	228	2	urol	urol	PROPN
aiua-10886	228	3	.	.	PROPN
aiua-10886	229	1	2016	2016	NUM
aiua-10886	229	2	;	;	PUNCT
aiua-10886	229	3	16:35	16:35	NUM
aiua-10886	229	4	.	.	PUNCT
aiua-10886	230	1	29	29	NUM
aiua-10886	230	2	.	.	X
aiua-10886	231	1	fisher	fisher	PROPN
aiua-10886	231	2	kw	kw	PROPN
aiua-10886	231	3	,	,	PUNCT
aiua-10886	231	4	zhang	zhang	PROPN
aiua-10886	231	5	s	s	PROPN
aiua-10886	231	6	,	,	PUNCT
aiua-10886	231	7	wang	wang	PROPN
aiua-10886	231	8	m	m	PROPN
aiua-10886	231	9	,	,	PUNCT
aiua-10886	231	10	et	et	PROPN
aiua-10886	231	11	al	al	PROPN
aiua-10886	231	12	.	.	PUNCT
aiua-10886	232	1	tmprss2	tmprss2	PROPN
aiua-10886	232	2	-	-	PUNCT
aiua-10886	232	3	erg	erg	NOUN
aiua-10886	232	4	gene	gene	NOUN
aiua-10886	232	5	fusion	fusion	NOUN
aiua-10886	232	6	is	be	AUX
aiua-10886	232	7	rare	rare	ADJ
aiua-10886	232	8	compared	compare	VERB
aiua-10886	232	9	to	to	PART
aiua-10886	232	10	pten	pten	VERB
aiua-10886	232	11	deletions	deletion	NOUN
aiua-10886	232	12	in	in	ADP
aiua-10886	232	13	stage	stage	NOUN
aiua-10886	232	14	t1a	t1a	PART
aiua-10886	232	15	prostate	prostate	NOUN
aiua-10886	232	16	cancer	cancer	NOUN
aiua-10886	232	17	.	.	PUNCT
aiua-10886	233	1	mol	mol	ADP
aiua-10886	233	2	carcinog	carcinog	PROPN
aiua-10886	233	3	.	.	PUNCT
aiua-10886	234	1	2017	2017	NUM
aiua-10886	234	2	;	;	PUNCT
aiua-10886	234	3	56:814	56:814	NUM
aiua-10886	234	4	-	-	PUNCT
aiua-10886	234	5	820	820	NUM
aiua-10886	234	6	.	.	PUNCT
aiua-10886	235	1	30	30	NUM
aiua-10886	235	2	.	.	PUNCT
aiua-10886	236	1	kidd	kidd	PROPN
aiua-10886	236	2	sg	sg	PROPN
aiua-10886	236	3	,	,	PUNCT
aiua-10886	236	4	bogaard	bogaard	PROPN
aiua-10886	236	5	m	m	PROPN
aiua-10886	236	6	,	,	PUNCT
aiua-10886	236	7	carm	carm	PROPN
aiua-10886	236	8	kt	kt	PROPN
aiua-10886	236	9	,	,	PUNCT
aiua-10886	236	10	et	et	PROPN
aiua-10886	236	11	al	al	PROPN
aiua-10886	236	12	.	.	PROPN
aiua-10886	237	1	in	in	ADP
aiua-10886	237	2	situ	situ	ADJ
aiua-10886	237	3	expression	expression	NOUN
aiua-10886	237	4	of	of	ADP
aiua-10886	237	5	erg	erg	PROPN
aiua-10886	237	6	protein	protein	NOUN
aiua-10886	237	7	in	in	ADP
aiua-10886	237	8	the	the	DET
aiua-10886	237	9	context	context	NOUN
aiua-10886	237	10	of	of	ADP
aiua-10886	237	11	tumor	tumor	NOUN
aiua-10886	237	12	heterogeneity	heterogeneity	NOUN
aiua-10886	237	13	identifies	identify	VERB
aiua-10886	237	14	prostate	prostate	NOUN
aiua-10886	237	15	cancer	cancer	NOUN
aiua-10886	237	16	patients	patient	NOUN
aiua-10886	237	17	with	with	ADP
aiua-10886	237	18	inferior	inferior	ADJ
aiua-10886	237	19	prognosis	prognosis	NOUN
aiua-10886	237	20	.	.	PUNCT
aiua-10886	238	1	mol	mol	ADP
aiua-10886	238	2	oncol	oncol	ADJ
aiua-10886	238	3	.	.	PUNCT
aiua-10886	238	4	2022	2022	NUM
aiua-10886	238	5	;	;	PUNCT
aiua-10886	238	6	16:2810	16:2810	X
aiua-10886	238	7	-	-	SYM
aiua-10886	238	8	2822	2822	NUM
aiua-10886	238	9	.	.	PUNCT
aiua-10886	239	1	31	31	NUM
aiua-10886	239	2	.	.	PUNCT
aiua-10886	240	1	yılmaz	yılmaz	PROPN
aiua-10886	240	2	ö	ö	PROPN
aiua-10886	240	3	,	,	PUNCT
aiua-10886	240	4	berber	berber	PROPN
aiua-10886	240	5	u	u	PROPN
aiua-10886	240	6	,	,	PUNCT
aiua-10886	240	7	okçelik	okçelik	PROPN
aiua-10886	240	8	s	s	X
aiua-10886	240	9	,	,	PUNCT
aiua-10886	240	10	et	et	PROPN
aiua-10886	240	11	al	al	PROPN
aiua-10886	240	12	.	.	PUNCT
aiua-10886	240	13	tmprss2	tmprss2	PROPN
aiua-10886	240	14	-	-	PUNCT
aiua-10886	240	15	erg	erg	NOUN
aiua-10886	240	16	gene	gene	NOUN
aiua-10886	240	17	fusion	fusion	NOUN
aiua-10886	240	18	in	in	ADP
aiua-10886	240	19	turkish	turkish	ADJ
aiua-10886	240	20	patients	patient	NOUN
aiua-10886	240	21	with	with	ADP
aiua-10886	240	22	localized	localized	ADJ
aiua-10886	240	23	prostate	prostate	NOUN
aiua-10886	240	24	cancer	cancer	NOUN
aiua-10886	240	25	:	:	PUNCT
aiua-10886	240	26	results	result	NOUN
aiua-10886	240	27	of	of	ADP
aiua-10886	240	28	radical	radical	ADJ
aiua-10886	240	29	prostatectomy	prostatectomy	NOUN
aiua-10886	240	30	specimens	specimen	NOUN
aiua-10886	240	31	.	.	PUNCT
aiua-10886	241	1	turk	turk	PROPN
aiua-10886	241	2	j	j	PROPN
aiua-10886	241	3	urol	urol	PROPN
aiua-10886	241	4	.	.	PROPN
aiua-10886	241	5	2016	2016	NUM
aiua-10886	241	6	;	;	PUNCT
aiua-10886	241	7	42:60	42:60	NUM
aiua-10886	241	8	-	-	SYM
aiua-10886	241	9	3	3	NUM
aiua-10886	241	10	.	.	NOUN
aiua-10886	241	11	32	32	NUM
aiua-10886	241	12	.	.	PUNCT
aiua-10886	242	1	lee	lee	PROPN
aiua-10886	242	2	sr	sr	PROPN
aiua-10886	242	3	,	,	PUNCT
aiua-10886	242	4	choi	choi	PROPN
aiua-10886	242	5	yd	yd	PROPN
aiua-10886	242	6	,	,	PUNCT
aiua-10886	242	7	cho	cho	PROPN
aiua-10886	242	8	nh	nh	PROPN
aiua-10886	242	9	.	.	PROPN
aiua-10886	242	10	association	association	PROPN
aiua-10886	242	11	between	between	ADP
aiua-10886	242	12	pathologic	pathologic	ADJ
aiua-10886	242	13	factors	factor	NOUN
aiua-10886	242	14	and	and	CCONJ
aiua-10886	242	15	erg	erg	NOUN
aiua-10886	242	16	expression	expression	NOUN
aiua-10886	242	17	in	in	ADP
aiua-10886	242	18	prostate	prostate	NOUN
aiua-10886	242	19	cancer	cancer	NOUN
aiua-10886	242	20	:	:	PUNCT
aiua-10886	242	21	finding	find	VERB
aiua-10886	242	22	pivotal	pivotal	ADJ
aiua-10886	242	23	networking	networking	NOUN
aiua-10886	242	24	.	.	PUNCT
aiua-10886	243	1	j	j	PROPN
aiua-10886	243	2	cancer	cancer	NOUN
aiua-10886	243	3	res	re	VERB
aiua-10886	243	4	clin	clin	PROPN
aiua-10886	243	5	oncol	oncol	PROPN
aiua-10886	243	6	.	.	PUNCT
aiua-10886	244	1	2018	2018	NUM
aiua-10886	244	2	;	;	PUNCT
aiua-10886	244	3	144:1665	144:1665	NUM
aiua-10886	244	4	-	-	NOUN
aiua-10886	244	5	1683	1683	NUM
aiua-10886	244	6	.	.	PUNCT
aiua-10886	245	1	33	33	NUM
aiua-10886	245	2	.	.	PUNCT
aiua-10886	245	3	baohong	baohong	PROPN
aiua-10886	245	4	j	j	PROPN
aiua-10886	245	5	,	,	PUNCT
aiua-10886	245	6	sedarsky	sedarsky	PROPN
aiua-10886	245	7	j	j	PROPN
aiua-10886	245	8	,	,	PUNCT
aiua-10886	245	9	srivastava	srivastava	PROPN
aiua-10886	245	10	s	s	PROPN
aiua-10886	245	11	,	,	PUNCT
aiua-10886	245	12	et	et	PROPN
aiua-10886	245	13	al	al	PROPN
aiua-10886	245	14	.	.	PUNCT
aiua-10886	245	15	erg	erg	PROPN
aiua-10886	245	16	tumor	tumor	NOUN
aiua-10886	245	17	type	type	NOUN
aiua-10886	245	18	is	be	AUX
aiua-10886	245	19	less	less	ADV
aiua-10886	245	20	frequent	frequent	ADJ
aiua-10886	245	21	in	in	ADP
aiua-10886	245	22	high	high	ADJ
aiua-10886	245	23	grade	grade	NOUN
aiua-10886	245	24	and	and	CCONJ
aiua-10886	245	25	high	high	ADJ
aiua-10886	245	26	stage	stage	NOUN
aiua-10886	245	27	prostate	prostate	NOUN
aiua-10886	245	28	cancers	cancer	NOUN
aiua-10886	245	29	of	of	ADP
aiua-10886	245	30	chinese	chinese	ADJ
aiua-10886	245	31	men	man	NOUN
aiua-10886	245	32	.	.	PUNCT
aiua-10886	246	1	j	j	PROPN
aiua-10886	246	2	cancer	cancer	NOUN
aiua-10886	246	3	.	.	PUNCT
aiua-10886	247	1	2019	2019	NUM
aiua-10886	247	2	;	;	PUNCT
aiua-10886	247	3	10:1991	10:1991	NUM
aiua-10886	247	4	-	-	SYM
aiua-10886	247	5	1996	1996	NUM
aiua-10886	247	6	.	.	PUNCT
aiua-10886	248	1	34	34	NUM
aiua-10886	248	2	.	.	PUNCT
aiua-10886	249	1	kong	kong	PROPN
aiua-10886	249	2	dp	dp	PROPN
aiua-10886	249	3	,	,	PUNCT
aiua-10886	249	4	chen	chen	PROPN
aiua-10886	249	5	r	r	PROPN
aiua-10886	249	6	,	,	PUNCT
aiua-10886	249	7	zhang	zhang	PROPN
aiua-10886	249	8	cl	cl	PROPN
aiua-10886	249	9	,	,	PUNCT
aiua-10886	249	10	et	et	PROPN
aiua-10886	249	11	al	al	PROPN
aiua-10886	249	12	.	.	PUNCT
aiua-10886	250	1	prevalence	prevalence	NOUN
aiua-10886	250	2	and	and	CCONJ
aiua-10886	250	3	clinical	clinical	ADJ
aiua-10886	250	4	application	application	NOUN
aiua-10886	250	5	of	of	ADP
aiua-10886	250	6	tmprss2	tmprss2	NOUN
aiua-10886	250	7	-	-	PUNCT
aiua-10886	250	8	erg	erg	NOUN
aiua-10886	250	9	fusion	fusion	NOUN
aiua-10886	250	10	in	in	ADP
aiua-10886	250	11	asian	asian	ADJ
aiua-10886	250	12	prostate	prostate	NOUN
aiua-10886	250	13	cancer	cancer	NOUN
aiua-10886	250	14	patients	patient	NOUN
aiua-10886	250	15	:	:	PUNCT
aiua-10886	250	16	a	a	DET
aiua-10886	250	17	large	large	ADJ
aiua-10886	250	18	-	-	PUNCT
aiua-10886	250	19	sample	sample	NOUN
aiua-10886	250	20	study	study	NOUN
aiua-10886	250	21	in	in	ADP
aiua-10886	250	22	chinese	chinese	ADJ
aiua-10886	250	23	people	people	NOUN
aiua-10886	250	24	and	and	CCONJ
aiua-10886	250	25	a	a	DET
aiua-10886	250	26	systematic	systematic	ADJ
aiua-10886	250	27	review	review	NOUN
aiua-10886	250	28	.	.	PUNCT
aiua-10886	251	1	asian	asian	PROPN
aiua-10886	251	2	j	j	PROPN
aiua-10886	251	3	androl	androl	PROPN
aiua-10886	251	4	.	.	PUNCT
aiua-10886	252	1	2020	2020	NUM
aiua-10886	252	2	;	;	PUNCT
aiua-10886	252	3	22:200	22:200	NUM
aiua-10886	252	4	-	-	SYM
aiua-10886	252	5	207	207	NUM
aiua-10886	252	6	.	.	PUNCT
aiua-10886	253	1	35	35	NUM
aiua-10886	253	2	.	.	PUNCT
aiua-10886	254	1	liu	liu	PROPN
aiua-10886	254	2	r	r	PROPN
aiua-10886	254	3	,	,	PUNCT
aiua-10886	254	4	zhou	zhou	PROPN
aiua-10886	254	5	j	j	PROPN
aiua-10886	254	6	,	,	PUNCT
aiua-10886	254	7	xia	xia	PROPN
aiua-10886	254	8	s	s	PROPN
aiua-10886	254	9	,	,	PUNCT
aiua-10886	254	10	li	li	PROPN
aiua-10886	254	11	t.	t.	PROPN
aiua-10886	254	12	the	the	DET
aiua-10886	254	13	impact	impact	NOUN
aiua-10886	254	14	of	of	ADP
aiua-10886	254	15	pten	pten	NOUN
aiua-10886	254	16	deletion	deletion	NOUN
aiua-10886	254	17	and	and	CCONJ
aiua-10886	254	18	erg	erg	PROPN
aiua-10886	254	19	rearrangement	rearrangement	NOUN
aiua-10886	254	20	on	on	ADP
aiua-10886	254	21	recurrence	recurrence	NOUN
aiua-10886	254	22	after	after	ADP
aiua-10886	254	23	treatment	treatment	NOUN
aiua-10886	254	24	for	for	ADP
aiua-10886	254	25	prostate	prostate	NOUN
aiua-10886	254	26	cancer	cancer	NOUN
aiua-10886	254	27	:	:	PUNCT
aiua-10886	254	28	a	a	DET
aiua-10886	254	29	systematic	systematic	ADJ
aiua-10886	254	30	review	review	NOUN
aiua-10886	254	31	and	and	CCONJ
aiua-10886	254	32	meta	meta	ADJ
aiua-10886	254	33	-	-	PUNCT
aiua-10886	254	34	analysis	analysis	NOUN
aiua-10886	254	35	.	.	PUNCT
aiua-10886	255	1	clin	clin	PROPN
aiua-10886	255	2	transl	transl	PROPN
aiua-10886	255	3	oncol	oncol	PROPN
aiua-10886	255	4	.	.	PUNCT
aiua-10886	256	1	2020	2020	NUM
aiua-10886	256	2	;	;	PUNCT
aiua-10886	256	3	22:694702	22:694702	NUM
aiua-10886	256	4	.	.	PROPN
aiua-10886	256	5	36	36	NUM
aiua-10886	256	6	.	.	PUNCT
aiua-10886	256	7	khosh	khosh	PROPN
aiua-10886	256	8	kish	kish	PROPN
aiua-10886	256	9	e	e	PROPN
aiua-10886	256	10	,	,	PUNCT
aiua-10886	256	11	choudhry	choudhry	PROPN
aiua-10886	256	12	m	m	PROPN
aiua-10886	256	13	,	,	PUNCT
aiua-10886	256	14	gamallat	gamallat	PROPN
aiua-10886	256	15	y	y	PROPN
aiua-10886	256	16	,	,	PUNCT
aiua-10886	256	17	et	et	PROPN
aiua-10886	256	18	al	al	PROPN
aiua-10886	256	19	.	.	PUNCT
aiua-10886	257	1	the	the	DET
aiua-10886	257	2	expression	expression	NOUN
aiua-10886	257	3	of	of	ADP
aiua-10886	257	4	proto	proto	NOUN
aiua-10886	257	5	-	-	PUNCT
aiua-10886	257	6	oncogene	oncogene	ADJ
aiua-10886	257	7	ets	et	NOUN
aiua-10886	257	8	-	-	PUNCT
aiua-10886	257	9	related	relate	VERB
aiua-10886	257	10	gene	gene	NOUN
aiua-10886	257	11	(	(	PUNCT
aiua-10886	257	12	erg	erg	NOUN
aiua-10886	257	13	)	)	PUNCT
aiua-10886	257	14	plays	play	VERB
aiua-10886	257	15	a	a	DET
aiua-10886	257	16	central	central	ADJ
aiua-10886	257	17	role	role	NOUN
aiua-10886	257	18	in	in	ADP
aiua-10886	257	19	the	the	DET
aiua-10886	257	20	oncogenic	oncogenic	ADJ
aiua-10886	257	21	mechanism	mechanism	NOUN
aiua-10886	257	22	involved	involve	VERB
aiua-10886	257	23	in	in	ADP
aiua-10886	257	24	the	the	DET
aiua-10886	257	25	development	development	NOUN
aiua-10886	257	26	and	and	CCONJ
aiua-10886	257	27	progression	progression	NOUN
aiua-10886	257	28	of	of	ADP
aiua-10886	257	29	prostate	prostate	NOUN
aiua-10886	257	30	cancer	cancer	NOUN
aiua-10886	257	31	.	.	PUNCT
aiua-10886	258	1	int	int	PROPN
aiua-10886	258	2	j	j	PROPN
aiua-10886	258	3	mol	mol	ADP
aiua-10886	258	4	sci	sci	PROPN
aiua-10886	258	5	.	.	PROPN
aiua-10886	258	6	2022	2022	NUM
aiua-10886	258	7	;	;	PUNCT
aiua-10886	258	8	23:4772	23:4772	NUM
aiua-10886	258	9	.	.	NOUN
aiua-10886	258	10	37	37	NUM
aiua-10886	258	11	.	.	PUNCT
aiua-10886	259	1	lotan	lotan	PROPN
aiua-10886	259	2	tl	tl	PROPN
aiua-10886	259	3	,	,	PUNCT
aiua-10886	259	4	gurel	gurel	PROPN
aiua-10886	259	5	b	b	PROPN
aiua-10886	259	6	,	,	PUNCT
aiua-10886	259	7	sutcliffe	sutcliffe	PROPN
aiua-10886	259	8	s	s	PROPN
aiua-10886	259	9	,	,	PUNCT
aiua-10886	259	10	et	et	PROPN
aiua-10886	259	11	al	al	PROPN
aiua-10886	259	12	.	.	PROPN
aiua-10886	259	13	pten	pten	PROPN
aiua-10886	259	14	protein	protein	NOUN
aiua-10886	259	15	loss	loss	NOUN
aiua-10886	259	16	by	by	ADP
aiua-10886	259	17	immunostaining	immunostaine	VERB
aiua-10886	259	18	:	:	PUNCT
aiua-10886	259	19	analytic	analytic	ADJ
aiua-10886	259	20	validation	validation	NOUN
aiua-10886	259	21	and	and	CCONJ
aiua-10886	259	22	prognostic	prognostic	ADJ
aiua-10886	259	23	indicator	indicator	NOUN
aiua-10886	259	24	for	for	ADP
aiua-10886	259	25	a	a	DET
aiua-10886	259	26	high	high	ADJ
aiua-10886	259	27	risk	risk	NOUN
aiua-10886	259	28	surgical	surgical	ADJ
aiua-10886	259	29	cohort	cohort	NOUN
aiua-10886	259	30	of	of	ADP
aiua-10886	259	31	prostate	prostate	NOUN
aiua-10886	259	32	cancer	cancer	NOUN
aiua-10886	259	33	patients	patient	NOUN
aiua-10886	259	34	.	.	PUNCT
aiua-10886	260	1	clin	clin	PROPN
aiua-10886	260	2	cancer	cancer	NOUN
aiua-10886	260	3	res	re	NOUN
aiua-10886	260	4	.	.	PUNCT
aiua-10886	260	5	2011	2011	NUM
aiua-10886	260	6	;	;	PUNCT
aiua-10886	260	7	17:6563	17:6563	NUM
aiua-10886	260	8	-	-	SYM
aiua-10886	260	9	73	73	NUM
aiua-10886	260	10	.	.	PUNCT
aiua-10886	261	1	38	38	NUM
aiua-10886	261	2	.	.	PUNCT
aiua-10886	262	1	lotan	lotan	PROPN
aiua-10886	262	2	tl	tl	PROPN
aiua-10886	262	3	,	,	PUNCT
aiua-10886	262	4	heumann	heumann	PROPN
aiua-10886	262	5	a	a	PROPN
aiua-10886	262	6	,	,	PUNCT
aiua-10886	262	7	rico	rico	PROPN
aiua-10886	262	8	sd	sd	NOUN
aiua-10886	262	9	,	,	PUNCT
aiua-10886	262	10	et	et	PROPN
aiua-10886	262	11	al	al	PROPN
aiua-10886	262	12	.	.	PROPN
aiua-10886	262	13	pten	pten	PROPN
aiua-10886	262	14	loss	loss	NOUN
aiua-10886	262	15	detection	detection	NOUN
aiua-10886	262	16	in	in	ADP
aiua-10886	262	17	prostate	prostate	NOUN
aiua-10886	262	18	cancer	cancer	NOUN
aiua-10886	262	19	:	:	PUNCT
aiua-10886	262	20	comparison	comparison	NOUN
aiua-10886	262	21	of	of	ADP
aiua-10886	262	22	pten	pten	ADJ
aiua-10886	262	23	immunohistochemistry	immunohistochemistry	NOUN
aiua-10886	262	24	and	and	CCONJ
aiua-10886	262	25	pten	pten	VERB
aiua-10886	262	26	fish	fish	NOUN
aiua-10886	262	27	in	in	ADP
aiua-10886	262	28	a	a	DET
aiua-10886	262	29	large	large	ADJ
aiua-10886	262	30	retrospective	retrospective	NOUN
aiua-10886	262	31	prostatectomy	prostatectomy	NOUN
aiua-10886	262	32	cohort	cohort	NOUN
aiua-10886	262	33	.	.	PUNCT
aiua-10886	263	1	oncotarget	oncotarget	NOUN
aiua-10886	263	2	.	.	PUNCT
aiua-10886	264	1	2017	2017	NUM
aiua-10886	264	2	;	;	PUNCT
aiua-10886	264	3	8:65566	8:65566	NUM
aiua-10886	264	4	-	-	SYM
aiua-10886	264	5	65576	65576	NUM
aiua-10886	264	6	.	.	PUNCT
aiua-10886	265	1	39	39	NUM
aiua-10886	265	2	.	.	PUNCT
aiua-10886	266	1	lotan	lotan	PROPN
aiua-10886	266	2	tl	tl	PROPN
aiua-10886	266	3	,	,	PUNCT
aiua-10886	266	4	wei	wei	PROPN
aiua-10886	266	5	w	w	PROPN
aiua-10886	266	6	,	,	PUNCT
aiua-10886	266	7	ludkovski	ludkovski	ADJ
aiua-10886	266	8	o	o	NOUN
aiua-10886	266	9	,	,	PUNCT
aiua-10886	266	10	et	et	PROPN
aiua-10886	266	11	al	al	PROPN
aiua-10886	266	12	.	.	PUNCT
aiua-10886	267	1	analytic	analytic	ADJ
aiua-10886	267	2	validation	validation	NOUN
aiua-10886	267	3	of	of	ADP
aiua-10886	267	4	a	a	DET
aiua-10886	267	5	clinical	clinical	ADJ
aiua-10886	267	6	-	-	PUNCT
aiua-10886	267	7	grade	grade	NOUN
aiua-10886	267	8	pten	pten	NOUN
aiua-10886	267	9	immunohistochemistry	immunohistochemistry	NOUN
aiua-10886	267	10	assay	assay	PROPN
aiua-10886	267	11	in	in	ADP
aiua-10886	267	12	prostate	prostate	NOUN
aiua-10886	267	13	cancer	cancer	NOUN
aiua-10886	267	14	by	by	ADP
aiua-10886	267	15	comparison	comparison	NOUN
aiua-10886	267	16	with	with	ADP
aiua-10886	267	17	pten	pten	ADJ
aiua-10886	267	18	fish	fish	NOUN
aiua-10886	267	19	.	.	PUNCT
aiua-10886	268	1	mod	mod	PROPN
aiua-10886	268	2	pathol	pathol	PROPN
aiua-10886	268	3	.	.	PUNCT
aiua-10886	269	1	2016	2016	NUM
aiua-10886	269	2	;	;	PUNCT
aiua-10886	269	3	29:904	29:904	NUM
aiua-10886	269	4	-	-	SYM
aiua-10886	269	5	14	14	NUM
aiua-10886	269	6	.	.	PUNCT
aiua-10886	270	1	40	40	NUM
aiua-10886	270	2	.	.	PUNCT
aiua-10886	271	1	navaei	navaei	PROPN
aiua-10886	271	2	ah	ah	INTJ
aiua-10886	271	3	,	,	PUNCT
aiua-10886	271	4	walter	walter	PROPN
aiua-10886	271	5	ba	ba	PROPN
aiua-10886	271	6	,	,	PUNCT
aiua-10886	271	7	moreno	moreno	PROPN
aiua-10886	271	8	v	v	PROPN
aiua-10886	271	9	,	,	PUNCT
aiua-10886	271	10	et	et	PROPN
aiua-10886	271	11	al	al	PROPN
aiua-10886	271	12	.	.	PROPN
aiua-10886	271	13	correlation	correlation	NOUN
aiua-10886	271	14	between	between	ADP
aiua-10886	271	15	erg	erg	NOUN
aiua-10886	271	16	fusion	fusion	NOUN
aiua-10886	271	17	protein	protein	NOUN
aiua-10886	271	18	and	and	CCONJ
aiua-10886	271	19	androgen	androgen	NOUN
aiua-10886	271	20	receptor	receptor	NOUN
aiua-10886	271	21	expression	expression	NOUN
aiua-10886	271	22	by	by	ADP
aiua-10886	271	23	immunohistochemistry	immunohistochemistry	NOUN
aiua-10886	271	24	in	in	ADP
aiua-10886	271	25	prostate	prostate	NOUN
aiua-10886	271	26	,	,	PUNCT
aiua-10886	271	27	possible	possible	ADJ
aiua-10886	271	28	role	role	NOUN
aiua-10886	271	29	in	in	ADP
aiua-10886	271	30	diagnosis	diagnosis	NOUN
aiua-10886	271	31	and	and	CCONJ
aiua-10886	271	32	therapy	therapy	NOUN
aiua-10886	271	33	.	.	PUNCT
aiua-10886	272	1	j	j	PROPN
aiua-10886	272	2	cancer	cancer	NOUN
aiua-10886	272	3	.	.	PUNCT
aiua-10886	273	1	2017	2017	NUM
aiua-10886	273	2	;	;	PUNCT
aiua-10886	273	3	8:2604	8:2604	NUM
aiua-10886	273	4	-	-	SYM
aiua-10886	273	5	2613	2613	NUM
aiua-10886	273	6	.	.	PUNCT
aiua-10886	274	1	41	41	NUM
aiua-10886	274	2	.	.	PUNCT
aiua-10886	275	1	squire	squire	PROPN
aiua-10886	275	2	ja	ja	PROPN
aiua-10886	275	3	.	.	PUNCT
aiua-10886	276	1	tmprss2	tmprss2	PROPN
aiua-10886	276	2	-	-	PUNCT
aiua-10886	276	3	erg	erg	PROPN
aiua-10886	276	4	and	and	CCONJ
aiua-10886	276	5	pten	pten	VERB
aiua-10886	276	6	loss	loss	NOUN
aiua-10886	276	7	in	in	ADP
aiua-10886	276	8	prostate	prostate	NOUN
aiua-10886	276	9	cancer	cancer	NOUN
aiua-10886	276	10	.	.	PUNCT
aiua-10886	277	1	nat	nat	PROPN
aiua-10886	277	2	genet	genet	PROPN
aiua-10886	277	3	.	.	PUNCT
aiua-10886	278	1	2009	2009	NUM
aiua-10886	278	2	;	;	PUNCT
aiua-10886	278	3	41:509	41:509	NUM
aiua-10886	278	4	-	-	SYM
aiua-10886	278	5	10	10	NUM
aiua-10886	278	6	.	.	PUNCT
aiua-10886	279	1	395archivio	395archivio	PROPN
aiua-10886	279	2	italiano	italiano	NOUN
aiua-10886	279	3	di	di	X
aiua-10886	279	4	urologia	urologia	PROPN
aiua-10886	279	5	e	e	PROPN
aiua-10886	279	6	andrologia	andrologia	PROPN
aiua-10886	279	7	2022	2022	NUM
aiua-10886	279	8	;	;	PUNCT
aiua-10886	279	9	94	94	NUM
aiua-10886	279	10	,	,	PUNCT
aiua-10886	279	11	4	4	NUM
aiua-10886	279	12	erg	erg	ADV
aiua-10886	279	13	and	and	CCONJ
aiua-10886	279	14	pten	pten	VERB
aiua-10886	279	15	status	status	NOUN
aiua-10886	279	16	in	in	ADP
aiua-10886	279	17	prostate	prostate	NOUN
aiua-10886	279	18	cancer	cancer	NOUN
aiua-10886	279	19	42	42	NUM
aiua-10886	279	20	.	.	PUNCT
aiua-10886	280	1	brady	brady	PROPN
aiua-10886	280	2	l	l	PROPN
aiua-10886	280	3	,	,	PUNCT
aiua-10886	280	4	carlsson	carlsson	PROPN
aiua-10886	280	5	j	j	PROPN
aiua-10886	280	6	,	,	PUNCT
aiua-10886	280	7	baird	baird	PROPN
aiua-10886	280	8	am	be	AUX
aiua-10886	280	9	,	,	PUNCT
aiua-10886	280	10	et	et	PROPN
aiua-10886	280	11	al	al	PROPN
aiua-10886	280	12	.	.	PUNCT
aiua-10886	280	13	correlation	correlation	NOUN
aiua-10886	280	14	of	of	ADP
aiua-10886	280	15	integrated	integrated	ADJ
aiua-10886	280	16	erg	erg	NOUN
aiua-10886	280	17	/	/	SYM
aiua-10886	280	18	pten	pten	ADJ
aiua-10886	280	19	assessment	assessment	NOUN
aiua-10886	280	20	with	with	ADP
aiua-10886	280	21	biochemical	biochemical	ADJ
aiua-10886	280	22	recurrence	recurrence	NOUN
aiua-10886	280	23	in	in	ADP
aiua-10886	280	24	prostate	prostate	NOUN
aiua-10886	280	25	cancer	cancer	NOUN
aiua-10886	280	26	.	.	PUNCT
aiua-10886	281	1	cancer	cancer	NOUN
aiua-10886	281	2	treat	treat	VERB
aiua-10886	281	3	res	re	NOUN
aiua-10886	281	4	commun	commun	PROPN
aiua-10886	281	5	.	.	PUNCT
aiua-10886	281	6	2021	2021	NUM
aiua-10886	281	7	;	;	PUNCT
aiua-10886	281	8	29:100451	29:100451	NUM
aiua-10886	281	9	.	.	X
aiua-10886	282	1	43	43	NUM
aiua-10886	282	2	.	.	PUNCT
aiua-10886	283	1	bismar	bismar	PROPN
aiua-10886	283	2	ta	ta	PROPN
aiua-10886	283	3	,	,	PUNCT
aiua-10886	283	4	hegazy	hegazy	PROPN
aiua-10886	283	5	s	s	PROPN
aiua-10886	283	6	,	,	PUNCT
aiua-10886	283	7	feng	feng	PROPN
aiua-10886	283	8	z	z	PROPN
aiua-10886	283	9	,	,	PUNCT
aiua-10886	283	10	et	et	PROPN
aiua-10886	283	11	al	al	PROPN
aiua-10886	283	12	.	.	PROPN
aiua-10886	284	1	clinical	clinical	ADJ
aiua-10886	284	2	utility	utility	NOUN
aiua-10886	284	3	of	of	ADP
aiua-10886	284	4	assessing	assess	VERB
aiua-10886	284	5	pten	pten	NOUN
aiua-10886	284	6	and	and	CCONJ
aiua-10886	284	7	erg	erg	NOUN
aiua-10886	284	8	protein	protein	NOUN
aiua-10886	284	9	expression	expression	NOUN
aiua-10886	284	10	in	in	ADP
aiua-10886	284	11	prostate	prostate	NOUN
aiua-10886	284	12	cancer	cancer	NOUN
aiua-10886	284	13	patients	patient	NOUN
aiua-10886	284	14	:	:	PUNCT
aiua-10886	284	15	a	a	DET
aiua-10886	284	16	proposed	propose	VERB
aiua-10886	284	17	method	method	NOUN
aiua-10886	284	18	for	for	ADP
aiua-10886	284	19	risk	risk	NOUN
aiua-10886	284	20	stratification	stratification	NOUN
aiua-10886	284	21	.	.	PUNCT
aiua-10886	285	1	j	j	PROPN
aiua-10886	285	2	cancer	cancer	NOUN
aiua-10886	285	3	res	re	VERB
aiua-10886	285	4	clin	clin	PROPN
aiua-10886	285	5	oncol	oncol	PROPN
aiua-10886	285	6	.	.	PUNCT
aiua-10886	286	1	2018	2018	NUM
aiua-10886	286	2	;	;	PUNCT
aiua-10886	286	3	144:2117	144:2117	NUM
aiua-10886	286	4	-	-	SYM
aiua-10886	286	5	2125	2125	NUM
aiua-10886	286	6	.	.	PUNCT
aiua-10886	287	1	44	44	NUM
aiua-10886	287	2	.	.	PUNCT
aiua-10886	288	1	hernández	hernández	PROPN
aiua-10886	288	2	s	s	PROPN
aiua-10886	288	3	,	,	PUNCT
aiua-10886	288	4	font	font	NOUN
aiua-10886	288	5	-	-	PUNCT
aiua-10886	288	6	tello	tello	PROPN
aiua-10886	289	1	a	a	DET
aiua-10886	289	2	,	,	PUNCT
aiua-10886	289	3	juanpere	juanpere	ADV
aiua-10886	289	4	n	n	CCONJ
aiua-10886	289	5	,	,	PUNCT
aiua-10886	289	6	et	et	PROPN
aiua-10886	289	7	al	al	PROPN
aiua-10886	289	8	.	.	PUNCT
aiua-10886	289	9	concurrent	concurrent	PROPN
aiua-10886	289	10	tmprss2	tmprss2	PROPN
aiua-10886	289	11	-	-	PUNCT
aiua-10886	289	12	erg	erg	PROPN
aiua-10886	289	13	and	and	CCONJ
aiua-10886	289	14	slc45a3	slc45a3	PROPN
aiua-10886	289	15	-	-	PUNCT
aiua-10886	289	16	erg	erg	PROPN
aiua-10886	289	17	rearrangements	rearrangement	NOUN
aiua-10886	289	18	plus	plus	CCONJ
aiua-10886	289	19	pten	pten	VERB
aiua-10886	289	20	loss	loss	NOUN
aiua-10886	289	21	are	be	AUX
aiua-10886	289	22	not	not	PART
aiua-10886	289	23	found	find	VERB
aiua-10886	289	24	in	in	ADP
aiua-10886	289	25	low	low	ADJ
aiua-10886	289	26	grade	grade	NOUN
aiua-10886	289	27	prostate	prostate	NOUN
aiua-10886	289	28	cancer	cancer	NOUN
aiua-10886	289	29	and	and	CCONJ
aiua-10886	289	30	define	define	VERB
aiua-10886	289	31	an	an	DET
aiua-10886	289	32	aggressive	aggressive	ADJ
aiua-10886	289	33	tumor	tumor	NOUN
aiua-10886	289	34	subset	subset	NOUN
aiua-10886	289	35	.	.	PUNCT
aiua-10886	290	1	prostate	prostate	NOUN
aiua-10886	290	2	.	.	PUNCT
aiua-10886	291	1	2016	2016	NUM
aiua-10886	291	2	;	;	PUNCT
aiua-10886	291	3	76:854	76:854	NUM
aiua-10886	291	4	-	-	SYM
aiua-10886	291	5	65	65	NUM
aiua-10886	291	6	.	.	PUNCT
aiua-10886	292	1	45	45	NUM
aiua-10886	292	2	.	.	PUNCT
aiua-10886	293	1	lahdensuo	lahdensuo	PROPN
aiua-10886	293	2	k	k	PROPN
aiua-10886	293	3	,	,	PUNCT
aiua-10886	293	4	erickson	erickson	PROPN
aiua-10886	293	5	a	a	PROPN
aiua-10886	293	6	,	,	PUNCT
aiua-10886	293	7	saarinen	saarinen	PROPN
aiua-10886	293	8	i	i	PRON
aiua-10886	293	9	,	,	PUNCT
aiua-10886	293	10	et	et	PROPN
aiua-10886	293	11	al	al	PROPN
aiua-10886	293	12	.	.	PUNCT
aiua-10886	293	13	loss	loss	NOUN
aiua-10886	293	14	of	of	ADP
aiua-10886	293	15	pten	pten	ADJ
aiua-10886	293	16	expression	expression	NOUN
aiua-10886	293	17	in	in	ADP
aiua-10886	293	18	erg	erg	ADJ
aiua-10886	293	19	-	-	PUNCT
aiua-10886	293	20	negative	negative	ADJ
aiua-10886	293	21	prostate	prostate	NOUN
aiua-10886	293	22	cancer	cancer	NOUN
aiua-10886	293	23	predicts	predict	VERB
aiua-10886	293	24	secondary	secondary	ADJ
aiua-10886	293	25	therapies	therapy	NOUN
aiua-10886	293	26	and	and	CCONJ
aiua-10886	293	27	leads	lead	VERB
aiua-10886	293	28	to	to	ADP
aiua-10886	293	29	shorter	short	ADJ
aiua-10886	293	30	disease	disease	NOUN
aiua-10886	293	31	-	-	PUNCT
aiua-10886	293	32	specific	specific	ADJ
aiua-10886	293	33	survival	survival	NOUN
aiua-10886	293	34	time	time	NOUN
aiua-10886	293	35	after	after	ADP
aiua-10886	293	36	radical	radical	ADJ
aiua-10886	293	37	prostatectomy	prostatectomy	NOUN
aiua-10886	293	38	.	.	PUNCT
aiua-10886	294	1	mod	mod	PROPN
aiua-10886	294	2	pathol	pathol	PROPN
aiua-10886	294	3	.	.	PUNCT
aiua-10886	295	1	2016	2016	NUM
aiua-10886	295	2	;	;	PUNCT
aiua-10886	295	3	29:1565	29:1565	NOUN
aiua-10886	295	4	-	-	PUNCT
aiua-10886	295	5	1574	1574	NUM
aiua-10886	295	6	.	.	PUNCT
aiua-10886	296	1	46	46	NUM
aiua-10886	296	2	.	.	PUNCT
aiua-10886	297	1	ullman	ullman	PROPN
aiua-10886	297	2	d	d	PROPN
aiua-10886	297	3	,	,	PUNCT
aiua-10886	297	4	dorn	dorn	PROPN
aiua-10886	297	5	d	d	PROPN
aiua-10886	297	6	,	,	PUNCT
aiua-10886	297	7	rais	rais	NOUN
aiua-10886	297	8	-	-	PUNCT
aiua-10886	297	9	bahrami	bahrami	NOUN
aiua-10886	297	10	s	s	PROPN
aiua-10886	297	11	,	,	PUNCT
aiua-10886	297	12	gordetsky	gordetsky	PROPN
aiua-10886	297	13	j.	j.	PROPN
aiua-10886	297	14	clinical	clinical	ADJ
aiua-10886	297	15	utility	utility	NOUN
aiua-10886	297	16	and	and	CCONJ
aiua-10886	297	17	biologic	biologic	NOUN
aiua-10886	297	18	implications	implication	NOUN
aiua-10886	297	19	of	of	ADP
aiua-10886	297	20	phosphatase	phosphatase	NOUN
aiua-10886	297	21	and	and	CCONJ
aiua-10886	297	22	tensin	tensin	PROPN
aiua-10886	297	23	homolog	homolog	PROPN
aiua-10886	297	24	(	(	PUNCT
aiua-10886	297	25	pten	pten	NOUN
aiua-10886	297	26	)	)	PUNCT
aiua-10886	297	27	and	and	CCONJ
aiua-10886	297	28	ets	et	NOUN
aiua-10886	297	29	-	-	PUNCT
aiua-10886	297	30	related	relate	VERB
aiua-10886	297	31	gene	gene	NOUN
aiua-10886	297	32	(	(	PUNCT
aiua-10886	297	33	erg	erg	NOUN
aiua-10886	297	34	)	)	PUNCT
aiua-10886	297	35	in	in	ADP
aiua-10886	297	36	prostate	prostate	NOUN
aiua-10886	297	37	cancer	cancer	NOUN
aiua-10886	297	38	.	.	PUNCT
aiua-10886	298	1	urology	urology	NOUN
aiua-10886	298	2	.	.	PUNCT
aiua-10886	299	1	2018	2018	NUM
aiua-10886	299	2	;	;	PUNCT
aiua-10886	299	3	113:59	113:59	NUM
aiua-10886	299	4	-	-	SYM
aiua-10886	299	5	70	70	NUM
aiua-10886	299	6	.	.	PUNCT
aiua-10886	300	1	47	47	NUM
aiua-10886	300	2	.	.	PUNCT
aiua-10886	301	1	fragkoulis	fragkoulis	PROPN
aiua-10886	301	2	c	c	NOUN
aiua-10886	301	3	,	,	PUNCT
aiua-10886	301	4	glykas	glykas	X
aiua-10886	301	5	i	i	PRON
aiua-10886	301	6	,	,	PUNCT
aiua-10886	301	7	dellis	delli	VERB
aiua-10886	301	8	a	a	PRON
aiua-10886	301	9	,	,	PUNCT
aiua-10886	301	10	et	et	PROPN
aiua-10886	301	11	al	al	PROPN
aiua-10886	301	12	.	.	PROPN
aiua-10886	301	13	clinical	clinical	ADJ
aiua-10886	301	14	impact	impact	NOUN
aiua-10886	301	15	of	of	ADP
aiua-10886	301	16	combined	combine	VERB
aiua-10886	301	17	pten	pten	NOUN
aiua-10886	301	18	and	and	CCONJ
aiua-10886	301	19	erg	erg	PROPN
aiua-10886	301	20	rearrangements	rearrangement	NOUN
aiua-10886	301	21	in	in	ADP
aiua-10886	301	22	localized	localized	ADJ
aiua-10886	301	23	prostate	prostate	NOUN
aiua-10886	301	24	cancer	cancer	NOUN
aiua-10886	301	25	.	.	PUNCT
aiua-10886	302	1	arch	arch	PROPN
aiua-10886	302	2	ital	ital	PROPN
aiua-10886	302	3	urol	urol	PROPN
aiua-10886	302	4	androl	androl	PROPN
aiua-10886	302	5	.	.	PROPN
aiua-10886	302	6	2021	2021	NUM
aiua-10886	302	7	;	;	PUNCT
aiua-10886	302	8	93:84	93:84	NUM
aiua-10886	302	9	-	-	SYM
aiua-10886	302	10	85	85	NUM
aiua-10886	302	11	.	.	PUNCT
aiua-10886	303	1	correspondence	correspondence	NOUN
aiua-10886	303	2	charalampos	charalampos	PROPN
aiua-10886	303	3	fragkoulis	fragkoulis	PROPN
aiua-10886	303	4	,	,	PUNCT
aiua-10886	303	5	md	md	PROPN
aiua-10886	303	6	harisfrag@yahoo.gr	harisfrag@yahoo.gr	PROPN
aiua-10886	303	7	ioannis	ioannis	PROPN
aiua-10886	303	8	glykas	glykas	PROPN
aiua-10886	303	9	,	,	PUNCT
aiua-10886	303	10	md	md	PROPN
aiua-10886	303	11	giannis.glykas@gmail.com	giannis.glykas@gmail.com	PROPN
aiua-10886	303	12	panagiotis	panagiotis	PROPN
aiua-10886	303	13	velissarios	velissarios	PROPN
aiua-10886	303	14	stamatakos	stamatakos	PROPN
aiua-10886	303	15	,	,	PUNCT
aiua-10886	303	16	md	md	PROPN
aiua-10886	303	17	(	(	PUNCT
aiua-10886	303	18	corresponding	correspond	VERB
aiua-10886	303	19	author	author	NOUN
aiua-10886	303	20	)	)	PUNCT
aiua-10886	303	21	pvstamatakos@gmail.com	pvstamatakos@gmail.com	PROPN
aiua-10886	304	1	georgios	georgios	PROPN
aiua-10886	304	2	papadopoulos	papadopoulos	PROPN
aiua-10886	304	3	,	,	PUNCT
aiua-10886	304	4	md	md	PROPN
aiua-10886	304	5	gipapadopoulos@yahoo.gr	gipapadopoulos@yahoo.gr	PROPN
aiua-10886	304	6	georgios	georgios	PROPN
aiua-10886	304	7	stathouros	stathouros	PROPN
aiua-10886	304	8	,	,	PUNCT
aiua-10886	304	9	md	md	PROPN
aiua-10886	304	10	gstathouros@yahoo.gr	gstathouros@yahoo.gr	PROPN
aiua-10886	304	11	konstantinos	konstantinos	PROPN
aiua-10886	304	12	ntoumas	ntoumas	PROPN
aiua-10886	304	13	,	,	PUNCT
aiua-10886	304	14	md	md	PROPN
aiua-10886	304	15	ntoumask@yahoo.com	ntoumask@yahoo.com	PROPN
aiua-10886	304	16	department	department	PROPN
aiua-10886	304	17	of	of	ADP
aiua-10886	304	18	urology	urology	NOUN
aiua-10886	304	19	,	,	PUNCT
aiua-10886	304	20	general	general	ADJ
aiua-10886	304	21	hospital	hospital	NOUN
aiua-10886	304	22	of	of	ADP
aiua-10886	304	23	athens	athens	PROPN
aiua-10886	304	24	“	"	PUNCT
aiua-10886	304	25	g.	g.	PROPN
aiua-10886	304	26	gennimatas	gennimatas	PROPN
aiua-10886	304	27	”	"	PUNCT
aiua-10886	304	28	,	,	PUNCT
aiua-10886	304	29	athens	athens	PROPN
aiua-10886	304	30	(	(	PUNCT
aiua-10886	304	31	greece	greece	PROPN
aiua-10886	304	32	)	)	PUNCT
aiua-10886	304	33	lazaros	lazaro	VERB
aiua-10886	304	34	tzelves	tzelve	NOUN
aiua-10886	304	35	,	,	PUNCT
aiua-10886	304	36	md	md	PROPN
aiua-10886	304	37	lazarostzelves@gmail.com	lazarostzelves@gmail.com	X
aiua-10886	305	1	charalampos	charalampos	PROPN
aiua-10886	305	2	deliveliotis	deliveliotis	PROPN
aiua-10886	305	3	,	,	PUNCT
aiua-10886	305	4	md	md	PROPN
aiua-10886	305	5	chdeliveli@gmail.com	chdeliveli@gmail.com	PROPN
aiua-10886	305	6	athanasios	athanasios	PROPN
aiua-10886	305	7	papatsoris	papatsoris	PROPN
aiua-10886	305	8	,	,	PUNCT
aiua-10886	305	9	md	md	PROPN
aiua-10886	305	10	agpapatsoris@yahoo.gr	agpapatsoris@yahoo.gr	PROPN
aiua-10886	305	11	2nd	2nd	PROPN
aiua-10886	305	12	department	department	PROPN
aiua-10886	305	13	of	of	ADP
aiua-10886	305	14	urology	urology	NOUN
aiua-10886	305	15	,	,	PUNCT
aiua-10886	305	16	school	school	NOUN
aiua-10886	305	17	of	of	ADP
aiua-10886	305	18	medicine	medicine	NOUN
aiua-10886	305	19	,	,	PUNCT
aiua-10886	305	20	sismanoglio	sismanoglio	NOUN
aiua-10886	305	21	hospital	hospital	PROPN
aiua-10886	305	22	,	,	PUNCT
aiua-10886	305	23	national	national	ADJ
aiua-10886	305	24	and	and	CCONJ
aiua-10886	305	25	kapodistrian	kapodistrian	ADJ
aiua-10886	305	26	university	university	PROPN
aiua-10886	305	27	of	of	ADP
aiua-10886	305	28	athens	athens	PROPN
aiua-10886	305	29	,	,	PUNCT
aiua-10886	305	30	athens	athens	PROPN
aiua-10886	305	31	(	(	PUNCT
aiua-10886	305	32	greece	greece	PROPN
aiua-10886	305	33	)	)	PUNCT
aiua-10886	305	34	athanasios	athanasio	NOUN
aiua-10886	305	35	dellis	delli	VERB
aiua-10886	305	36	,	,	PUNCT
aiua-10886	305	37	md	md	PROPN
aiua-10886	305	38	aedellis@gmail.com	aedellis@gmail.com	PROPN
aiua-10886	305	39	1st	1st	PROPN
aiua-10886	305	40	department	department	PROPN
aiua-10886	305	41	of	of	ADP
aiua-10886	305	42	urology	urology	NOUN
aiua-10886	305	43	,	,	PUNCT
aiua-10886	305	44	school	school	NOUN
aiua-10886	305	45	of	of	ADP
aiua-10886	305	46	medicine	medicine	NOUN
aiua-10886	305	47	,	,	PUNCT
aiua-10886	305	48	laiko	laiko	ADJ
aiua-10886	305	49	hospital	hospital	NOUN
aiua-10886	305	50	,	,	PUNCT
aiua-10886	305	51	national	national	ADJ
aiua-10886	305	52	and	and	CCONJ
aiua-10886	305	53	kapodistrian	kapodistrian	ADJ
aiua-10886	305	54	university	university	PROPN
aiua-10886	305	55	of	of	ADP
aiua-10886	305	56	athens	athens	PROPN
aiua-10886	305	57	,	,	PUNCT
aiua-10886	305	58	athens	athens	PROPN
aiua-10886	305	59	(	(	PUNCT
aiua-10886	305	60	greece	greece	PROPN
aiua-10886	305	61	)	)	PUNCT
aiua-10886	305	62	akrivi	akrivi	PROPN
aiua-10886	305	63	kostopoulou	kostopoulou	PROPN
aiua-10886	305	64	,	,	PUNCT
aiua-10886	305	65	md	md	PROPN
aiua-10886	305	66	akrivikostopoulou@hotmail.com	akrivikostopoulou@hotmail.com	PROPN
aiua-10886	305	67	department	department	PROPN
aiua-10886	305	68	of	of	ADP
aiua-10886	305	69	pathology	pathology	PROPN
aiua-10886	305	70	,	,	PUNCT
aiua-10886	305	71	general	general	ADJ
aiua-10886	305	72	hospital	hospital	NOUN
aiua-10886	305	73	of	of	ADP
aiua-10886	305	74	athens	athens	PROPN
aiua-10886	305	75	“	"	PUNCT
aiua-10886	305	76	g.	g.	PROPN
aiua-10886	305	77	gennimatas	gennimatas	PROPN
aiua-10886	305	78	”	"	PUNCT
aiua-10886	305	79	,	,	PUNCT
aiua-10886	305	80	athens	athens	PROPN
aiua-10886	305	81	(	(	PUNCT
aiua-10886	305	82	greece	greece	PROPN
aiua-10886	305	83	)	)	PUNCT